<SEC-DOCUMENT>0001193125-14-020502.txt : 20140124
<SEC-HEADER>0001193125-14-020502.hdr.sgml : 20140124
<ACCEPTANCE-DATETIME>20140124170424
ACCESSION NUMBER:		0001193125-14-020502
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		8
FILED AS OF DATE:		20140124
DATE AS OF CHANGE:		20140124

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TherapeuticsMD, Inc.
		CENTRAL INDEX KEY:			0000025743
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870233535
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-193558
		FILM NUMBER:		14546644

	BUSINESS ADDRESS:	
		STREET 1:		6800 BROKEN SOUND PARKWAY NW
		STREET 2:		THIRD FLOOR
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487
		BUSINESS PHONE:		561-961-1911

	MAIL ADDRESS:	
		STREET 1:		6800 BROKEN SOUND PARKWAY NW
		STREET 2:		THIRD FLOOR
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMHN, Inc.
		DATE OF NAME CHANGE:	20090930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF ENTERPRISES INC
		DATE OF NAME CHANGE:	19970915

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF OIL CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>d664229ds3.htm
<DESCRIPTION>FORM S-3
<TEXT>
<HTML><HEAD>
<TITLE>Form S-3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on January&nbsp;24, 2014 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>FORM S-3
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>TherapeuticsMD, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Nevada</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>87-0233535</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ALIGN="center"><B>(State or other jurisdiction of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(I.R.S. Employer</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ALIGN="center"><B>incorporation or organization)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Identification Number)</B></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>6800 Broken Sound Parkway NW, Third Floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Boca Raton, Florida 33487 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(561) 961-1900 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(Address,
including zip code, and telephone number, including area code, of registrant&#146;s principal executive offices) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Robert G.
Finizio </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>TherapeuticsMD, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>6800
Broken Sound Parkway NW, Third Floor </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Boca Raton, Florida 33487 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(561) 961-1900 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(Name,
address, including zip code, and telephone number, including area code, of agent for service) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to:
</I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Daniel A. Cartwright<BR>Chief Financial Officer<BR>TherapeuticsMD, Inc.<BR>6800 Broken Sound Parkway
NW</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Third Floor<BR>Boca Raton, FL 33487<BR>(561) 961-1900</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Robert S. Kant, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Masha Shmukler, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Greenberg Traurig, LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>2375
East Camelback Road</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Suite 700</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Phoenix, Arizona 85016</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(602) 445-8000</B></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public:</B> From time to time after the effective date of this registration
statement. </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans,
please check the following box.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on
this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If this form is filed to register additional securities for an offering pursuant to Rule 462(b)
under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>
</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If this form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective
upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If this form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act. (Check one): </P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Title of securities to be registered</B></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Amount</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>to be<BR>registered(1)</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>offering
price<BR>per share</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Proposed<BR>maximum</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>aggregate</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>offering
price</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount of<BR>registration fee(2)</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Common Stock, par value $0.001 per share</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">12,000,000 shares</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$5.55</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$66,600,000</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$8,578.08</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), we are also registering an indeterminate number of shares that may be issuable with respect to
the shares being registered hereunder as a result of stock splits, stock dividends, or similar transactions. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The proposed maximum offering price per share was computed in accordance with Rule 457(c) promulgated under the Securities Act, based upon the average of the high and low sales prices of our common stock on January 21,
2014 as reported on the NYSE MKT. </TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>The registrant hereby amends
this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in
accordance with Section&nbsp;8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section&nbsp;8(a), may determine.</B> </P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#de1a1e"><B>The information in this prospectus is not complete and may be changed. The selling
stockholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting offers to buy these
securities in any state where the offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#de1a1e"><B>SUBJECT TO COMPLETION, DATED JANUARY 24, 2014 </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g664229g72q23.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>12,000,000 Shares </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling
stockholders may offer and sell, from time to time, in one or more offerings, up to 12,000,000 shares of our common stock, par value $0.001 per share. These securities may be sold at fixed prices, prevailing market prices at the times of sale,
prices related to the prevailing market prices, varying prices determined at the times of sale, or negotiated prices. The securities offered by this prospectus and any prospectus supplement may be offered by the selling stockholders to or through
underwriters, dealers, or other agents, directly to investors, or through any other manner permitted by law, on a continued or delayed basis. See &#147;Plan of Distribution&#148; beginning on page 5 of this prospectus. The plan of distribution for
any particular offering of these securities may also be described in any applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are not selling any common
stock under this prospectus and will not receive any of the proceeds from the sale of the securities sold by the selling stockholders. The registration of the securities covered by this prospectus does not necessarily mean that any of these
securities will be offered or sold by the selling stockholders. The timing and amount of any sale is within the respective selling stockholders&#146; sole discretion, subject to certain restrictions. To the extent that any selling stockholder
resells any securities, the selling stockholder may be required to provide you with this prospectus and a prospectus supplement identifying and containing specific information about the selling stockholder and the terms of the securities being
offered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the NYSE MKT under the symbol &#147;TXMD.&#148; On January 23, 2014, the closing price of our
common stock as quoted on the NYSE MKT was $5.89 per share. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>See
&#147;Risk Factors&#148; in the section entitled &#147;<A HREF="#toc664229_2">Risk Factors</A>&#148; on page 3 of this prospectus and risk factors in any applicable prospectus supplements for a discussion of certain risk factors that should be
considered by prospective purchasers of the securities offered under this prospectus. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:60pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014
</B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="97%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc664229_1">PROSPECTUS SUMMARY</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc664229_2">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc664229_3">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc664229_4">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc664229_5">SELLING STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc664229_6">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc664229_7">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc664229_8">EXPERTS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc664229_9">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc664229_10">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a
&#147;shelf&#148; registration process. Under this shelf registration process, the selling stockholders may, from time to time, offer and sell the securities offered under this prospectus, as described herein, in one or more offerings. Each time the
selling stockholders sell securities, we will provide a prospectus supplement that contains specific information about any offering by the selling stockholders, including the names of any selling stockholders. <B>This prospectus may not be used to
offer or sell securities unless it is accompanied by a prospectus supplement.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent we file any prospectus supplements, such
prospectus supplements may add, update, or change information contained in this prospectus to the extent permitted by the Securities Act of 1933, as amended, or the Securities Act. You should read both this prospectus and any prospectus supplement
together with additional information described under the heading &#147;Where You Can Find More Information.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>We and the selling
stockholders have not authorized anyone to provide any information or make any representations other than those contained in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you. We take
no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
selling stockholders are offering to sell, and seeking offers to buy, the securities only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus and the
information in the incorporated documents is only accurate as of their respective dates, regardless of the time of delivery of this prospectus or of any sale of the common stock. Neither the delivery of this prospectus, nor any sale made hereunder,
will under any circumstances create any implication that there has been no change in our affairs since the date hereof or that the information contained herein or incorporated by reference herein is correct as of any time subsequent to the date of
such information. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc664229_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following summary does not contain all of the information that may be important to purchasers of our securities. Prospective purchasers
of securities should carefully review the detailed information and financial statements, including the notes thereto, appearing elsewhere in or incorporated by reference into this prospectus. Unless otherwise indicated, the terms
&#147;TherapeuticsMD,&#148; &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; and &#147;our company&#148; refer to TherapeuticsMD, Inc. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our
Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a women&#146;s healthcare product company focused on creating and commercializing products targeted exclusively for
women. We currently manufacture and distribute branded and generic prescription prenatal vitamins as well as over-the-counter vitamins and cosmetics. We are currently focused on conducting the clinical trials necessary for regulatory approval and
commercialization of advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness.
We are developing these proposed hormone therapy products, which contain estradiol and progesterone alone or in combination, with the aim of providing equivalent efficacy at lower doses, thereby enabling an enhanced side effect profile compared with
competing products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The hormone therapy market includes two major components: an FDA-approved drug market and a non-FDA approved drug
market supplied by compounding pharmacies. We believe the FDA-approved products are easily measured and monitored, while non-FDA approved hormone therapy drug products, typically referred to as bioidenticals when produced by compounding pharmacies,
are sold by compounding pharmacies and not monitored or easily measured. We estimate the non-FDA approved compounded bioidentical hormone therapy combination sales of estradiol and progesterone products sold by compounding pharmacies are
approximately $1.5 billion per year. Our phase 3 trials are intended to establish an indication of the safety and efficacy of our proposed bioidentical products at specific dosage levels. We intend our proposed hormone therapy products, if approved,
to provide an alternative to the non-FDA approved compounded bioidentical market based on our belief that our proposed products will offer advantages in terms of proven safety, efficacy, and stability, lower patient cost as a result of insurance
coverage, and improved access as a result of availability from major retail pharmacy chains rather than custom order or formulation by individual compounders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As we continue the clinical development of our proposed hormone therapy products, we continue to market our prescription and over-the-counter
dietary supplement and cosmetic product lines, consisting of prenatal vitamins, iron supplements, vitamin D supplements, natural menopause relief products, and cosmetic stretch mark creams under our VitaMed brand name and duplicate formulations of
our prescription prenatal vitamins products, also referred to as &#147;generic&#148; formulations, under our BocaGreenMD brand name. All of our prenatal vitamins are gluten-, sugar-, and lactose-free. We believe our product attributes result in
greater consumer acceptance and satisfaction than competitive products while offering the highest quality and patented ingredients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
sales model focuses on the &#147;4Ps&#148;: patient, provider, pharmacist, and payor. We market and sell our current dietary supplement and cosmetic products primarily through a direct national sales force of approximately 30 full-time professionals
that calls on healthcare providers in the obstetrics and gynecologic market space as well as through our website directly to consumers. In addition, our products allow healthcare providers to offer an alternative to patients to meet their individual
nutritional and financial requirements related to co-payment and cost-of-care considerations and help patients realize cost savings over competing products. We also believe that our combination of branded, generic, and over-the-counter lines offers
physicians, women, and payors cost-effective alternatives for top-quality care. We supply our prescription dietary supplement products to consumers through retail pharmacies. We market our over-the-counter products either directly to
</P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consumers via our website and phone sales followed by home shipment or through physicians who then re-sell them to their patients. Our fully staffed customer care center uses current customer
relationship management software to respond to healthcare providers, pharmacies, and consumers via incoming and outgoing telephone calls, e-mails, and live-chat. We also facilitate repeat customer orders for our non-prescription products through our
website&#146;s auto-ship feature. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Growth Strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our goal is to become the women&#146;s healthcare company recommended by healthcare providers to all patients by becoming the new standard in
women&#146;s health with a complete line of products all under one quality brand. Key elements of our strategy to achieve this goal are as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">focusing exclusively on women&#146;s health issues to enable us to build long-term relationships with women as they move through their life cycles of birth control, pregnancy, child birth, and pre- and post- menopause;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">focusing on our development, clinical trials, and commercialization of hormone therapy products designed to (1)&nbsp;alleviate the symptoms of and reduce the health effects resulting from menopause-related hormone
deficiencies, including hot flashes, osteoporosis, and vaginal dryness, and (2)&nbsp;provide equivalent efficiency at lower doses, enabling an enhanced side effect profile compared with competing products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">providing an alternative to the non-FDA approved compound bioidentical market for estradiol and progesterone products sold by compounding pharmacies; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">maintaining a marketing emphasis on large group OB/GYN practices that provide opportunities to reach large patient bases and that are receptive to the data and savings we provide; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">expanding our geographic market and sales team to cover the entire country by increasing our current inside sales force. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Offices </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a Nevada corporation.
We began our current business in May 2008. We maintain our principal executive offices at 6800 Broken Sound Parkway NW, Third Floor, Boca Raton, Florida 33487. Our telephone number is (561)&nbsp;961-1900. We maintain websites at
<I>www.therapeuticsmd.com</I>,<I> www.vitamedmd.com</I>, <I>www.vitamedmdrx.com</I>, and <I>bocagreenmd.com</I>. The information contained on our websites or that can be accessed through our websites does not constitute part of this prospectus. </P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc664229_2"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our securities involves a high degree of risk. Please see the risk factors described under the caption &#147;Risk Factors&#148;
in our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2012, which is incorporated by reference in this prospectus, as well as the risk factors and other information contained in or incorporated by reference in the applicable
prospectus supplement and any related free writing prospectus. Before making an investment decision, you should carefully consider these risks as well as other information we include or incorporate by reference in this prospectus or in the
applicable prospectus supplement or any related free writing prospectus. The risks and uncertainties we have described are not the only ones facing our company. Additional risks and uncertainties not presently known to us or that we currently deem
immaterial may also affect our business operations. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc664229_3"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus and the documents incorporated by reference herein contain forward-looking statements that involve risks and
uncertainties. These forward-looking statements are not historical facts but rather are based on current expectations, estimates, and projections about our industry, our beliefs, our assumptions, and changes in circumstances that may cause our
actual results, performance, or achievements to differ significantly from those expressed or implied in any forward-looking statement. You should not place undue reliance on these <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements,
which reflect our view only as of the date of this prospectus, and we undertake no obligation to update these forward-looking statements in the future. In many cases, you can identify forward-looking statements by terms such as &#147;may,&#148;
&#147;should,&#148; &#147;expects,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;could,&#148; &#147;intends,&#148; &#147;target,&#148; &#147;projects,&#148; &#147;contemplates,&#148; &#147;believes,&#148; &#147;estimates,&#148;
&#147;predicts,&#148; &#147;potential,&#148; or &#147;continue&#148; or the negative of these terms or other similar expressions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
forward-looking statements contained in this prospectus reflect our views as of the date of this prospectus about future events and are subject to risks, uncertainties, assumptions, and changes in circumstances that may cause our actual results,
performance, or achievements to differ significantly from those expressed or implied in any forward-looking statement. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future
events, results, performance, or achievements. A number of important factors could cause actual results to differ materially from those indicated by the forward-looking statements, including, without limitation, those factors described under the
caption &#147;Risk Factors&#148; in our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2012, which is incorporated by reference in this prospectus. Some of the key factors that could cause actual results to differ from our
expectations include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our operating losses incurred since inception and anticipated for the foreseeable future; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to continue as a going concern; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to maintain or increase sales of our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability of our products to produce the intended effects; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to develop and commercialize our proposed advanced hormone therapies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our estimates regarding our capital requirements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our lack of experience in bringing a drug to regulatory approval; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the uncertainty of results from our clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delays, suspensions, or discontinuation of our clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our reliance on third-parties to conduct our clinical trials and research and development; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the effects of laws, regulations, and enforcement; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our dependence on third-party manufacturers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our expectations with respect to the potential commercial value of our proposed products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the competitive nature of the industries in which we conduct our business; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the availability of reimbursement from government authorities and health insurance companies for our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the impact of product liability lawsuits; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">unfavorable publicity or lack of customer acceptance; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to use hazardous or biological materials in compliance with applicable law; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to gain and retain market acceptance for our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our reliance on our executive officers and key personnel; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to expand our direct sales force; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our dependence on certain customers and distribution channels; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to maintain optimal inventory levels; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our response to changing consumer preferences and demand; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">product recalls, withdrawals, or safety alerts; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our inability to manage our growth; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the conduct of our employees; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to protect our intellectual property and not infringe on the intellectual property of others; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to establish and maintain proper internal controls and comply with the financial reporting obligations of the SEC and Sarbanes-Oxley Act of 2002. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue
reliance on these forward-looking statements. All of the forward-looking statements we have included in this prospectus are based on information available to us on the date of this prospectus. We undertake no obligation to publicly update or revise
any forward-looking statement, whether as a result of new information, future events, or otherwise, except as otherwise required by law. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc664229_4"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive any of the proceeds from the offer and sale of the securities by the selling stockholders. The selling stockholders will
receive all of the proceeds from this offering, if any. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc664229_5"></A>SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus relates to the possible resale by certain of our stockholders of up to 12,000,000 shares of our common stock that were issued
on October&nbsp;4, 2011 in connection with a reverse merger, or the Merger, pursuant to an Agreement and Plan of Merger, dated as of July&nbsp;18, 2011, among our company, VitaMed Acquisition, LLC, a Delaware limited liability company and wholly
owned subsidiary of our company, and VitaMedMD, LLC, a Delaware limited liability company. The Merger is described in greater detail in our Current Report on Form 8-K filed with the SEC on October&nbsp;11, 2011. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The identity of any selling stockholder, including any material relationship between us, our
affiliates or predecessors, and a selling stockholder within the last three years, the number of shares of our common stock held by a selling stockholder before and after the offering, the number of shares of common stock to be offered by a selling
stockholder, and the percentage of our shares of common stock held by a selling stockholder before and after the offering will be set forth in a prospectus supplement to this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling stockholders may not sell any shares of our common stock pursuant to this prospectus until we have identified the selling stockholders
and the shares being offered for resale by the selling stockholder in a subsequent prospectus supplement. However, selling stockholders may sell or transfer all or a portion of their shares of our common stock pursuant to any available exemption
from the registration requirements of the Securities Act. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc664229_6"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The securities being offered by this prospectus may be sold by a selling stockholder in one or more of the following ways: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to or through underwriters or dealers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">directly to one or more purchasers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">through agents; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">through a combination of any of those methods of sale; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">through any other methods described in a prospectus supplement. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement
with respect to the offered securities will describe the terms of the offering, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the name or names of any underwriters or agents; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any public offering price; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the proceeds from such sales; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any underwriting discounts or agency fees and other items constituting underwriters&#146; or agents&#146; compensation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any over-allotment options under which underwriters may purchase additional securities from the selling stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any discounts or concessions allowed or reallowed or paid to dealers; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any securities exchanges on which such securities may be listed. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders may
sell the securities from time to time in one or more of the following ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at a fixed public offering price or prices, which may be changed; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at prices relating to prevailing market prices at the time of sale; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at varying prices determined at the time of sale; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at negotiated prices. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the applicable prospectus supplement, if
underwriters are used for a sale of securities, the underwriters will acquire the securities for their own account. The underwriters may resell the securities in one or more transactions, including negotiated transactions, at a fixed public offering
price, or at </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
varying prices determined at the time of sale. The obligations of the underwriters to purchase the securities will be subject to the conditions set forth in the applicable underwriting agreement.
Unless otherwise indicated in a prospectus supplement, the underwriters will be obligated to purchase all the securities of the series offered if they purchase any of the securities of that series. Underwriters with whom the selling stockholders
have a material relationship may be used, and if so, the applicable prospectus supplement will name the underwriter and the nature of any such relationship. The selling stockholders may designate agents who agree to use their reasonable efforts to
solicit purchases for the period of their appointment or to sell securities on a continuing basis. The selling stockholders may also sell securities directly to one or more purchasers without using underwriters or agents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers, or agents may receive compensation in the form of discounts, concessions, or commissions from the selling stockholders
or from purchasers of the securities as their agents in connection with the sale of the securities. These underwriters, dealers, or agents may be considered to be underwriters under the Securities Act. As a result, discounts, commissions, or profits
on resale received by underwriters, dealers, or agents may be treated as underwriting discounts and commissions. Each prospectus supplement will identify any underwriter, dealer, or agent and describe any compensation received by them from the
selling stockholders. Any public offering price and any discounts or concessions allowed or reallowed or paid to dealers may be changed from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with any offering, the underwriters may engage in stabilizing transactions, over-allotment transactions, syndicate covering
transactions, and penalty bids in accordance with Regulation M under the Securities Exchange Act of 1934, as amended, or the Exchange Act. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Over-allotment transactions involve sales by the underwriters of shares of our common stock in excess of the number of shares the underwriters are obligated to purchase, which creates a syndicate short position. The
short position may be either a covered short position or a naked short position. In a covered short position, the number of shares of our common stock over-allotted by the underwriters is not greater than the number of shares that they may purchase
in the over-allotment option. In a naked short position, the number of shares of our common stock involved is greater than the number of shares in the over-allotment option. The underwriters may close out any covered short position by either
exercising their over-allotment option or purchasing shares of our common stock in the open market. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Syndicate covering transactions involve purchases of our common stock in the open market after the distribution has been completed to cover syndicate short positions. In determining the source of shares to close out the
short position, the underwriters will consider, among other things, the price of shares of our common stock available for purchase in the open market as compared to the price at which they may purchase shares through the over-allotment option so
that if there is a naked short position, the position can only be closed out by buying shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there could be downward pressure on the
price of the shares of our common stock in the open market after the pricing of any offering that could adversely affect investors who purchase in that offering. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Penalty bids permit the representatives of the underwriters to reclaim a selling concession from a syndicate member when the common stock originally sold by the syndicate member is purchased in a stabilizing or
syndicate covering transaction to cover syndicate short positions. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These stabilizing transactions, over-allotment
transactions, syndicate covering transactions, and penalty bids may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of our common stock. As a result, the price
of our common stock may be higher than the price that might otherwise exist in the open market. These transactions may be effected on the NYSE MKT or otherwise and, if commenced, may be discontinued at any time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers, and agents may be entitled under agreements entered into with us or a
selling stockholders to indemnification by us or the selling stockholders against certain civil liabilities, including liabilities under the Securities Act, or to contribution by us or the selling stockholders with respect to payments they may be
required to make in respect of these liabilities thereof. If required, the prospectus supplement will describe the terms and conditions of such indemnification or contribution. Underwriters, dealers, and agents and their affiliates may be customers
of, engage in transactions with, or perform services for us, our subsidiaries, or one or more of the selling stockholders in the ordinary course of business for which they receive compensation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc664229_7"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the securities offered hereby has been passed upon for us by Greenberg Traurig, LLP, Phoenix, Arizona. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc664229_8"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements as of and for the years ended December&nbsp;31, 2012 and December&nbsp;31, 2011 and management&#146;s
assessment of the effectiveness of internal control over financial reporting as of December&nbsp;31, 2012 incorporated by reference in this prospectus and in the registration statement have been so included in reliance on the reports of Rosenberg
Rich Baker Berman&nbsp;&amp; Company, an independent registered public accounting firm, incorporated herein by reference, given on the authority of said firm as experts in accounting and auditing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements as of and for the year ended December&nbsp;31, 2010 incorporated by reference in this prospectus and in
the registration statement have been so included in reliance on the report of Parks&nbsp;&amp; Company, LLC, an independent registered public accounting firm, incorporated herein by reference herein, given on the authority of such firm as experts in
accounting and auditing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc664229_9"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to incorporate by reference the information we file with the SEC, which means that we can disclose important information to
you by referring you to those documents. The information that we incorporate by reference is considered to be part of this prospectus. Information that we file with the SEC in the future and incorporate by reference in this prospectus automatically
updates and supersedes previously filed information as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incorporate by reference into this prospectus the following
documents filed by us with the SEC, other than any portion of any such documents that are not deemed &#147;filed&#148; under the Exchange Act in accordance with the Exchange Act and applicable SEC rules: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2012. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Quarterly Reports on Form 10-Q for the quarters ended March&nbsp;31, 2013,&nbsp;June&nbsp;30, 2013, and September&nbsp;30, 2013. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Current Reports on Form 8-K filed with the SEC on January&nbsp;25, 2013,&nbsp;February&nbsp;6, 2013,&nbsp;March&nbsp;15, 2013,&nbsp;April&nbsp;23, 2013,&nbsp;May&nbsp;16, 2013,&nbsp;August&nbsp;22,
2013,&nbsp;September&nbsp;24, 2013,&nbsp;September&nbsp;25, 2013 (two reports filed), and December&nbsp;18, 2013. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE="font-family:Times New Roman; font-size:10pt">The description of our common stock included under the heading &#147;Description of Common Stock&#148; in the prospectus forming a part of the
Registration Statement on Form S-3 (File No.&nbsp;333-186189), as </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-family:Times New Roman; font-size:10pt">
filed on January&nbsp;25, 2013, including exhibits, which description has been incorporated by reference in Item&nbsp;1 of the Registration Statement on Form 8-A (File No.&nbsp;001-00100), as
filed on April&nbsp;22, 2013, including any amendment or report filed for the purpose of updating such description. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
also incorporate by reference into this prospectus all documents (other than any portions of any such documents that are not deemed &#147;filed&#148; under the Exchange Act in accordance with the Exchange Act and applicable SEC rules) filed by us
under Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act after the date of this prospectus and prior to the termination of the offering covered by this prospectus or any prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may request a copy of these documents, which will be provided to you at no cost, by contacting us as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TherapeuticsMD, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention:
Corporate Secretary </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6800 Broken Sound Parkway NW, Third Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Boca Raton, Florida 33487 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(561)
961-1900 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any statement contained in a document that is incorporated by reference will be modified or superseded for all purposes to the
extent that a statement contained in this prospectus or in any other document that is subsequently filed with the SEC and incorporated by reference, modifies, or is contrary to that previous statement. Any statement so modified or superseded will
not be deemed a part of this prospectus, except as so modified or superseded. Since information that we later file with the SEC will update and supersede previously incorporated information, you should look at all of the SEC filings that we
incorporate by reference to determine if any of the statements in this prospectus or any accompanying prospectus supplement or in any documents previously incorporated by reference have been modified or superseded. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc664229_10"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly, and current reports, proxy statements, and other information with the SEC. You may read and copy any document we
file with the SEC at the SEC&#146;s public reference room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. Our SEC filings are also available to the public
from the SEC&#146;s website at <I>www.sec.gov.</I> The SEC&#146;s website contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement on Form S-3 that we filed with the SEC to register the securities offered hereby under the
Securities Act. This prospectus does not contain all of the information included in the registration statement, including certain exhibits and schedules. For further information with respect to our company and the securities offered by this
prospectus, as well as the exhibits and schedules to the registration statement, we refer you to the registration statement, those exhibits and schedules, and to the information incorporated by reference in this prospectus. You may obtain the
registration statement and exhibits to the registration statement from the SEC at the address listed above or from the SEC&#146;s website. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>12,000,000 Shares </B></P>
<P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g664229g72q23.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:180pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014 </B></P>
<P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;14.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Expenses of Issuance and Distribution. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the fees
and expenses payable by us in connection with the offering described in the registration statement. All of the amounts shown are estimates, except for the SEC registration fee: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount<BR>to&nbsp;be&nbsp;Paid</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC Registration Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,578.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and Engraving Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal Fees and Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting Fees and Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer Agent Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">103,578.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;15.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Indemnification of Directors and Officers. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a Nevada corporation and are
generally governed by the Nevada Private Corporations Code, Title&nbsp;78 of the Nevada Revised Statutes, or the NRS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;78.138
of the NRS provides that, unless the corporation&#146;s articles of incorporation provide otherwise, a director or officer will not be individually liable unless it is proven that (i)&nbsp;the director&#146;s or officer&#146;s acts or omissions
constituted a breach of his or her fiduciary duties, and (ii)&nbsp;such breach involved intentional misconduct, fraud, or a knowing violation of the law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;78.7502 of the NRS permits a corporation to indemnify its directors and officers against expenses, judgments, fines, and amounts
paid in settlement actually and reasonably incurred in connection with a threatened, pending, or completed action, suit, or proceeding, if the officer or director (i)&nbsp;is not liable pursuant to the Section&nbsp;78.138 of the NRS, or
(ii)&nbsp;acted in good faith and in a manner the officer or director reasonably believed to be in or not opposed to the best interests of the corporation and, if a criminal action or proceeding, had no reasonable cause to believe the conduct of the
officer or director was unlawful. Section&nbsp;78.7502 of the NRS also precludes indemnification by the corporation if the officer or director has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals, to be liable to
the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court determines that in view of all the circumstances, the person is fairly and reasonably entitled to indemnity for such expenses and
requires a corporation to indemnify its officers and directors if they have been successful on the merits or otherwise in defense of any claim, issue, or matter resulting from their service as a director or officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;78.751 of the NRS permits a corporation to indemnify its officers and directors against expenses incurred by them in defending a
civil or criminal action, suit, or proceeding as they are incurred and in advance of final disposition thereof, upon determination by the stockholders, the disinterested board members, or by independent legal counsel. Section&nbsp;78.751 of NRS
requires a corporation to advance expenses as incurred upon receipt of an undertaking by or on behalf of the officer or director to repay the amount if it is ultimately determined by a court of competent jurisdiction that such officer or director is
not entitled to be indemnified by the corporation if so provided in the corporation&#146;s articles of incorporation, bylaws, or other agreement. Section&nbsp;78.751 of the NRS further permits the corporation to grant its directors and officers
additional rights of indemnification under its articles of incorporation, bylaws, or other agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;78.752 of the NRS
provides that a corporation may purchase and maintain insurance or make other financial arrangements on behalf of any person who is or was a director, officer, employee, or agent of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
corporation, or is or was serving at the request of the corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise, for
any liability asserted against him or her and liability and expenses incurred by him or her in a capacity as a director, officer, employee, or agent, or arising out of his or her status as such, whether or not the corporation has the authority to
indemnify him or her against such liability and expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing discussion of indemnification merely summarizes certain aspects
of indemnification provisions and is limited by reference to the above discussed sections of the Nevada Private Corporations Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
amended and restated articles of incorporation and bylaws provide that we may indemnify to the full extent of our power to do so, all directors, officers, employees, and/or agents. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;16.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Underwriting Agreement*</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Securities Purchase Agreement (1)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Certificate of Common Stock (2)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Opinion of Greenberg Traurig, LLP</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Greenberg Traurig, LLP (included in Exhibit 5.1)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Rosenberg Rich Baker Berman &amp; Company, independent registered public accounting firm</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Parks &amp; Company, LLC, independent registered public accounting firm</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Power of Attorney (included on the Signatures page of the registration statement)</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">To be filed by amendment to this registration statement or by a report filed under the Exchange Act and incorporated herein by reference. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Filed as an exhibit to Form 8-K filed with the Commission on October&nbsp;2, 2012 and incorporated herein by reference. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Filed as an exhibit to Form S-3 filed with the Commission on January&nbsp;25, 2013 and incorporated herein by reference. </TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;17.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Undertakings. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The undersigned registrant hereby undertakes: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) To include any prospectus required by section 10(a)(3) of the Securities Act; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC
pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the effective
registration statement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) To include any material information with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such information in the registration statement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided, however</I>, that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii) of this section do not apply if
the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated
by reference into the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(2) That, for the purpose of determining any liability under the Securities Act, each such
<FONT STYLE="white-space:nowrap">post-effective</FONT> amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
<I>bona fide</I> offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(3) To remove from registration by means of a post-effective amendment any of the securities being
registered which remain unsold at the termination of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(4) That, for the purpose of determining liability under the
Securities Act to any purchaser: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of
the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x)&nbsp;for the purpose of
providing the information required by section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of
the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective
date of the registration statement relating to the securities in the registration statement to which that prospectus related, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering thereof.
<I>Provided, however</I>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or
prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of
the registration statement or made in any such document immediately prior to such effective date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The undersigned registrant hereby
undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&#146;s annual report pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee
benefit plan&#146;s annual report pursuant to Section&nbsp;15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the initial <I>bona fide </I>offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Insofar as
indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the
opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses
incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
expressed in the Act and will be governed by the final adjudication of such issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Boca Raton, state of Florida, on January&nbsp;24, 2014. </P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">THERAPEUTICSMD, INC.</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><I>/s/ Robert G. Finizio</I></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Robert G. Finizio</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>KNOW ALL PERSONS BY THESE PRESENTS</B>, that each person whose signature appears below constitute and appoint Robert G. Finizio and Daniel
A. Cartwright, and each one of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place, and stead, in any and all capacities, to sign any and all amendments
(including post-effective amendments) to this registration statement, and to sign any registration statement for the same offering covered by this registration statement that is to be effective upon filing pursuant to Rule 462(b) under the
Securities Act, and all post-effective amendments thereto, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and
each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents or any of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:33.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:30.65pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Capacity</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:16.00pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>/s/ Robert G. Finizio</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Robert G. Finizio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Chief Executive Officer, Director<BR>(Principal&nbsp;Executive&nbsp;and&nbsp;Accounting&nbsp;Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;24, 2014</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>/s/ John C.K. Milligan, IV</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">John C.K. Milligan, IV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">President, Secretary, Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January 24, 2014</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>/s/ Daniel A. Cartwright</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Daniel A. Cartwright</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Financial Officer, Treasurer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Principal Financial Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January 24, 2014</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>/s/ Tommy G. Thompson</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Tommy G. Thompson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Chairman</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January 24, 2014</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>/s/ Brian Bernick</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Brian Bernick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January 24, 2014</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>/s/ Cooper C. Collins</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cooper C. Collins</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January 24, 2014</TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:33.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:30.65pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Capacity</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:16.00pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>/s/ Robert V. LaPenta, Jr.</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Robert V. LaPenta, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January 24, 2014</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>/s/ Jules A. Musing</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Jules A. Musing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January 24, 2014</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>/s/ Nicholas Segal</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Nicholas Segal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;24, 2014</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>/s/ Randall S. Stanicky</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Randall S. Stanicky</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January 24, 2014</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Underwriting Agreement*</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Securities Purchase Agreement (1)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Certificate of Common Stock (2)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Opinion of Greenberg Traurig, LLP</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Greenberg Traurig, LLP (included in Exhibit 5.1)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Rosenberg Rich Baker Berman &amp; Company, independent registered public accounting firm</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Parks &amp; Company, LLC, independent registered public accounting firm</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Power of Attorney (included on the Signatures page of the Registration Statement)</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">To be filed by amendment to this registration statement or by a report filed under the Exchange Act and incorporated herein by reference. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Filed as an exhibit to Form 8-K filed with the Commission on October&nbsp;2, 2012 and incorporated herein by reference. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Filed as an exhibit to Form S-3 filed with the Commission on January&nbsp;25, 2013 and incorporated herein by reference. </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d664229dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g664229g96q07.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">January&nbsp;24, 2014 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TherapeuticsMD, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6800 Broken Sound Parkway NW, Third Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boca Raton, FL 33487
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Registration Statement on Form S-3</B> </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>TherapeuticsMD, Inc.</B> </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="88%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ROWSPAN="7"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen:</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">We have acted as legal counsel to TherapeuticsMD, Inc., a Nevada
corporation (the &#147;Company&#148;), in connection with the Registration Statement on Form S-3, filed with the Securities and Exchange Commission (the &#147;Registration Statement&#148;) under the Securities Act of 1933, as amended. The
Registration Statement relates to the offering by certain selling stockholders of up to 12,000,000 shares of the Company&#146;s common stock, par value $0.001 per share (the &#147;Shares&#148;).</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">With respect to the opinion set forth below, we have examined
originals, certified copies, or copies otherwise identified to our satisfaction as being true copies, of the Registration Statement and such other corporate records of the Company, agreements and other instruments, and certificates of public
officials and officers of the Company, as we have deemed necessary as a basis for the opinion hereinafter expressed. As to various questions of fact material to such opinion, we have, where relevant facts were not independently established, relied
upon statements of officers of the Company.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Based solely upon the
foregoing, and upon our examination of such questions of law and statutes as we have considered necessary or appropriate, and subject to the assumptions, qualifications, limitations, and exceptions set forth herein, we are of the opinion that
(a)&nbsp;the Shares have been lawfully and duly authorized; and (b)&nbsp;the Shares have been validly issued and are fully paid and nonassessable.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">For purposes of our opinion, we also have assumed that the Company has paid all taxes, penalties, and interest that are due and owing to
the state of Nevada.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">We express no opinion as to the
applicability or effect of any laws, orders, or judgments of any state or other jurisdiction other than federal securities laws and the substantive laws of the state of Nevada. Further, our opinion is based solely upon existing laws, rules, and
regulations, and we undertake no obligation to advise you of any changes that may be brought to our attention after the date hereof.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">We hereby expressly consent to any reference to our firm under the heading &#147;Legal Matters&#148; in the Registration Statement, to the
inclusion of this opinion as an exhibit to the Registration Statement, and to the filing of this opinion with any appropriate governmental agency.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20.40em; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Very truly yours,</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20.40em; text-indent:2.00em; font-size:10pt; font-family:Times New Roman"><I>/s/ Greenberg Traurig, LLP</I></P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">GREENBERG TRAURIG, LLP&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#110;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;ATTORNEYS AT LAW&nbsp;&nbsp;&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#110;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;WWW.GTLAW.COM</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">2375 East Camelback Road, Suite 700&nbsp;&nbsp;&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#110;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;Phoenix, Arizona 85016&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#110;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;Tel&nbsp;602.445.8000&nbsp;&nbsp;&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#110;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;Fax&nbsp;602.445.8100</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD ROWSPAN="7" VALIGN="top">&nbsp;</TD>
<TD ROWSPAN="7" VALIGN="top" ALIGN="right">


<IMG SRC="g664229g60r08.jpg" ALT="LOGO">
&nbsp;</TD>
<TD ROWSPAN="7" NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d664229dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 (the &#147;Registration Statement&#148;) of TherapeuticsMD,
Inc. (the &#147;Company&#148;) of our reports dated March&nbsp;11, 2013 and March&nbsp;27, 2012 relating to our audits of the financial statements as of December&nbsp;31, 2012 and 2011 and for each of the two years in the period ended
December&nbsp;31, 2012 and of internal control over financial reporting as of December&nbsp;31, 2012, which appear in the Annual Report on Form 10-K of the Company for the year ended December&nbsp;31, 2012. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also consent to the reference to our firm under the caption &#147;Experts&#148; in the Prospectus, which is a part of this Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>/s/ Rosenberg Rich Baker Berman&nbsp;&amp; Company </U></I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rosenberg Rich Baker Berman&nbsp;&amp; Company </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Somerset, NJ
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;24, 2014 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>4
<FILENAME>d664229dex233.htm
<DESCRIPTION>EX-23.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Parks &amp; Company, LLC</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Certified Public Accountants &amp; Consultants</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>1761 W. Hillsboro Boulevard, Suite 326</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Deerfield Beach, FL 33442</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><B>Phone (954) 719-7569</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>www.parkscpas.com</U></B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><B>Fax (954) 719-3704</B></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.3 </B></P>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 (&#147;Registration Statement&#148;) of TherapeuticsMD, Inc. of
our report dated February&nbsp;28, 2012 relating to our audit of the December&nbsp;31, 2010 financial statements of VitamedMD, LLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also consent to
the reference to our Firm under the caption &#147;Experts&#148; in the Prospectus, which is part of the Registration Statement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g664229g93b60.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certified Public Accountants </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deerfield Beach, Florida </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;24, 2014 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g664229g60r08.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g664229g60r08.jpg
M_]C_X09B17AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!````
M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4
M````D(=I``0````!````I````-``+<;````G$``MQL```"<0061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q-#HP,3HR,R`R,#HR,SHP,@```Z`!
M``,````!``$``*`"``0````!````8Z`#``0````!```"T0`````````&`0,`
M`P````$`!@```1H`!0````$```$>`1L`!0````$```$F`2@``P````$``@``
M`@$`!`````$```$N`@(`!`````$```4L`````````$@````!````2`````'_
MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`H``6`P$B``(1
M`0,1`?_=``0``O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`]-MM=6RO;977N$?I#SQ]
M'5J>K)K(#;+JG6$P`PQ_9@N<HW/#&UR]C)'#Q,\?1U"EC^]N\N98"=',;&H/
MN[N_.24G22224__0]-ML+&5Q:*I'=NZ>%+&M%@=^D%L'D-VP".%&Q^QM7Z3T
MY'&W<#`_Z*?'O:[V%[GOU,EA9I\VA)2=))))3__1]-N<X,K(<]NG^#;NG0<^
MUZ3;A6"UQLL,S.PZ:<#8U/9.VJ#8.!^C$^'TY#E''<?4C],9;_A![=/./I)*
M2#(807`/AL3[7=SM\$D5))3_`/_2]-M$UUC])J!_-?+Z2C5::P[]'>Z>SH/E
M[?<GN:2RLAECX'^#<&^'TI>Q390V&N)>"-=I>=#Y[2DI,DDDDI__T_3+F%S:
MR*W60#]%^R)'Q;NW*5;KF$5BDBL&`XO!TG^TY1NKWLK_`$0M('=VV)"BQCV.
M]5N.!89!]_8P[_JDE-M)##KO3+BP!_9F[_OVU))3_]3TRYF]E?Z-EA`T#G;2
M./H^URC4UU1/ITU,F>'GM_84K@TLKD5&!_A?E]!*G&K<T^I33!C;L$@_YS4E
M,P[*UFMGE[SS_F)(R22G_]7TN_;LJ#O2@B/TWP'T%%N1:-!;C@#L"?\`R2G<
MX-97+ZV$C3U!,Z#Z/N8HUVTEQ-ME#A!X$&1]+Z3G)*;/J5[-^X;/WIT\.4E'
M=3Z6Z1Z7,]DDE/\`_];TRZT5LK)L;6(U#F[@>/\`-2:W(L8',O:6GC]'X:=W
MJ5C]C:CO+!&HV[@1'>/HJ%62QK2ZRTV=OH$<?R0U)3:20AD5&LV@G8.3!_)"
M22G_U_3+G%K*X>]DC_!LWSQ]+V6;4U5X:3N?:\$@#=66Q]S&N4KI;2QX<\!H
M`(9&LP/=N!5<W2(#[@>VK-=-OTG-24W!<PUFR'0.VTS_`)L;DE`9#RPV&EP:
M!N!ENH_SDDE/_]#TW(.W&!W%F@]P^7@^M`IM(,^N!'[\[>8VG],[W*QD>V@`
MEHB-7$@?>',5>JUE;@7/K(`+2-_'?\^Q[4E)Q<36YWKTF`#N'`U^D[])]'^T
MDG]?V>IL&R)W[F[8_K))*?_9_^T.0%!H;W1O<VAO<"`S+C``.$))300$````
M```/'`%:``,;)4<<`@```@```#A"24T$)0``````$,W/^GVHQ[X)!7!VKJ\%
MPTXX0DE-!#H``````.4````0`````0``````"W!R:6YT3W5T<'5T````!0``
M``!0<W138F]O;`$`````26YT965N=6T`````26YT90````!#;')M````#W!R
M:6YT4VEX=&5E;D)I=&)O;VP`````"W!R:6YT97).86UE5$585`````$`````
M``]P<FEN=%!R;V]F4V5T=7!/8FIC````#`!0`'(`;P!O`&8`(`!3`&4`=`!U
M`'````````IP<F]O9E-E='5P`````0````!";'1N96YU;0````QB=6EL=&EN
M4')O;V8````)<')O;V9#35E+`#A"24T$.P`````"+0```!`````!```````2
M<')I;G1/=71P=71/<'1I;VYS````%P````!#<'1N8F]O;```````0VQB<F)O
M;VP``````%)G<TUB;V]L``````!#<FY#8F]O;```````0VYT0V)O;VP`````
M`$QB;'-B;V]L``````!.9W1V8F]O;```````16UL1&)O;VP``````$EN=')B
M;V]L``````!"8VMG3V)J8P````$```````!21T)#`````P````!29"`@9&]U
M8D!OX````````````$=R;B!D;W5B0&_@````````````0FP@(&1O=6)`;^``
M``````````!"<F1456YT1B-2;'0```````````````!";&0@56YT1B-2;'0`
M``````````````!2<VQT56YT1B-0>&Q`<L````````````IV96-T;W)$871A
M8F]O;`$`````4&=0<V5N=6T`````4&=0<P````!09U!#`````$QE9G15;G1&
M(U)L=````````````````%1O<"!5;G1&(U)L=````````````````%-C;"!5
M;G1&(U!R8T!9````````````$&-R;W!7:&5N4')I;G1I;F=B;V]L``````YC
M<F]P4F5C=$)O='1O;6QO;F<`````````#&-R;W!296-T3&5F=&QO;F<`````
M````#6-R;W!296-T4FEG:'1L;VYG``````````MC<F]P4F5C=%1O<&QO;F<`
M`````#A"24T#[0``````$`$L`````0`!`2P````!``$X0DE-!"8```````X`
M````````````/X```#A"24T$#0``````!````'@X0DE-!!D```````0````>
M.$))30/S```````)```````````!`#A"24TG$```````"@`!``````````$X
M0DE-`_4``````$@`+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8`````
M``$`,@````$`6@````8```````$`-0````$`+0````8```````$X0DE-`_@`
M`````'```/____________________________\#Z`````#_____________
M________________`^@`````_____________________________P/H````
M`/____________________________\#Z```.$))300(```````0`````0``
M`D````)``````#A"24T$'@``````!``````X0DE-!!H``````T\````&````
M``````````+1````8P````T`-@`V`#0`,@`R`#D`(`!%`%@`(``U`%\`,0``
M``$``````````````````````````0``````````````8P```M$`````````
M`````````````0`````````````````````````0`````0```````&YU;&P`
M```"````!F)O=6YD<T]B:F,````!````````4F-T,0````0`````5&]P(&QO
M;F<``````````$QE9G1L;VYG``````````!"=&]M;&]N9P```M$`````4F=H
M=&QO;F<```!C````!G-L:6-E<U9L3',````!3V)J8P````$```````5S;&EC
M90```!(````'<VQI8V5)1&QO;F<`````````!V=R;W5P241L;VYG````````
M``9O<FEG:6YE;G5M````#$53;&EC94]R:6=I;@````UA=71O1V5N97)A=&5D
M`````%1Y<&5E;G5M````"D53;&EC951Y<&4`````26UG(`````9B;W5N9'-/
M8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG``````````!,969T
M;&]N9P``````````0G1O;6QO;F<```+1`````%)G:'1L;VYG````8P````-U
M<FQ415A4`````0```````&YU;&Q415A4`````0```````$US9V5415A4````
M`0``````!F%L=%1A9U1%6%0````!```````.8V5L;%1E>'1)<TA434QB;V]L
M`0````AC96QL5&5X=%1%6%0````!```````):&]R>D%L:6=N96YU;0````]%
M4VQI8V5(;W)Z06QI9VX````'9&5F875L=`````EV97)T06QI9VYE;G5M````
M#T53;&EC959E<G1!;&EG;@````=D969A=6QT````"V)G0V]L;W)4>7!E96YU
M;0```!%%4VQI8V5"1T-O;&]R5'EP90````!.;VYE````"71O<$]U='-E=&QO
M;F<`````````"FQE9G1/=71S971L;VYG``````````QB;W1T;VU/=71S971L
M;VYG``````````MR:6=H=$]U='-E=&QO;F<``````#A"24T$*```````#```
M``(_\````````#A"24T$%```````!`````(X0DE-!`P`````!4@````!````
M%@```*````!$```J@```!2P`&``!_]C_[0`,061O8F5?0TT``?_N``Y!9&]B
M90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43$Q@1#`P,
M#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-$`X.$!0.
M#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#/_``!$(`*``%@,!(@`"$0$#$0'_W0`$``+_Q`$_```!!0$!`0$!
M`0`````````#``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$``@,$!08'
M"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R!A21H;%"
M(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#
MTW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W
M$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P
M,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S
M1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@`,`P$`
M`A$#$0`_`/3;;75LKVV5U[A'Z0\\?1U:GJR:R`VRZIUA,`,,?V8+G*-SPQM<
MO8R1P\3/'T=0I8_O;O+F6`G1S&QJ#[N[OSDE)TDDDE/_T/3;;"QE<6BJ1W;N
MGA2QK18'?I!;!Y#=L`CA1L?L;5^D].1QMW`P/^BGQ[VN]A>Y[]3)86:?-H24
MG22224__T?3;G.#*R'/;I_@V[IT'/M>DVX5@M<;+#,SL.FG`V-3V3MJ@V#@?
MHQ/A].0Y1QW'U(_3&6_X0>W3SCZ22D@R&$%P#X;$^UW<[?!)%224_P#_TO3;
M1-=8_2:@?S7R^DHU6FL._1WNGLZ#Y>WW)[FDLK(98^!_@W!OA]*7L4V4-AKB
M7@C7:7G0^>TI*3))))*?_]/TRYA<VLBMUD`_1?LB1\6[MRE6ZYA%8I(K!@.+
MP=)_M.4;J][*_P!$+2!W=MB0HL8]CO5;C@6&0??V,._ZI)3;20PZ[TRXL`?V
M9N_[]M224__4],N9O97^C980-`YVTCCZ/M<HU-=43Z=-3)GAY[?V%*X-+*Y%
M1@?X7Y?02IQJW-/J4TP8V[!(/^<U)3,.RM9K9Y>\\_YB2,DDI__5]+OV[*@[
MTH(C]-\!]!1;D6C06XX`[`G_`,DIW.#65R^MA(T]03.@^C[F*-=M)<3;90X0
M>!!D?2^DYR2FSZE>S?N&S]Z=/#E)1W4^END>ES/9))3_`/_6],NM%;*R;&UB
M-0YNX'C_`#4FMR+&!S+VEIX_1^&G=ZE8_8VH[RP1J-NX$1WCZ*A5DL:TNLM-
MG;Z!''\D-24VDD(9%1K-H)V#DP?R0DDI_]?TRYQ:RN'O9(_P;-\\?2]EFU-5
M>&D[GVO!(`W5EL?<QKE*Z6TL>'/`:`"&1K,#W;@57-TB`^X'MJS73;])S4E-
MP7,-9LAT#MM,_P";&Y)0&0\L-AI<&@;@9;J/\Y))3__0]-R#MQ@=Q9H/</EX
M/K0*;2#/K@1^_.WF-I_3.]RL9'MH`):(C5Q('WAS%7JM96X%SZR`"TC?QW_/
ML>U)2<7$UN=Z])@`[AP-?I._2?1_M))_7]GJ;!LB=^YNV/ZR22G_V3A"24T$
M(0``````50````$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`
M<````!,`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'``(`!#`%,`-@``
M``$`.$))300&```````'``@````!`0#_X0X1:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87`O,2XP+P`\/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E
M:&E(>G)E4WI.5&-Z:V,Y9"(_/B`\>#IX;7!M971A('AM;&YS.G@](F%D;V)E
M.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U+C,M8S`Q,2`V
M-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@("`@("`@("(^(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B
M('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+R(@>&UL
M;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(B!X;6QN<SIX
M;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+VUM+R(@>&UL;G,Z
M<W1%=G0](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C945V96YT(R(@>&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M
M96YT<R\Q+C$O(B!X;6QN<SIP:&]T;W-H;W`](FAT='`Z+R]N<RYA9&]B92YC
M;VTO<&AO=&]S:&]P+S$N,"\B('AM<#I#<F5A=&5$871E/2(R,#$T+3`Q+3(S
M5#(P.C(Q.C(R*S`U.C,P(B!X;7`Z0W)E871O<E1O;VP](DUI8W)O<V]F=,*N
M($]F9FEC92!7;W)D(#(P,#<B('AM<#I-;V1I9GE$871E/2(R,#$T+3`Q+3(S
M5#(P.C(S.C`R*S`U.C,P(B!X;7`Z365T861A=&%$871E/2(R,#$T+3`Q+3(S
M5#(P.C(S.C`R*S`U.C,P(B!P9&8Z4')O9'5C97(](DUI8W)O<V]F=,*N($]F
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M(B!P:&]T;W-H;W`Z0V]L;W)-;V1E/2(S(B!P:&]T;W-H;W`Z24-#4')O9FEL
M93TB<U)'0B!)14,V,3DV-BTR+C$B/B`\>&UP34TZ2&ES=&]R>3X@/')D9CI3
M97$^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)D97)I=F5D(B!S=$5V=#IP87)A
M;65T97)S/2)C;VYV97)T960@9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N
M<&AO=&]S:&]P('1O(&EM86=E+VIP96<B+SX@/')D9CIL:2!S=$5V=#IA8W1I
M;VX](G-A=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7`N:6ED.C!$1D(U-#8X
M,S0X-$4S,3%!138W0D4S1D-%,S`X13`S(B!S=$5V=#IW:&5N/2(R,#$T+3`Q
M+3(S5#(P.C(S.C`R*S`U.C,P(B!S=$5V=#IS;V9T=V%R94%G96YT/2)!9&]B
M92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(@<W1%=G0Z8VAA;F=E9#TB+R(O
M/B`\+W)D9CI397$^(#PO>&UP34TZ2&ES=&]R>3X@/'AM<$U-.D1E<FEV961&
M<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(B\^(#PO<F1F.D1E<V-R:7!T
M:6]N/B`\+W)D9CI21$8^(#PO>#IX;7!M971A/B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(#P_>'!A8VME="!E;F0](G<B/S[_X@Q824-#7U!23T9)3$4``0$`
M``Q(3&EN;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5```
M``!)14,@<U)'0@```````````````0``]M8``0````#3+4A0("``````````
M`````````````````````````````````````````````````````!%C<')T
M```!4````#-D97-C```!A````&QW='!T```!\````!1B:W!T```"!````!1R
M6%E:```"&````!1G6%E:```"+````!1B6%E:```"0````!1D;6YD```"5```
M`'!D;61D```"Q````(AV=65D```#3````(9V:65W```#U````"1L=6UI```#
M^````!1M96%S```$#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#
M```$/```"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY
M."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)
M14,V,3DV-BTR+C$``````````````!)S4D="($E%0S8Q.38V+3(N,0``````
M````````````````````````````````````````````````````````````
M6%E:(````````/-1``$````!%LQ865H@`````````````````````%A96B``
M``````!OH@``./4```.06%E:(````````&*9``"WA0``&-I865H@````````
M)*````^$``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```
M````````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````````
M``````````````````````````````````````````!D97-C`````````"Y)
M14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`
M`````````````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S
M<&%C92`M('-21T(`````````````````````````````9&5S8P`````````L
M4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``
M````````````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V
M,3DV-BTR+C$``````````````````````````````````'9I97<``````!.D
M_@`47RX`$,\4``/MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G
M;65A<P`````````!`````````````````````````H\````"<VEG(`````!#
M4E0@8W5R=@````````0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%
M`$H`3P!4`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`
MMP"\`,$`Q@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R
M`3@!/@%%`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!
MV0'A`>D!\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B
M`JP"M@+!`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#
MH@.N`[H#QP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$
M!-,$X03P!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&
M)P8W!D@&609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L
M![\'T@?E!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)
M>0F/":0)N@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI
M"X`+F`NP"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-
MJ0W##=X-^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)
M$"800Q!A$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2
MPQ+C$P,3(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;
M%;T5X!8#%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8
MU1CZ&2`911EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ
M'%(<>QRC',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?
MZB`5($$@;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"
M(_`D'R1-)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH
M#2@_*'$HHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN
M+*(LURT,+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q
M2C&",;HQ\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W
M-G(VKC;I-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[
MJCOH/"<\93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I
M06I!K$'N0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'
M-4=[1\!(!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*
M39--W$XE3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3
M]E1"5(]4VU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF
M6O5;15N56^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A
M]6))8IQB\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#
M:9II\6I(:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q
M.G&5<?!R2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ
M>8EYYWI&>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!
MS8(P@I*"](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HID
MBLJ+,(N6B_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3
MMI0@E(J4])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SW
MG62=TIY`GJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF
M_:=NI^"H4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#J
ML6"QUK)+LL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[
MI[PAO)N]%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&
MQL/'0<>_R#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1
MOM(_TL'31-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0
MW9;>'-ZBWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI
M1NG0ZEOJY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50
M]=[V;?;[]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@`.061O
M8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#`P,#`0$!`0$!`0$!`0$"
M`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P/_P``1"`+1`&,#`1$``A$!`Q$!_]T`!``-_\0!H@````8"`P$`
M````````````!P@&!00)`PH"`0`+`0``!@,!`0$````````````&!00#!P((
M`0D`"@L0``(!`P0!`P,"`P,#`@8)=0$"`P01!1(&(0<3(@`(,11!,B,5"5%"
M%F$D,Q=2<8$88I$E0Z&Q\"8T<@H9P=$U)^%3-H+QDJ)$5'-%1C='8RA55E<:
MLL+2XO)D@W23A&6CL\/3XRDX9O-U*CDZ2$E*6%E:9VAI:G9W>'EZA8:'B(F*
ME)66EYB9FJ2EIJ>HJ:JTM;:WN+FZQ,7&Q\C)RM35UM?8V=KDY>;GZ.GJ]/7V
M]_CY^A$``@$#`@0$`P4$!`0&!@5M`0(#$00A$@4Q!@`B$T%1!S)A%'$(0H$C
MD152H6(6,PFQ),'10W+P%^&"-"624QAC1/&BLB8U&50V160G"G.#DT9TPM+B
M\E5E=58WA(6CL\/3X_,I&I2DM,34Y/25I;7%U>7U*$=79CAVAI:FML;6YO9G
M=X>7I[?'U^?W2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*
MVNKZ_]H`#`,!``(1`Q$`/P#>RZ>9FZDZM9W>1VZYV0SR2N\LCL=LXPL\DDC-
M)(['DLQ))Y)]^Z]T(WOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[K__0WL>G?^91=6?^(XV/_P"\SB_?NO="/[]U
M[I&9_?\`M;;&Y]D[0S60>DSO8=9F:#:M-]G6305U5@<3)FLC%/6PP/1XXK0Q
M'QFH>,32D1QZI&"GW7ND?F>\]CX?`[4W((MSYC&;PQN3S>+.`VMF<O508#"P
M4]3F<[E**FI34X[&8R&KB,C2*'+2*J(S$#W[KW4?/?(?J+;<6\JC)[K04^P>
MOL#VGNBHI,9EJ^&@V)N.3(+C,[#)1T4RY",Q8R2:6*G\L\$#1R.BK+&6]U[I
MRRO=_6^%R&<H,EG7IQM_`9+<E9D!CZ^?$5./Q&"PNY\A#B<K!3RT68R<&W]P
MT56M+3/)42P3AHU?2^GW7NA0HZD5M'25BPU-.M7305*T]9!)2UD`GB640U=+
M*!+35,0?3)&P#(P(/(]^Z]U)]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_1
MWL>G?^91=6?^(XV/_P"\SB_?NO="/[]U[HN?9/2NX=][PJ-Z4>]*C!9'!4&R
M4V%CZ9Z_^!Q9/;.[3O#)U6\\8E0L6>I\K64U+3QI$86@@B?EC(;>Z]T%FX_C
MEV#NG:NR-JYE.J\A0[#HMU;?Q4$]1OV"GJL1N/%T^.@S<[8VIH:R#.XO[;_@
M,)9*6=)G&N-EC9?=>Z><I\:-W50K<Q%V2^2W5G*G)8G<29^CEJ-FUVSJJAVK
MB:6.FVS3NBTVXXJ3K_"SR2F1J>2I6J!CT3\>Z]TYT?QGEIUJ,;6YW%YS;U!W
MYM'MC9F.RF+J?)M;:FU\3C:6BV3&\5;HK9,/4Q5,./J9!I3&M!3R1N(03[KW
M1L_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_2WL>G?^91=6?^(XV/
M_P"\SB_?NO="/[]U[J'/D,?2U5#0U-=1T];DVJ$QM'/4PQ560>E@:IJDH:>1
MUEJVIJ93)((PQ1`6-AS[]U[IN3=&V9*>AJX]Q8)Z7)Q5\^-J4R^/:GR$&+CD
MFR<U#,M08ZN+'11,T[1EA"JDO8`^_=>Z:&[(Z[6'&5#;]V6L&;$APT[;IP8A
MRPBJ11RG&2&NT5XCK&$3>(O:0Z3ZN/?NO==_Z1^O/'D9O[^;,\6'EB@RTO\`
M>C!^/%S5%4]#!#D7^^TT4LU=$T*+*5+2J4%V!'OW7NI<6^-E356'H8=X;6EK
M=PTD-?M^CBW!B9*K.4-1YOMZS#TZU9FR=)/]O)HD@#HWC:Q.DV]U[IQ?<&!B
M9UDS>(C:/+T^WY%?)4:-'GJN.GEI<(X:8%<O4Q5431TQ_>=9$(4AA?W7NIE+
M7T%<U6E%6TE8^/JWH*]:6IAJ&HJ^.*&>2BJUB=S35:05$;F-]+A)%)%F%_=>
MZE^_=>Z][]U[KWOW7NO>_=>Z_]/>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7N
MBG]P;$[)W/V9MW?NW,30U5'T['MK+[2H:I:-<QN3+9K//'V13;;RS9FDCV_)
M4=?4YQCM6P2Q51K&1`NDN?=>Z+WA/C?OS'XC`[>R?7O\2VOL3"]NX?:N(QFY
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M-+,*2RNDDOOW7NFO+]`=J5_WE35[<Q=15=@=@['[\R!PT])C9]H]G;#W+E=R
MT%'G)J[-5L&1RM1@A@\)_$:$)"$PH]&EA(?=>Z,_\=]D[BV9@M]5&[,'38'<
M>_.QLGV3FZ>EJJ6MADS&\=M[4K\Q"M32S3K,F!RJ38E')'D3'JZWC9&/NO=&
M"]^Z]U[W[KW7O?NO=>]^Z]U__]3>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[K_U=['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z)YW=N#?%)VCM7<&WL)NBO
MVGTY#A,_N^;"5^4IJ?(4^_LM-MK<-#-MB''SQ=AG!;'AJJ^*&"19,?6-!+<N
M54>Z]TB-N4>(ZKWO!N&JAW)MO;T??78FW:ZNJ9M[9+&G;$?6U9+MBBE@J9LE
M#_`VSU4STKA!3?="R,'L#[KW20W+5=D;PR>^*B"?L7:&W>_<UA<;L#>>#R.Y
MIY=LMUSV+MBCVON.BVO_``REJ=A4N9VB*_)5D=0WBSD<*K*$$A0^Z]TJ=K8>
MKWWE\5N'LW:6Y\;F,=\@.QL1N&CJZS>D>-H</M;KG)U!J<1]M604U?L+.;HP
M<.7Q#NDD3">"-?WM:'W7NA&^.F;W]_>?>$&^L%NC%0=GT,'<VV1E\G6Y['8T
M9*M;"Y;;U)+4T5,^S4H\$N`FCP4S/+#4S5L@)/DM[KW1NO?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7_UM['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_7
MWL>G?^91=6?^(XV/_P"\SB_?NO="/[]U[HJO;W<6;V=VOL##8FIR,6U,%)AL
MCVN]/A*+)8-,/V%FGV1M<;BS\K?<[,&&R*SY=)185<5&T;60DGW7N@QKNW>Q
M<EM;:%)B-[X0;GR'7L=5N.&HR^T]MU%5N0]A8?;\^`H\WD*&LQ.T]\YVBBK\
M=B!60?:FOCDC9!*@>/W7NI[[UW37T.S]R8[LCL*C^XZ[[QR>1P^<AV#3NVX^
MHJZCQE)_%8<'BLKAZ_[2KKIXJRHQ=;_#LIX8JB$K$P4^Z]UBZY[OW[7;^VAM
M#=6Y:*NIM_\`8F3DV55TV-QT#UFW=L=2_P`1WOL'*-34XCCS>)W.\.=HYAIE
MJ,34/'J_R20'W7NCW>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z_]#>
MQZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7NFRHPN&JQD15XG&50R\4,&6%104LP
MRD%,KK3PY$21,*V*G61@BRZ@@)M:_OW7NFM]D[,DBST$FT=L/#NF9*C<\+X#
M%-%N.HCD:6.?/1FD*9>9)7+!J@2,&)(-_?NO=.$>W\##34=%#A,1%1X^@GQ6
M/I(\;1)34.+JHX8:G&T<"PB*FH*B&GC1X4"QNJ*""`+>Z]URAP6$IS3-3X;%
M0-15<E?1F''TD1I*Z:CDQ\M;3%(5,%7+02M`TB6=H6*$Z21[]U[IU]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]'>QZ=_YE%U9_XCC8__`+S.+]^Z
M]T(_OW7NBU]F]R;CV1V)1;>I*;$';L..Z\K\K/7[?W/6%TWIOK*[3R#U6[<9
M4#;FRZ?$T-`M1!)DH9(ZN<F'4EPX]U[I,UW=G:U#B<-FH]I[:RX[%VSGMS=?
M;?PD&;K=RXFFPDV-R3TN=HFKHAN_*/LO(/7&DQPH)FKJ5J&/R&5*A?=>ZYT?
M=F\\F>O*_%YKKS)8'/U^_P"@W34TNT]\T^:H7Z\I\ME\C`FW,WE\+E]M;AJ,
M9CUIY\5D(9I:&K)<2U$90'W7NFG<'?G;.V,!LS.R[-VAN:J[0I]M[AV1MC`5
M>8ILI2X6;/;=FW1MS*5]<\U)E-RQ[$W`)\9501T]/59B`TC4ZI+%*?=>Z'SJ
M;L,=F8/-[BIWQ51B8-X;AP^WZ_#S33TN4V_CZB(8K)2/.=25U332CSQ@+XI@
MR%596`]U[H4??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__2WL>G?^91=6?^
M(XV/_P"\SB_?NO="/[]U[H/=P]7[/W3N&DW-FJ7(U%?3P8:FGI8LYF:3"Y>#
M;N6J<]M^+.X*EKH<3F4PV:JY*F`5$,@$C'5J6R^_=>Z87Z'ZPE?+-)@:MAE3
M4F./^\.XDAV^:W.4^YZP[-BCRJ)LQZK<M)'7NV+%(QJ8T:]D0+[KW2APO5^R
M<"V"FH,0[5VW<CG,Q0Y2MR.2K\K/FMS4DE#N#,9;(5E7-4YK)Y:FE*2RU33,
M!8)I"J%]U[IDQ71W66%J5JJ';\VN"NPU;C(ZK-YVNIL"NW\N-P8G&[<IJW)3
MP8#!TN>O5_8TBQ4KRZ0T9C2-$]U[I8;/V1M38.-K</L["TF`Q60W!N'=%3CZ
M'RK2'.[KS%7G]PUT,,DDB4O\3S-?-4-'%HA5Y6T*HX]^Z]TJO?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7__T]['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z"
M;=G9F2P>YUVSMS8>>WQ/C<=A\YN^;"UF*I7VYA,[DJW&8V:EI,A40S9_+3-B
MJNH-%!H<4M*S:O(\,4ONO=(>#Y,;.K*?;ST-,M?69F?*09+&T>=P536[6&,[
M`VWU^9MP00UCS4,515;C%4NI`RPT[HP$EE]^Z]UFE[[R--MC<^\JGJC>IVY2
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M[H)MX=6ON;<2[AQ>]=T;.?(XW&8'=]+MR2BA7=6`P^0K<GCJ)JRHI9:[!U\$
M^2J8?OJ*2*I-)52QW#>*2+W7NDTGQXVC'0[7HH:VM@.V)LG,*B&CP\<N9&3W
MWMS?DD.8*T`-5!%7;;CIU%P33RR:B9"''NO=0#\=,96KC<3N#?&\-Q;)P&2Q
ML^W=BU\V.BP-!A\56G+T6!R/VM'#5;A@H\M!2-3U%6[U%/34$,*,-4\DWNO=
M-53\7-NC%';F'W3F,)M>J<4F1P<6)VSD8FV]0;@S6X-KXC"U.7Q-;-MNLV:<
M_446-R-+IK(J'Q(6:6"":/W7NEWMOIJBVYN3&91=T9^OVYM:LS^2V+LJH7'1
M8?:N1W2*],S4BLIJ2+*YM(8,K4P8^.KFD6@IZF2-=?[9C]U[H9_?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7_]7>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7N
M@[W-VKL;9^<@V_N++3X^NEIL36SSG#YJHQ&*I,_EJC!82JSN>I<?-A<%3Y7,
M4DE/"]7/"ID0W(%C[]U[KR=L==RY;-X.+=5!+EMM[RP77V<HHHZR27&[RW+B
M\?FL'@J@I3-']S7XW*02*ZDPIK*NZNKJONO=/K[RVS'1;MR+Y:%:+8DM;!NV
MH,52$PLN.PM%N*M2<>#5-]OA<A#.3$)`5<`78$#W7NDC_IMZR:#:M7!N7[VC
MWG@\!N;!UF/Q&=R%(-N;JJ(:/;F=S%11XR:+;F+S5?.E/3RY`TJR3ZD'JCDT
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M475G_B.-C_\`O,XOW[KW0C^_=>Z8ZW<VV\;E*#!Y'<&#H,WE0IQ>'K<M04N4
MR09VB4T&/GJ(ZNL#2(RCQHUV!'U'OW7NHM%O39V2K*G'8[=FV:_(450E)64-
M%GL755E)525+44=-4TL%5)/!425B-$J.H8R@J!J%O?NO=.=5F\-0S34]=E\9
M1U%/20U\\%57TM/-!0U%2:*"LFBFE1XZ2:L!B21@$:4:02W'OW7NL?\`>#`7
MF7^-XC535%=1U"_Q*BO!5XRG%7DJ68>:\51CZ4B6=&LT49U,`.??NO=0:O>>
MSZ";$4]=NO;5%/N".GEP,-7G<73S9N*KDABI),1'-5(^2CJI:B-8S"'#LZ@7
M+"_NO=9Z#=6U\KE*[!XO<F!R6:QAF&2Q%!F,?693'FFG6FJ!78^GJ)*ND,%2
MPC?R(NER%-CQ[]U[I^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__T-['IW_F475G
M_B.-C_\`O,XOW[KW0C^_=>Z*EV[M',9W?&X*>AZ]K-QS[OV)L';VW=V+38,8
MG:6:V_O/=N7K<SD\S65\68PTNW(,K39"F%+!*]5,@2(^50/?NO=!9@MG;TPF
M"H:2HV-OO)UNTNV<-O&LQO\`=;K^@I'Q5%V3G<K45FTLMBZVDR>YZJ6BR,=2
MT=?4M)XB74"8%#[KW3GGNK>P.P=][D[&R.T8*'#=@4F8ZIJ=OYRBQ\N\L5UQ
M%M22HVKFZ^M&?GQE'C*#M>B.46AA@:MA&0,Q<Z6C]^Z]TDL+TGVX,9DGK=FX
M3'YSLC9F$W'NBHF.&R5%MSN;N7+TN`[[FJ*.FR-*];C<)UY@X49X);51F:*G
M?4VI?=>ZXU'0W:R8YL3#@<3)0[$V74[!I<6N+VS/0[^Z\Q78M9F<-M79>7S%
M?D\SU]DHNN\@M#C*AF/VN0I8FFDM%'(/=>Z,!T5@\SMS-[FQN5P>\L6DN6WQ
MDJ,9?;&RJ/;L='F=^93-X[['=&&>HW/E\A68W)122)73S6<2:CK0>_=>Z,Y[
M]U[KWOW7NO>_=>Z][]U[KWOW7NO_T=['IW_F475G_B.-C_\`O,XOW[KW0C^_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO_2WL>G?^91=6?^(XV/_P"\SB_?NO="/[]U[HFG=DN-7LZO5ZC<L>^%
MV)L!NHH\)-NQ7DW<^]MXID%I(<:W]VIJ:6(42YC[U2HQUO+:#4??NO=`;AJ+
M.YO#5F-V]N:7;_8=?VWMPU&8VU_I'J=WXIL=VMF\C`=^TFY)Y<-4;1K*BBIZ
M6OBHXXZ:7'32(/V&CM[KW2VV?E]]9ZNQ<59B^R,!4=[;VW1A]RX;)2;A5^O<
MAU;V9E<KN31E>:+`[?W!L2GJ<=BYX&ABRB1TLD=S(H]^Z]TB-JT61W1LO"XS
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MC8__`+S.+]^Z]T(_OW7NBS[]W'ON/N1,-M\;HR&`V]UQC=YU>'V[E=IXZEDR
M3YS=D:IGJ+*XRMW-G:+-+@8:1(L;)&T/K)]4BL/=>Z!G)=G[[I\1L(8KLW);
MUJNSZ#8&=W!2;6I=D4^>V94YK=.$QM7C-J25E+%BL=B]S0Y&HQU)3Y9Y:J*H
MQ<KK4-*9]/NO=/\`L;=^]=VYOI*:?LG=$&,W;E.TZ.OP9AVI29S[#KS(5%1A
ML)ONF7;\YQV_\9J./W'%120Q>:`HH5E,C>Z]T(NY.V,KM_:W>U7_`!)JW/;>
MW['LG86,QU'CZS-19'<.U=@0[=H<?AM*/GJU-R;H>H2"0,]0#X[Z`+>Z]T%>
M![UWI4;<R;9C<]/09S`=-9RGK1EL5AL)D:SM;9>^LALS+Y63!SQZZ#(9A4H*
MH8D:HX!DZ=%0^6,O[KW3'G>TNQ,3MJFRM%V)DLGF=Y-V/#D\&S;)HIMHG:O9
MV/VSB*K;M5689*7;T<]/4?P>5\M]W`*NKAE8K)&PD]U[J7OGL7L/:E?C*#^\
MN_,0,?LRBS<M36Y/K'.8W`9S<'9M5MC'YSMC-4^/CAJ.O:>F2):AL3'YJ"C$
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M6)LS3U$U*\L&5:.AA4U"D3%84&JR+;W7NH9Z^V$?XY?9&T#_`'FU?WDOMK#?
M[^'75/7/_'/\B_W+:ZV1IC]QY+RL7_42??NO=2Z+9VT,;13XS';5VW08VIHZ
MO'5./HL'C*6BJ,?D))9J^AGI(*6."6CK9IW>:)E*2,[%@23[]U[K%1;'V5C:
MJLKL=L_:U!6Y">DJJ^LHMOXFEJJZIH*Q,C0U-9404D<M3/19")9XG<LT<RAU
M(8`^_=>ZY5^R=F93(Q9C)[1VQD<M!.*J'*5^`Q57D8:E5ID6HBK:BDDJ8YU2
MBA`<,&`B07]*V]U[K-@MI;4VO]T=L[9V]MTUQB-:<%A<;B/O#!Y/":K^'TU/
M]P8?,^G7?3J-OJ??NO=*'W[KW7__UM['IW_F475G_B.-C_\`O,XOW[KW0C^_
M=>Z+KVGW97]?[@W!M^EPWW]12;(VIN+!U`P^Y,C1/EMP;OS.VJFGW!78:CJ:
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MGOW7NO>_=>Z][]U[KWOW7NO>_=>Z_]?>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_
MOW7ND;GM@;3W-+FI\UBS5S;AP6-VUEI%K:^F:JPV(R5?E\=2`TM5#X#3Y#)S
MR"2/1*==BQ4`#W7NDPW1_6DM7G:FJP,U=#GZ+<6/J,779C,U6%QM/N^K3(;L
M.W,1+7M0;:J-R9&)*BKEH4@EDF4.&4DW]U[J!+T%UO44D-+/2;@FEOF%RV4?
M>&Z?XSNFDW",<F?Q>[\LN66MW-B,Q'B*5)J6K>2$1TZ(BH@T^_=>Z5.0ZOV+
MDX=RT]7@HO'NUL!)F?MJNOHG,^U8*:#;=7C9*.J@DPE9@UHX6IIJ,P2121*Z
MD.`??NO=)J?H'J>OP&8VUF-K+G\5N/;FX=K[E7/9/+Y6KW'C-V5]/E-QRYK(
M5==)6UV4RF1HXI36-)]S`8D$+QJB*ONO="]3P1TM/!30AA%3PQ01!G:1A'"B
MQH&=RSNP51<DDG\^_=>ZS>_=>Z][]U[KWOW7NO>_=>Z][]U[K__0WL>G?^91
M=6?^(XV/_P"\SB_?NO="/[]U[I*)NRD.\,QM&2GE@DPNUL)NNIRDTM.E`U)F
MLEN+&K3B\@ECEI#MV221F`CT2+8DAK>Z]T7Z?Y4X4;7VSG8-FYFDR>Z-W[CV
ME28'=69V[LM(*C`WKZ!ZC<6>KX-NQ5N]MM5%%D\!2O4(^1IZZ/U1Z)3'[KW0
MH;E[=QVU<E68S+;?ST$T?7T6^\<62C_W*SMG*7;L^TX%CJI1'N"DRN7QL;@D
MP7R$=I"%8^_=>Z06(^1@R=-G*E]G1)+0YEMJX?`X_?&ULONS+;MEW=/LS'X7
M(X&EF0;7BK,G322-55LZPP4\;/)8J5'NO=/D_><N'395-NKKS=.`S>ZM]5&S
M*_'_`'&'R>/V]CZ6GC:;?\^>I*P4%=L09'(XVA^Z31.M9D8XGA1DE">Z]T\=
M=]P4W8NY]XX''8"6DH]I9#(XJIR$F>V_4Y*FR6*RU5AJF@W-M*"N_O-M&JR$
MU')4XW[JG:.NH%\X=-2(WNO=#+[]U[KWOW7NO>_=>Z][]U[KWOW7NO_1WL>G
M?^91=6?^(XV/_P"\SB_?NO="/[]U[H&-^=4Y;=^;S&3Q6_\`*;2H]S[-I=C;
MGQ]!@L'D9J[#TM7N"=)\9E<C!)6X7(F+<U5'Y(S(EQ&^C5&"?=>Z1-?\7MKT
M]!N#";(SM=L?:FZ8,52YW9$6%VYNC9>0IZ'$QX&J:?;^Z\9E8'K:K%4%`L4Q
M8FGEH(V"NKRQO[KW0@9?IK;>4_T1+'D<]01].5^/J,(L%>)I,WC,=AEQ<&!W
M-45<4\V2QSUU%C\C(;I*]=C:>0OPP;W7ND;B_CY_#J#*X@[WK'QTF9FW-MFI
MIMK[9H-R;9W,F[IMXXO+R;@AHV?<9QE?421&&NADBJJ=V68/J8M[KW3!_LI.
MR<C3YL[KRU=N/(9F@S?AF7%8+!8C;NYL]5XZKK-W[8V[AZ&FQN+S'EP.,?U"
M999Z!9I?)+)(S>Z]T(6TNEZ?;F^WW_E-V9K=N:IL)7;>P]9F*#`TN7I\5EZN
MAR&3I,[G</C<?D-V0Q5N.B_AR5A*8Z#4B!F8R>_=>Z&SW[KW7O?NO=>]^Z]U
M[W[KW7O?NO=?_]+>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7NF23<F"ARF2PT
M^3IH,CA\+2;CRD$[-`E#@ZZ?)TU-DZFIE5*6.FDFPU4"2]T$+%@!8GW7N@ZH
M>_.H\A_"1%O*DIVSVX=N[7PB9/'9K#R9;,;OI\C5;23')EL;1-5T&Z(<14_P
M^M0&BK'B,<4K264^Z]U*C[NZQERM#AXMR-+59"HQU)#/'A-POBH*W,9K)[<P
M]%DLVN*.'Q-9ELYAZFEIHZJ>%YIHPJ`EX]?NO=-]=\A.G,92;AR&3WQ08[&;
M7BDJ<OEJZAS%+B!10;AIMJ5F2QN5FQR8_.8K&[CK(J.KJJ*2HIZ29U\SH"#[
M]U[H3\7GL3FILS3XNM2KFV]EWP.9C1)D:@RT=!C\F]%)Y8XP[B@RE/+J34A6
M46-[@>Z]T[^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_]/>QZ=_YE%U9_XC
MC8__`+S.+]^Z]T(_OW7N@)WSL+=6X=U;M%%38:7:G8G5]+UOFLE+F:FBSFVC
M'4;T:IR]'B/X)646>1Z?=4?CA:KI#KA8,=+`^_=>Z#S*=&;S[$S>#R_92[,I
M:?$XO![6JL9M?(9F05./PU-N#(?WOQE;58FCFP^XJ3>-1C*[$4H$B8U:1V>I
MFD8*/=>Z3NW^A.VZ;;$^RMU9G9V=7>6%V1CNP]\X^NR^+R?W6V=Y[IW%N+)X
M/;W\%DA;*[II,U$T,AK((Z"M>5PDB11+)[KW3]E>CM^;HQNW]L;C7K^?;FQ,
M+6;5PT8DR\R;YP&6SNVX\BFZ\4^,$&'@?8F%DI)Z6&:M6LR4QF\D$*JI]U[I
M<=.=*5/7^2S^;W5DX-T;@AS^ZL=L?<,=7F%R%%U9EAMG^`[;W)2S5"8O)[@P
MM-MJFHVK_#)-+3TL;"13),A]U[HPOOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[K__U-['IW_F475G_B.-C_\`O,XOW[KW0C^_=>ZPBHIVG>E$\)JHX8ZB2F$J
M&>."9Y8X9GA#>1899('56(LQ1@#<'W[KW3!_?/9_\-R.9_O7MK^#X>KDQ^7R
MO\=Q?\-Q5?%)'%+19&N^Z^UH:N.69%:.5E<,X!%R/?NO=/+Y''Q4]-5R5U''
M2UDE'#25+U4"4]5+D)(X:"*FF9Q'/)72S(L*J296<!;DCW[KW7&/*8R9_'%D
M:&5_O9L9HCJZ=W_B-/&\U1C]*R$_>P0QL[Q?YQ54D@`'W[KW3&^^]D1XZ?+R
M;RVJF)ILDV&J<H^X<0N.I\NBZWQ4]::P4T621.3`S"4#G3[]U[IP.Y-NKBY\
MXV?PJX6F@BJJG,'*4(Q=/33PQ5$-1/D#/]I%!-!.CJ[.%9'4@V(/OW7NH=/O
M79M4F*DI=V[9J8\[63X_!R4^>Q4R9FOI6T55#BFCJF7(UE,_$D4.MT/!`]^Z
M]TIO?NO=>]^Z]U[W[KW7O?NO=?_5WL>G?^91=6?^(XV/_P"\SB_?NO="/[]U
M[HMG8>-W)+OC?-%A]O;E>3L;IS&[%P.\,32TSX7`9^"L[&<R[@R462@RV'@H
M&W!22I+%3S7$C%#K0@^Z]T!N;ZWS&51<QB>G]X==X7`X#9>`FQ&TZ3KNOW%3
M[UVO+N-Z?=F+VKE:G);0W_MC;U-D?X:[5B+4Y"ER$DU,BM2QO[]U[I2[VZL[
M;["ZJZHZ[;`;)VSDL#B:_>&;ECQQHMJX7>FT(H_]%M+AL3@,S"<1EZ3<E9!F
MA%32U&-H)\68@TT?BU^Z]TB#T[VU79;*9?`;2J=J4O;&]^SMX;UH<CG\='4;
M*WO5]2Y7:>U=WX\X^JJ1]EN>@K'V]DC27J%:*DK@H/F/OW7NIN5V;NNLRM)F
M,3TK6;!VQB<[L_\`:VWL38.0WG1U>%V?OS;]1C1@JS/YG:>\]LX-\W#'2YHT
MM-5`5C"!)(H0Z^Z]TI-TX'=&1VAVSM*CZ\WS+4[QKNN=XXG)G:VSS25&/VWA
M.K8,E!/B:C*)@EW933;:K-.(FITHY9(%C!,<@'OW7NF;=NR-X9BKV5G-K;#W
M?7;CIJ48B.HWKLSK%=G9F&FWK-G:C";^V8OV4NQX*58HZS'[CP+I6N;B5)IH
MX(I/=>Z/_P"_=>Z][]U[KWOW7NO>_=>Z_];>QZ=_YE%U9_XCC8__`+S.+]^Z
M]T(_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[K_U]['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z(O\AI.PJ3LS/1
M;/K=\1TF^N@<EU93/@WS;X7:V]=RUN]LQMG?,:40:EQV5QE#MNO@DKDTS0M/
M1AF`:('W7ND#M[(809#L^?>>0S,=4<%74E-3X>O[1;O%*.?9&REQ*;5II)SM
M@UWWLJ?920Q7,Y1IF\AJ3[]U[KAC,GV:N.P,'8M7O*/=='!EE^20Q)W1'04]
M)_?CK%MP5>UCB56EBVH^RY:<T$F)(J(L2^192M0*EA[KW3YFLCM<XJ84V4[F
MCVA'M?<J_'F62HWB]9D>Q%S^<C@?`2X^^4R<5(KXN':D6;,B2XLU!59*4NWO
MW7NA$[*K98\_M>/MNJ[`HH6ZOPT^UJ?K=\Y%+5=VG(U$><@PAVYJIJS=T434
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M7NO>_=>Z_]'>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7NB7=\]O=A=?\`8>X,
M!MW.T$%%G^@LVG7^+J<3CZAJ7O6:OW)4;1K)ZN:)IJJER>#P=<XHI28)#BFL
MMV<^_=>Z1=3\A=_8^OVPASD^6Q>)WRV?[`J\5L^DRSP]34NWM@X:9,NV/CCB
MVI1R9[>=;G&R4EF$&#F@!\;$#W7ND\OR%[;^V_A+[MP3YC;VY^[,[N/(4^&Q
M#K7=:5N$[:FZ%%,?`<>DPR6UBTLL0,E7'M^;R$B:35[KW5ANW*R?(;>P-?52
M":IKL-BZRHF54199ZFA@FFD5(P(T#R.2`H`%^./?NO=//OW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO_]+>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7N
MFJLP6$R%0E7D,/BJZJC-.4J:S'TE34(:1,A'2E)IH7D4TT>6JECL?0*F4"WD
M>_NO=1X=K[:IER"T^W<%3KEJ5:'*K#B:")<G1+":9:/(!*=16TJT[&,1R:D"
M'3:W'OW7NL*;.VC'"M/'M7;D=.E-!1K`F#QBPK1TT63@IJ58EI0@IJ>#-UJ(
M@&E$JY@`!*^KW7NE!'''#''##&D442+'%%&JI''&BA4CC10%1$4`````#W[K
MW7/W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__T]['IW_F475G_B.-
MC_\`O,XOW[KW0C^_=>Z*UV]WUN3K/>>[MNTVVL1E:#'_`!^W+V9M&::NJX<A
MG^Q,%E:VCIMD3P1QM%'09.B6&9)8[S@1U!"D(/?NO=/_`%GW!G]Z;SK-L9;$
MX.BI:/;M;EVKL;55LK/54<FU8RBBI58_M'.>F(;]5HT_JWOW7N@GP'RSR>9Q
MN)S\>W]LU^%_TNY#`;K.'ST]76[7Z=R&ULUNO:7852B0S1RYJGQ--2U69QRW
M^TIHZPJVJ!0WNO=##UEW;)O6FVO293:&Z*?+9^2KADS>$VYELAUTA@H,AEX:
MNDWDR&@GQ=10T:Q)4:O&];((%.L@>_=>Z'WW[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7__U-['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z#[<_5>P]Y
M9FAW!N7`193+XQL<^/K):NOA:C?%4^YZ2B:&.FJH8O13[QR"L"I63S*7#&*(
MI[KW25K?C_US4L7I8-QX0RX[(X>O_@&[]R8C^+8C*4V-I*S&93[3)(:ND>#$
MPA02'C(8HP+L3[KW2A3J'KN/<&#W+%MNFBR6W=N1[2Q4<=16+C(L!#0Y'&4]
M#48;[C^%5WVV-R]53QR30R2+#4.FJQM[]U[I1;*V9MKKO:>W]C;-QB87:NU<
M9387;^(CGJJF+&8JB3QT=!#-6SU-4\%+"`B:W8J@`OQ[]U[I4>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z_]7>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_
MOW7N@0WIWG@MD;XK=AY'!9ZHR<77J=AXVOIUH$Q.9I8=PS8/+X&BJJBLB==P
MXBG5*]X'11+1,[QLQAE"^Z]TFL#\C*/+U9>IVQ%18-MVG:AR5-O+;&7R6*/\
M8SV&3+[KV]05+5VU\:U3A+'[AC(CSI&RAU<+[KW2KZD[GHNW*+'5V/VMGMOI
M5[1QFZ*^GSDF,%9@ZC+9G.XFEV[E*>AK*IHLQXL!+5,`3&()(SJNX]^Z]TEL
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MF!:6GF"^Z]T+'OW7NO>_=>Z][]U[KWOW7NO_UM['IW_F475G_B.-C_\`O,XO
MW[KW0C^_=>Z!/LSH_`]H2Y.?+9G-8RHK$Z\EQ]5B#115>$R?6^Z\SNG%Y+'U
M$]+.^K*_QVHH*^%]4-3CY7B*^MC[]U[I%UGQK7);-W]U_6;[K8-M;VBR"05&
M%VKMK"[KPCUV[)-U)/\`WGIZ:2;-34KS-3JU5"S.C%V)D)8^Z]T(%)T[C,1%
MVNVWMQ;BV_DNU,_2;CFRV+J*:"KVM7X_;N`P-##MY13B),;%)@?N7IYA(DLE
M5.K?MR:1[KW21Q?0$^%S%%F,=O<^:3$T5%N1J[9FV*RKRN0CS&Z,YD\OA:]8
M::;:#Y.MW;4VIZ,&"F18Q$H(8M[KW4>E^-F)VY15%)L#=-9LD9':VUL!N"EI
M-M;3R6!W=D-JT%3A8MP[LV_78DT&8KLWM^NEH\BG[8J5CII`4DI8F]^Z]UGV
M3\>XNO<[A<AMC=<<>'QF.V]CJG#9+9FV*ZIFBP--D:<KB,['3TE=MNCJ_P"(
M$I24JBEHT7QT\<<9*^_=>Z&?:6UJ3:-!D<?1SRU$>2W/NS=$KRPTT+)6;NW'
MD]RUT*K2PPHT<-7E'578&1P-3LS$D^Z]TJ/?NO=>]^Z]U[W[KW7O?NO=?__7
MWL>G?^91=6?^(XV/_P"\SB_?NO="/[]U[I"9GLW86WL[D=L9K=&-Q^X,5M>B
MWK7XB=IOOH-JY#-S;<I<[X8XG:6@?.0-3,R:C'(5UA0Z%O=>Z;\;V_U]EJFE
MIJ+-51&0STFV,;6U6WMS8_$97/Q563HGQF)S>0P]-A\K4+4X:J7_`">>13X2
M;V*D^Z]U`Q_>O4V5VPV\\;O3'UVUX]H+OZ3-4M+E)J2/9S9"NQ7]X)=%`98Z
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MC8__`+S.+]^Z]T(_OW7NBQ=S=([D[`W!6[KVQEL'A=Q4F#V/A-OY'("L;7AZ
M3>.7R/9NU<U'34LC28#>VU:Z"&)D9I*?(T<%0%!A&KW7ND=/TCV0W76^=EX6
M+"8+==37Y/-;+WWD=_;MW#A8,S-OK(;AQU9%LNHQHI-H218C)RH[8\,1(3'Z
MDLWOW7NA=ZMZA'7]=V73U,N,K]J[FRV-I-FX"."22GV_L.@V]20MMFM@JHO!
M*)-TY',U15-<3PUBZO47`]U[I`;+Z9WQU1MWKW^XT>T,MN#:N#WWMC+8K/9O
M<--AZVEWKN+'9ZGSM+GOX=ELLV0Q53@Z%*E)J=S542&))(VA@O[KW28@^,N[
M\-18\8C=\=;-AZ_$B/!9#*96'9F8H4ZVH=IUN8J-M_9UU%C-VX'=$39'$U"B
MI44\$-/+^'B]U[H7NA^KMP=.X.MV/-D:'*;.IX<-DMMS/793);CH<W78]?[]
M8_+Y7*QM69W'5&Y(7R&/K*B9ZI8ZYZ5U2&FIP?=>Z'GW[KW7O?NO=>]^Z]U[
MW[KW7O?NO=?_T=['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z;:_-8?%38^GRF
M6QF-J,O5K08F"OKZ6CFR=<XNM%CXJB6-ZVK8<B.,,Y_I[]U[J-1[FVWD<E78
M;'[@PE=F,6';)XFCRM!4Y+'+%(L4AKJ&&H>JI!'*X5O(BV8@'D^_=>ZDKF<0
MZ+*F5QKQ/COXPDBUU*R-B;`_Q17$I5L=8@^<?M?[5[]U[J.VY-NI6UF.?/X5
M,ACL;_&,A0-E:%:V@Q`"L<K64IG$]+C0K`^=U6*Q'J]^Z]U[%[DV[G*&?)X3
M/X7,8VE>2.IR&+RE#D*&GDAB6:5)ZNDGF@A>*%U=@S`JI!/!]^Z]U@.[=J#&
MX[-'<^WAA\O514.)RQS6-_AN4K:B22*"DQU=]S]K6U4TL+JD<3L[,A`%P??N
MO=.,V6Q5/'++/D\?!%3SR4L\DU931QPU,4!JI:>5WD58YXJ93(R$AEC&HBW/
MOW7NH&4W7M;!JCYK<N`PZ2NB1ME,SCL>LCR0/4QHC5=3"'=Z:-I`!R44M]`3
M[]U[J92YK#UT%!5466QE939226'&5%+7TM1!D9H$J))XJ"6*5XZR2&.DE9UC
M+%1$Y/"FWNO=.?OW7NO>_=>Z_]+>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7N
MBI=S[.R>3W/N>J?K6I[&7>76=-LC963IEPDR;`W5%7[CJ:BJKVRU923[>QN2
MFRE!6OEZ023Q/BE729$I5?W7N@7JNG.X,%-35^/Q--G<QESW#MO%96EP>`P^
M0VCNO>V?J,:G8.\,_1Y>GS>\-E;DVY65N3:)U^[HJ]*8/'*SQFE]U[I-Y/H/
ML[`8O)4&U^OZ2MRW5'4N^>M=@TV*RR8G9N^^L]Y[DILA+U=1_P`7RM;DZ1Z3
M:4D-)229!BE)DL)3R>0Q327]U[I7[JZTWN<?FMJT/55/N'<OV_;55G.QJS!8
M7[O<N,WA@=P4V)R^!W8VY*6N_O#+25E)AY-NUU#/2/'%ZVCIX*>4^Z]T+W]V
MLYN'I+<N`HMN[BR->=PX2OJMN[JVKM3K:LW9AL7FMM9C-;;CH=O+2X-J7.X6
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MYE%U9_XCC8__`+S.+]^Z]T(_OW7NB@=ZUT5/NW+1[ARF^,=.O7]'-T=3[4EW
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M-;JJJ)\+#419Q7U8*9))E"RU\@]U[JQ6D-2:6F-:L25AIX35K`6:!:DQKYUA
M+>HQ"6^DGFWOW7NI'OW7NO>_=>Z][]U[KWOW7NO>_=>Z_]7>QZ=_YE%U9_XC
MC8__`+S.+]^Z]T(_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[K_UM['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z*
MWV=NCLF'M,[>V5E,M24V*V9LK<S@T^S4V/CX\AO;<=%NK*]AY'.^/<,>)&U<
M&_VR8UQ*LL+LMG(O[KW2#ZG[WW?NW?FW,#F\O64D&[=T;IWA@\1G-JT6W*VM
MZAS>T\OE=DQ8YG'W&5I-MY7%K%-E([?>/4(K<?7W7NF#KSO?M#<.[NOMI93<
M&&GJAVWOV7>WAQ%!%49#J?<,O8\'2E%`T4:TU%7RU6`=)IH1YYQ@)]9_<DO[
MKW26P_='<=;1XJ"IS^?DJ=YYC;;8H4XZO2NRE)/V;F]M9I=EUGVC8_;-`,+3
MTL7AW!$]4\A)IY#*LX]^Z]TN]S]\;ZV3O*'%TYSN1P>W]@9#;N<I-SX''9..
M7NC-;8R6_=I4N7WYM*&DP(R%#CL-38Z?'TFA*C^/02)ZD4GW7NE$G9&^=L[V
MV+MC#;]IN]1N.@K\[E<5BJ?8V`RU'35&SCE:.9<QY\?@EP5=7Q&NQT&I:^.E
METR25,`60>Z]UAINS=X[@PFR&R/:&+ZW`^/N-[=RVZZG"X*II,UGY9Z>GR0R
M=)D8A1-M7;T:AZ^GQSTU3(:^'QU,`">3W7NDOG>Y^PJ#9%%V+2[]HCD]U93=
MV*J.O7P^!$>Q,5MO*3$[@IEFI$ST1VQCL>#FVRK2QE<HC::4QPJWNO===K?(
M+?>P^P^T:NFW/@5ZNV1L/,R9-IL90U<VV,YD<5M>#;F\4KZ=3+7X?:VZZQJ?
M.4\I<04V228@+3.#[KW3QF-[]L;0B[2WE2;QRF[XNIJC9>6K>OLS3[+QE)N7
M!;DV909C<."3-TV"QE5A<O39+*>?&U<DS11K3K!,DJ2,X]U[H8_[K_(3[+[;
M_2;M7[K_`$8_;_?_`-UH/-_IA_O!_%?XIX?M?MO[@?PC_<9]MI^]\'[NOS_N
M>_=>Z__7WL>G?^91=6?^(XV/_P"\SB_?NO="/[]U[IOJ,3BJMZR2KQF/JI,C
MC_X3D)*BBIIGKL4#4L,96-)&S5./#5DQ\+ZH[ROQZFO[KW3!E^OMA[@^P.=V
M7M3,-BJ1<?BWR6W\36R8R@4QE:''25%)(]%1@Q+^U$53TCCCW[KW3A3;4VO1
M24\U'MO`4DU+]F*66FP^.@DIOX?_`!/[#[=XJ9&A^Q_C=;X=)'B^[FTV\KZO
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MLG'8UL-C]G[7HL0^.K\/)BZ7`8J#'R8G*R^?*8R2CBI%IY,?DYO740LICG?U
M.&//OW7NG.3;^!FBR,,V$Q$L.82"/+128VC>+*1TL"4M-'D8VA*UJ4]-$L<8
ME#!(U"BP`'OW7NG?W[KW7__0WL>G?^91=6?^(XV/_P"\SB_?NO="/[]U[HM/
M9W<>Z]G]E8W96W<;@<P9\%M/,Q;>EQNZ:O=&YWS^[<Q@<I2X7(XJ&7;^`BPF
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M<QU-)5PI44T\9(!T30R*PN`;'W[KW4OW[KW7O?NO=>]^Z]U__]'>QZ=_YE%U
M9_XCC8__`+S.+]^Z]T(_OW7NF>/!8R+/UFYHX9%S%?A\;@JNH^XJ#%+C,16Y
M;(8^$TAE^U62GJLW4L)`@D(EL6(``]U[I"-TQUU)0X#&R8.22BVSC*?#X>G?
M*Y9EI\=396BS4--(36ZJD#(8^)BTA9F5=).DD>_=>Z;,/T-U]BJ2NH:B+<&X
MJ:MV;5=?(FZMSYS/_P`.V97*B5F`Q)KJQSCJ:J2&(221VJ&$$=Y/0MO=>ZC?
M[+YUR\65IZJ/<U?39+'9?&4]-D-X;CJX<!'N!H9<]6;:6;(L<-ELQ4TZS3U<
M1^Y,FHJZB20/[KW4UNDMLR5>-R4^X.P:C+8VFK\<<O/OG//D<CA<E6TF0J<#
MEYQ4A<CAQ542M'%(I,>IPI`=@?=>Z6Z[*VVE!LW&1T#)1;!J*"IVK`M76#^&
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M>_=>Z][]U[K_U-['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z#K=/;'7^RLS!@
M-SY_^%Y.:CQV19&Q6:JZ.BQ^7RLN$QM=ELI0XVJQ>&HZS*P/"DM7-`A9&YL"
M1[KW3'EN_NG\"NZI,QOC'8ZGV519;);DK:JERL>.HZ'`5M-C=P5--D3C_L,O
M'M[(5<<&0^SDJ#0RN%G\9X]^Z]TZ9CN/K;!YS([9KMRQR[CQ-3@J3(X#%8S-
M9[,TU1N7$YO/82,XS!8W(UDAK\-MRMJ@41@D-.6<J"M_=>Z$.BK(,A1TE?3>
M;[:MIH*N#[BFJ:*?PU$:RQ>:CK8:>LI9=#C5'+&DB'AE!!'OW7NI7OW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_]7>QZ=_YE%U9_XCC8__`+S.+]^Z
M]T(_OW7NBU]L].[JWMN?([JP&?-%)3[=V)28_;E5F\I1;6W=4[5W?N3/9G;F
M_P#$T5%41U^WLYB<PM-#.I>>CF9Y/&Z:HY/=>Z06XOC_`+XW7M&+J_*G:PV;
MMZEWCC\;FSDJ^3.[OQN]<B]+)39BB3#QP8.6@VIDZU*]HYJL9+(>&1!!$74>
MZ]TW4_Q][)Q>3I]T5T^#W1G)MP8_*YR+`;OW+U[7UM+A]N;_`-BX&FH-SXN@
M.4I4Q6T<GA/*A8"HJ$K`3I*>3W7NC'[:ZKVGCMP4_84F#K\?OFKI&?)O)O/=
M.?I8*NOPN"PV0B\5?DABJYA1[?IHQ.:1&=T>8!99I6?W7NA3]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__];>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_
MOW7NFZKR^)H*O'8^NRF.HJ_+R318FBJZVFIZO*2TT8EJ(L=332I-6R01,&=8
MU8HIN;#W[KW7I\QB:6ER%=4Y3'4]%B3*N5K)ZVFBI<8T$23SKD*B258J(PPR
MJ[B0KI5@3P1[]U[J$VZMKI68O'ON3`K7YNGAJ\+0MF,>M9EZ2H5VIZK%TQJ!
M-7T\ZQ,4>)75@IL38^_=>ZG-EL6ITMDL>K?Q!<3I:LIP?XHZ+(F-L9+_`,0>
M-PPA_P`X5(-K>_=>Z;\ANW:N(:),KN;;^,>>JEH84R&9QM$TU=!X//1Q+4U,
M9DJH?N8]<8NZ^1;CU"_NO=2:S<&!QU+]]D,WB*"AU3)]Y69*BI:753S?;U"_
M<3S)#J@J/VW%[J_I-CQ[]U[J+!NW:E2N,>FW/MZH3-5510X=H,UC95RU;2$K
M5T>,:.I85]52E2)(XM;H1R![]U[I0^_=>Z][]U[KWOW7NO>_=>Z__]?>QZ=_
MYE%U9_XCC8__`+S.+]^Z]T(_OW7NBA=W;1W17]H;7W+M;9>5W#DH,?MJD!R.
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MCP>&%51*M$R8]KJ`=1]U[ITPG6.\]M;LQ^XLULO<=&^X=Q=B;OSLVWMF;/[!
M89WL+.]>;OJ\971YJ:K;#T]$\=1CQ6TBAI!C3Z@J0EO=>ZE8;I'?6,RT=%+L
M..MV9N'#_)3=U519"LQV4EVOV-O3-2I'BDQ]?42T[X3LNGFBS,/CUI19*&I$
M@C6I4+[KW3QD>J\UC=MKM^;J23<>3W1TQUYL[8M9C:/;E-1]4[TQ&/RC9V;)
M5WW<$VTQ2;AR$&8;)8])9*J:ET`M-!2J_NO='TIHY8J>GBGF^XGC@BCFJ-`C
M\\J1JLDWC7TIY7!:PX%[>_=>ZS>_=>Z][]U[KWOW7NO_T-['IW_F475G_B.-
MC_\`O,XOW[KW0C^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
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MJ,OUR*Q8WW7VS2=!Q4VYVVMG8,QO_P`,G9<,>VI:>CV?G:+S;KRM!BZ5*N3#
MPU;U%)-FOO8Z<3&&"*+W7NCG==2[DGV!LJ?>"31[KEVK@9-Q)4Q1P58S+XRF
M;(_>00JD,%::HL9D0"-)=2KZ0/?NO=+/W[KW7O?NO=?_TM['IW_F475G_B.-
MC_\`O,XOW[KW0C^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO_3WL>G?^91=6?^(XV/_P"\SB_?NO="/[]U[HL/
M;?8&Z]H=@X(P9RHI-@T-)M*7<J[939V;R^!KL]O5<&E?OW:F<>#=E3L;<5',
MM'0UN!E%11UL53+-%.D:JONO=`W6=^=NC:N/CDA;`[CW+UE54&U<K)C]M[G&
M<[&W!OS`;/P6Z,-MS;M55Y*OI-MT%?4Y"7&R10_=00L"ET?3[KW6"?Y([_CE
M@RK9:AIMN9W!=*[2CHJC;\%-N;9_=V>WOEL'N';F=HY]2T46_/X;48BEBJDU
MXW+4\"G2*M=/NO=/N4[BWWA\-19V'?DN9S>\MMON7$;/BVAM^+;]'64?9&V<
M/F-J;<W?+)3?99S:6(R4F*RM+FO.\M9,E1'+2-&\+>Z]U&W-\A^P\/GDIZBE
MK\/!MWM',YO?&"@P&,W9D\1TSM_$;*Q-7192LV[/78_"05&;W?/E_P"+R36B
MI\3-`S#U!?=>Z-?U9G\GN7:M3D\OD*7*54>\^Q\1#7T<,$-+/C-O]A;GP.&,
M(IOV9$CQ&-@7R"YETZR26)]^Z]T(WOW7NO>_=>Z][]U[KWOW7NO>_=>Z_]3>
MQZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7ND[DMH[5S.6Q.?R^V\#E,Y@GUX7,U
M^)H:O*8I@_E!Q]?/`]52`36<!&4"0!OU`$>Z]US3:NUXY,5+'MO`1RX%2F#E
M3#XY9,,AU73%.M.&QRG6UQ"4')_K[]U[K'_<[:.G*)_=;;NC.9&ER^:7^"8W
M3E\M0UD>1HLIDQ]M:NR-'D(EGBGEU21SJ)%8,`??NO=1(^O]B0Y'*Y>+9FU4
MRF==),SD5P&*^]RLD=7#D%?(5/VOEJW&0IHY[N6)GC60^M01[KW3D=L;::?+
M5+;>P9J<]2O0YVH.)H#/FJ*1'CDI,M*:?R9&EDCD96CF+H0Q!%C[]U[J=C<9
MC<-10X[$8^AQ>/I]?V]#CJ6"BHX/+(\TGBIJ:.*&/R32,[64:F8D\D^_=>ZG
M>_=>Z][]U[KWOW7NO>_=>Z][]U[K_]7>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_
MOW7N@![([7S^R.PMF;=:@P^*VEGWPU/+NW<U%N@X;*YK+YR7%-M*AW'@L?7X
M3:>XJ:CCCJ*7^,^.GRTU3'30NC++(GNO=)+!]^;HR_7&]=XMMG"097;,6SS0
MXYJ[(+1U4VY1CA.E;(U/]S3BD>M(4*K$Z>??NO=3CV_V.U!)NJEVOLZLVGN?
M*UFV.OJ=\]74&X8MQOO6CV1MM]TQRTU13U6)S\]1)75)H$,^*IH-#+4%C)'[
MKW24SGR-WILG=#;0W?MG:DLN`IMQIO;=V+RV2H=MX>>LP.%S'5^9^TR%/45M
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ML+V)L+D"PO\`FP))`O[]U[KOW[KW7O?NO=?_UM['IW_F475G_B.-C_\`O,XO
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M*?:+Y&;`Y;$;BS5!G*:JRV5I,]75M3EHZPU64JYLY0Q5FNJ,^FH0,+<W]U[K
M'6=![.R*YB.OS._JJ+<.,QU#GX9-[YU8\Q7X>EQU'BMSUBQ5$9&Z\?#AZ3QU
ML1CDU4T9()!O[KW2TQW7V(HJ?`0UN1W)N&?;.X*K<N'R.X\_7Y7)4^3J\9D\
M.XDJG>,U5'%CLO41QP2!HTUA@-2J1[KW2Z]^Z]U[W[KW7O?NO=?_U]['IW_F
M475G_B.-C_\`O,XOW[KW0C^_=>Z";=O8^;VUOW9FR:/8E;G8=Z?=_9Y^#<."
MQ]+1'$I]UG15X^NFCR,G\.QK+,GA23SLV@:2+^_=>Z:=H]YX+>-;BJ.AV_N.
MB7,[\W;LC'U.3IZ.FCJ8=LX/)[CQ^[88Q6//)M?>.&QOW&*FT"2>*569$`:W
MNO=3<YW)C,+UIGNR(]M[DS28;,;@P--M7"P457NC<&4P&[,AM)Z/!4;5L5/6
M5-?58Z2>&,RJY@Y8`@@>Z]U#D[[V.,S682"IBJ*R/*]98W$QC*86"HW'!VE+
MBDPV6P=!59"'(U>-H8\JLE0WB#:(Y-`?0UO=>Z3-?\E]MTNWLEFX\#D8)H.Q
MJKKO$4VX\MM[:F-S<B4M?D<1NQ=Q9C)QXC%[0W7C<7.V(JJEXVKZCQT\:>65
M5]^Z]U,J_D-C:7/[CP9V=GEEV?M"3=6ZJ6IRVT:7<>!T[83=:15FU'S[9>HP
MQI)DHFR](*G'#*/]NLC".:2+W7NF:;Y(208K;M6^SL0:_<]=F(,;`G:_7;X-
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M^Z]T[GX]#*M08?>6\I]U[`QF\L[ORFV5+M['XE9]P9NMSN5C;)9S'5*5]70X
MC,;BGJJ:)%A(DC@#LXB(?W7NHN.^,>`Q6WZ[$46XZX918MDTVUMUU."VY5[B
MV=2=>3J^TX,375&/>20XVE@@@U2&[I#<^IY"WNO=08OBO@,#1U-'L3<E3M:E
MR>V=N[?W%AZ_;NW]W[8WE4;?^_A7,;PP&X*::/+U5919*1&CCEIHDE2*0#T%
M&]U[K#+\5,1)'MO%MO7,S[>V?M^?$[6I*_"[>K-P;?JJC;%?M:5<3N\T<68I
MMJSTF0::7"'51O*`EUIO\G'NO=3IOCOE9L?MB)M[;:&1VG4YA\=(O4.SDP$]
M)F\'BL35+7;629<<V5CFQ$4L5;"T$B1L\&GQ,1[]U[HS-)%)!2TT$TJ3S0T\
M,4LT<*TR321QJCRI3HS)`DC`D("0H-@>/?NO=2/?NO=>]^Z]U[W[KW7_T=['
MIW_F475G_B.-C_\`O,XOW[KW0C^_=>Z0&?[0V1M?=&#V9F\K4TFY=RV_@6-C
MP6X:[^)^LI)]O68_%56/_P`EMJGU2C[>,B270A#'W7NH=/W'U?52XZ&GWKA)
M9,MV)F>I<:J3R6K.R-O09>IS.SX6,04YB@@P-8SH2%(@;2QXO[KW33+W]T]%
M514AWSC9'DR66Q+U%-2Y2KQM'7X+==5L;+193+TM!-BL1%1;NH9L>TM5-#":
MB)E5CI)]^Z]TO,#O':^Z*W=&-V]G*#+5^RL^=K[KI*.;R3X+<`Q6,SG\*KT(
M!BJ?X5F:6?\`*E)AS<$#W7NE+[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[K_]+>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7N@EW_`+3W7EMV;%W9M:3"
MFHV9C>PRM+FJBL@@J\MN#;28[;R/]G33L:%<I$IJFNKI"24#-Q[]U[HL-3\7
M.R\3AJ#";8W?@,A-AZ?!=@;>SFYT"MM[O3:^T\Y@:/)TN-P^WZ:&JVMG:^LI
M)ZZ68R9!PDQ<RLZCW[KW2XVI\9%QF7R$6=JYI]FJF9DIMKX;<>5QN-W+4Y'?
M6:WEX]Z8Z*EAARU%45>3,K1/*\8DFGC=98Y&U>Z]TK.GNHM\=<[JK-Q9K=%%
MN%=\[8DJ^PX!34E*:7L9-S9'<%/5[?>CQ-!+D,&:7=60H3+7,U8(**B7]`*1
M^Z]T93W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__3WL>G?^91=6?^
M(XV/_P"\SB_?NO="/[]U[ICKMS;;QE=%B\EN'!X_)SK`T&.KLM04E=,M5*T%
M,T5)/41U$BU$R%$(4ZV!`N1[]U[KV,W-MO-22PX?<.#RTL$WV\\6,RU!7R0U
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M(R;%KZ>/<=#2]8;8VWEL8:KJK<&VA'CJ;;]3`=V4D&7G6*6K9YI(_(I!*.S>
M_=>Z$/N';79.Z.Q]M;_VYM"/)8KI^CVUF,)0Y*G6'<>X*S=F5>E[*QNT)/XQ
M38Z&H?KI&QU4F3B:*22J*0Z65G/NO=(:EZ8W;6+C]O9_9=3D-M;/[`VOU1@'
MKY\95U&0Z7PT.[LG-O%`M24Q]"\>[*'&B(`52R8-'\>DH3[KW2XZ^Z1S6\,+
MCMQ=KPY?;V^-N[KQTN#\=;C,A4I+U91KLG9.\I9C%70R-F*:'+Y>"F9BD<6Y
M95E3S*"GNO='%]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_U=['IW_F475G
M_B.-C_\`O,XOW[KW0C^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO_6WL>G?^91=6?^(XV/_P"\SB_?NO="/[]U
M[HM?:FT,=N#M_J&"L&YA0Y^BWY09]</N3>&&H)Z?#X!:["_>K@<M04-//2UU
M7(\$K!93(;!B5`'NO=%^S/\`?>GV-D*K>O8T\F2P_9U1UO02;GE[%V[L;=FT
M.LX\_B\1_?;<VS%&:V;NK>4U:<Q59V`24E;EZ*EI5CD@\<+>Z]U/AW3FJF&F
MRDE7V/B^Z)'V!)U;L+<&4W)5PU>P9]N[;?.C<,%-#3;:W!39!H,S/G<E5HM9
M3U%-$6---'2QGW7N@Z3.=B4N`I=G;IWGO"*'!]6]5Y:CWUO_`/OI#M3?FWMV
M[BS%7AJ'?^<V:*?/;=W#'!!)B,_DHVCFBJ*:BFJ`]/6O"_NO=#S7;E?(=>=$
MY#?*[TVCUEEOX^O84F3W1N.KR\,]/B<A'LF//;WQL.%W34[;RU?&:FFKI4HI
MJQA0BJ"/,T+^Z]TD%S^1D>DDI=Q]KOVL*SKJ'I;![K?/45=G^O*BBV\<KD]U
M8"CIZ+:^1K<PD67DW%45R"IHQ2P-(*658`?=>Z0.+@[*CI=MX3"YC=FP\]N.
MBZ%W)M[*Q[EWSO''[MJ9=P5&4RVY=S+N&EB;"2UM120X'=&%C&G^'Y0U!=U6
MG\7NO=*/8F\<ANWL/`9O>4TNVQ6Y2LK:/:O9VXNP=OY[!9&/N'?V,R6#VOC,
M/+3[<S;XNKQT-+']ZK13TL=&\0^VEL?=>Z$'XU'=%)NRC@W.,]AI,YU#AMR4
M])6Y[>>Z:#?M?4YI%SF[,E/N>GAI-G;RVS-)#2UF*I[B9,FLJL\,4:P^Z]T=
MOW[KW7O?NO=?_]?>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_T-['IW_F
M475G_B.-C_\`O,XOW[KW0C^_=>Z)]WEVWO?KW?=/@L1G:*EH:G"8#M`4U9B*
M"8?Z.NL<U75??V/AK)6$IKJW:U9B_M9B&>EFGN@Y`/NO=(*I^0G8--G\3%'G
M**JP59USGA6Y)MIRQX.C[$WQM_</9O4YEW0L8Q5++AMFX6AH)\;*PDKILY3R
MV+`$^Z]U'V_VSW%G,;+38G/;IR==35.RHLOM[+8WJ#;'=-34Y38N8W3F)NM\
M'DS#L7<>W9X/L<A3_=D5-3!2Y.GAF62G#)[KW4QN_P#?FY,]#3;*SE958'+]
M9+M[;>9EV%'2T&1[N@V5)V8E35UE6]528RMR&(I'Q4NW&FDJ*:I8NK-8$^Z]
MT[]9=^;XWIN-IJ.H.[\)G:>O[CV9MS`XK`TN>RG2&Y<?2[9V-CA49'(XZB3(
MT>]L?7U515S5$324YC0G38-[KW1QMM9Q]QX6CS+X3.[=-8)&&)W)1PX_-4RQ
MRO"/O:*&JK%IFE,>I5+EBA!(%[>_=>Z???NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M_]'>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7NFC([?P.7FCJ<MA,1E*B+'Y3$
MQ5&1QM'6S18K.)3)FL9'+4PRNF/S"44(JH01'4")!(&TK;W7NHDNT-ISXZJQ
M$^V-OS8JNGI:JLQLF'Q[T%74T-+145%45-(U.8)IZ.BQM/#$[*6CBIXT4A44
M#W7NH.9Z]V)N*`T^=V;M?+PFCQN/\>0P>-J0*##2U4^(HE,M,Q6DQ<M?.U/&
M"$A,\F@#R/?W7NG%-J;7BBB@BVY@HH8,O#N"&*/$T$<<6>IU1(,U$B4X5,M"
MD:JM0+2JH`#6%O?NO=<L9M?;.$>DEPVW<%B)*##T^WJ&3&8C'T#T6`I)6GI,
M'2/2T\34V'I9W+QTR:84<DA03[]U[I]]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=?__2WL>G?^91=6?^(XV/_P"\SB_?NO="/[]U[HM7:G>&=ZZW='MR'`8;
M)PRS=>YE7ER-=3UJ;`K\_F<?VQN9X4HY86EZ]P^-AK5C#:)EJ5#LGU]^Z]TC
MQ\F-PG<T^VJ?:>WLQE)^ML]NG`[?Q&Y6EW5FMWP_Q3<VU]K08:6E$IH\UUC1
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M*W=M2IP&<J:S)45-EK3?W<W#05U/`]3DL?0U%/(^0I+4<LDCQB--"O+[KW0P
M>_=>Z][]U[K_T]['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z#K>/5&Q-^Y6FS
M6Z<+_$<E2[.WML*&H%;7TG^_6[#@Q=-NS&NE)4P1R?Q"'#P!)6!EI[,8F0N]
M_=>Z3M7\?NJJ_"#;]7MV>7'#<&*W*A3-YRER$62P>%H-NXD09BCR-/EJ>BH<
M'C(*9*>.=8O%'8J;L3[KW4S$=)[&Q(S$S)G,MEMQ[>S&U]Q[ASFX,IDMP9_$
MYI:**>/*Y*6H62>:DI,=#!22`*U+`FB,J&:_NO=-P^//4_\`#I<6^W))Z63/
M;*W/%]QE<I//1Y_KS<$NY]I92@J):MIJ.IQF8F=VT$+/$[12AXF9#[KW6:GZ
M%Z\@?-ZJ;.U5)E\!N/:U+BZS<N:J<5MC;N\#"^Z<3M"ADK##MVDS<E/$9/!9
MHEB2.$Q1(L8]U[IRS/3>Q\]N-MR5]-E3-4C'/E\1!G,I3[:W%6X6".FP.4W'
MMV.I&*S&3P<,2"FFFC8CQ1%]9@@\?NO=8L3TSLW;FZ,9O#:\5;M_.4FVMJ;)
MRU515<LQW/L[9%+G8-KX+/K6FI2K_A<^?EE%6`M:^E8WE:,!1[KW4?!='[*V
M[D:C)T$^YI9S+DVQ,61W)DLG1;8IL[GHMQ[BQVV**NDGIL30;BKX$2M559Y:
M9?!J$7H]^Z]U)VITQLO9>3&7P)S\-=#%18VAEK-Q93)C%;6Q@JCC=BXE,A/4
MKCMET-16/-'01:4\BQZBRPPJGNO="Q[]U[KWOW7NO__4WL>G?^91=6?^(XV/
M_P"\SB_?NO="/[]U[H%=\]WX'8&>7`9C"9Z:>3-]98F*IHEQLE.]+V9G\MMZ
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M>Z__U=['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z`_LOHS"]E[DI=S5N=S.'J
MZ?KCL3KEX<8M&8:BFW[3XV"GSKFI@E=<QM)J.>3'LI"*]9*6!]-O=>Z9*7XX
M[;@B8RY>HKLFM3UC-2YZNPV!J,Y0Q=:8;#8>"GI<F]":N&//KB#+5:'72]3*
M(]*NP/NO=>S/QXQ^6VM5;:7=>2@\_4NQNJHJR;$XC(1I!L7*U.7H<W58ZIA^
MSKY<E//HJJ20?;20@J`-1]^Z]T_U'3=/FMHX/:6Z<EA<G18;?&*WC)3XK96$
MP6#RD.)KQD(<)7[<$F1QTE-43<S3?YQVLP`8`^_=>Z;=U=(UV7K=RQ[7WN^Q
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MDTW-%DU_A_\`=Q,#304SXN>AEU57WK5$L<B:8O$&U/I]U[HL6[.^M]XW>51M
M?!8O`9"HJM[5>T8,!C\)F-P;SVO0XRCDK:?=VX\4VX=LT%;A=Z&(18\BHQ\<
M"S)(LU84FBC]U[I(4?R3[3^QILCE\-L2A_AV4S']_::EGI\E0;#PFW,QBL-G
M<CN#)TF^GS&,PV.DK)WFR%1B4J(_"KICY:?R3)[KW3C6_(OLFIP=;N'&X?;6
M!3$U&ZTR6#W;M[/4.1^PH]T;7CV;E16Y3<FV*'&TN?V1O6DJI7J_'2K5TLVF
MH\)U)[KW3[3?('>"4.__`"4NT-PYO";.HLELS%;0BJMP+G-PY2IQ>$Q5-EZW
M;VX=PQT4]5N3,0PRXR-#*8/WJ&JR,9D>#W7NN\3\C,WF8MY55.-I4\.+P>$R
M&'CJ*3-L,)Y\S@]M;IR._I8*YZ_!/L_,Y&J:NQ550XZI2FH_)!45,1FFI_=>
MZ0E5\H>R@!54>'VG_`I<T=J4FYLMBI<#B<MF*,T'\0K,)49/?\>/F=H*_P"Z
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MSB_?NO="/[]U[KWOW7NB==A[A[IV]NW=55M_/559@:'+TT\D*[`Q,@PFTJ/;
MD&X*RL_B`2?);RIL-5U<HDH*-4R=1#Y4I&-2`']U[I*MW=V2N-W=%!M&LQ&[
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M8S*B2$:U24PIJ`-FTB_T'OW7NLGOW7NO_]#>QZ=_YE%U9_XCC8__`+S.+]^Z
M]T(_OW7NFRKS>&H,AB\3797&T>4S;528;&U5;305V6>A@^YK5QM)+(L]:U)3
M^N01JVA.38>_=>ZQ5FX<!CC7#(9S#T!Q<=%-DA69.BI3CHLG,]/C9:[SSI]I
M'D*B-HX&DTB5P56Y%O?NO=1SNS:HJ_L#N7;XK_XA'B?LCF<=]W_%)EU0XW[;
M[GS?Q"5>5AT^1A]![]U[KE7[IVQBYEI\GN/`XZH>*29(*_+X^CF:&*6:&658
MJBHC=HHYJ>1&8"P:-@>5-O=>ZDTF=P=>)30YG%5H@HZ7(SFDR-)4"''UL<DU
M'7RF&9Q'1U<4+M%*;)(JDJ2`??NO=2(,ECJJJJ:&FKZ*HK:*.FFK*."J@EJJ
M2*M1Y*.6IIXY&F@CJTC9HF<`2!25O;W[KW4WW[KW7O?NO=>]^Z]U[W[KW7O?
MNO=?_]'>QZ=_YE%U9_XCC8__`+S.+]^Z]T(_OW7NH-1C,;5UE#D*K'T-37XM
MIVQE=44E/-68YJJ+P534-3)&TU(U3#Z)#&RZUX-Q[]U[HGV[ND:+);YR69SF
M^=C[>PN&W=_?O(Y.*GQD6^JVEW5#D<9%@MYUNX5R.#&`Q%1(O\$>:FF#/!&J
M+#)")']U[I&1=#8W!XZ?`0[_`.NL0=DU^:DV935V>&1@KJ[(Y;%Y?:FWNP,?
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M5,$%5320U,,D=1354<LU-40.CLLL%3#`[1NI*NJ,02`??NO=0H]Q[>F3)2Q9
M[#2QX82'+R1Y2A=,4(:<U4QR3K.5H1%2@R-Y=.F,:CQS[]U[J3+EL5!#0U$V
M3Q\-/E)Z6FQD\M931PY&IK4+T5/0RO($JYZM`3$D99I`+J#[]U[K+#7T-34U
MM%3UM)/68YH$R%)#4PRU-`]3"M33)6P([2TK5%.XD0.%+H0PN.??NO=2_?NO
M=?_2WL>G?^91=6?^(XV/_P"\SB_?NO="/[]U[KWOW7NBA[I^->7W9O6IR=3N
M3$XG;LNY,SN:3(X;%4Z[\RL^:I9$I<?ELEE:#*X^6#9M:D38UF6:"2B4TKTT
M9_R@^Z]TC*7XP[\H5Q7VM1U[&^&RV>R%,M+5[AI**1<Y1/2*M/1U.&RTV,IJ
M!R)#2M45@J?T^:(`>_=>Z;,G\.]U/5U--B]V[;_@";6V-M?;T5=193[S;.*V
M10QM#@BMZP[BQ53DY:I*66>>"?'4M0@/W1IT5O=>Z6[_`!HSU15T^Y9LEMAL
MY!4P3/M;)1U>=V;6P8S"XVBH8:^N&-PN9JY\K58YH<B98GHY*&9;4IF@1V]U
M[I3S?'9LKM?8V&S5;MXY;;F#RF'KMP4&W\:F7HH\GO/;6Z:==J9"?',F,?!T
MN)J*>GD-,J/)*LI@52\7OW7NDKA?CQV7M7*4V>PV\]DY*JHZ1-MQ8'+;9K*#
M"U.V<%%N?'[3KJG(XFI&73<PI]W9"MKM'^0_?5]1'2Q00.H7W7NFS'_$K)X!
MMN28O<.W,P=O8PO)2[DPU0U#FLC1-/%3[:JX*"2../K_`#ZSK65U/.M=54^1
MIHVAD>`O`WNO=+.LZ2WK5[*Z[V\M1L@Y_K[-U$]%G<A25=5CTQU:U-7S-2[?
M@HX</6K#*7H6I:BGB\L4*5,,U'+91[KW0A;"Z\W!M'=F?RU13[`./RU=F:AL
MKC<1D(]]96+.9.KW"R[DW#43,N23!Y&J^RI(F1@U(OEUQL?`/=>Z&SW[KW7_
MT]['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z265Q^[ZC=&V\ABL_0X_:V.BR2
M[CP,N-CJ:K<,M;$D5"Z9)P9<6N&>/RH(O^!#2,LEE"^_=>Z+MN_<?><E9V[#
M1X3<V*V]/+MR/KK*T5)25\]+28/=.&P&]YZ>CV[@\[NV+^.8ZNFKZ8RTE94O
M34[R4<36`/NO=(/%;@^4],B5D^'W-E,GN3(PRX_&/2X.GI,?B-J;IH9LU%F6
MR.$H,7L^IW#M6B:+'6GK),JF4=W%#6T7C]^Z]UW0[M^1]33TQW1C>S,;1OM4
M9_;M?L[9NV*K/Y3<FX<EF<OM#:N[<+E*62APD^V-O2#&YY:AJ.D>NI:>4U4*
MSD/[KW2ODSG?8PC-O!-R8J3^/;=^XJ>K=MIN#)0XU]BP5U%'0TF<PYGJ%K=]
M`PYMC`T=-'IB#Q0/--%[KW0K=&4W:)VM49;MJ9UW/FZO[R3%?>":'"J@>*:A
M@H(\924^*C6H#:(XJK(1/$$=9VU$GW7NAL]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7__U-['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z][]U[HE>]Z#Y`YC>N7PVU
MY=VT<&1SU;_$,C69A,'L2BVE0Q35NQXMLY'"455G*2LRLT34V:FA)KXJJ1#+
M&U"%/OW7ND"*CODR44]<W=,S#.Y:3-1-BLI1SR4<..9=NTYBVY6MAHS-5J`[
M8L_8W]54&N/?NO=8LV_RRAR<E$QWW5U6(V;L[&XS+8FFQ,6,W=7_`,*2;>NX
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M`"B.8.2/=>Z1<^SOD+/6RYC;N4[)Q>UL8^*I=O[=W-NZDK]^3553_$X-P9#+
M57\=J-LY'!#."G=XZU*NL3%,TF/>G<)`/=>ZGX&+Y!X9]JY2CP_8-3MS;%;B
MMQ;[Q^\-U8W,;GW57IB:_;&^L)M?&15&6GKL+JJUS.*I):JCB>KID-.45A3M
M[KW3YV%0=V9/(9>APO\`I#HL11;BR&X8,E@:_&Q09O!9^BPE/M[:T4<6=PFY
MJ6GQ&1HZULE]M)2UE`K1RQ-4QR/`_NO="?TTW;PK=WS]H8B7%TNX:C$[FVQC
MI-Q8_<K[3CFQT6&R>R:JOH:3'Q--028>&MUPI403S5\[K,"?%'[KW0[^_=>Z
M][]U[KWOW7NO>_=>Z][]U[K_UM['IW_F475G_B.-C_\`O,XOW[KW0C^_=>Z;
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MC)(D.(BW)/\`WIR,L-30N^NLHZ>81A)(]4GNO=3Y]S]Q9&GSL,W7M'E3#%D:
M8T$^U(_LMR8>@P^/J<76U;9,TPJJ+-Y.9J66".U4(X28:4&.[^Z]T^B?L&DI
MZ*7:FR:2@G?)5F,R45-L3%8F;(4F%HL-7X".EGJLG34N.I<+7Y*MQ]%/5:H'
M:E,H"*2[^Z]TS8S>_;Y&X:JDZACQ&=SDNQ*K"9"GVJV/K\[ALGN5<9N>/<4]
M5D!38G<>UL:E;6+%D)EA`JX77RKY`WNO=*G#;\[BJHZ_^*[/JZ2H2?,T=`D>
MV:R.$XVBDI/!N.I,N3E>7(HSU$"T$)*UKP++"?#/&X]U[I/5?8?>K4DII]J9
M#&5E35YV7!R5NS)\G05^(VSFC0.*U<5F)*W#9G<^)"38V&I1!43S^4::>"6+
MW[KW7'-]H=\XFKG@PO7%5NRD2EGRE/D(MO9"DCJ,=A4H*G)T>FIK<7(-PY2A
M:<8^(1F&MJ2BH8M$D1]U[IX3MOM[%R;'I]P=35#U.Z*NHILZ^,.7GI=KUM/%
M'61XFG^UQ=>V4BR&*BDEAKY7IH5J=4,J1!"??NO==?Z4.Z_X9]S_`***S^*?
MP;P?POP5/_'S?WO_`(5H^[U_;?9_W/\`]S&O5]O_`,HWF\_H]^Z]U__0W^/?
MNO=>]^Z]TP9&JW)#E,9#B\1BJW$3.HRU?5YJ>AK:%#*%=J/'QXFLBR#"&[`-
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MT4FVJJ),=2+D-P58S5#+%MG%TF#W!5[BRV=C2G\]'C=L;CQV/QE4X5G`RBU0
M3PP2^_=>Z=L+\B<WN"KZ_@Q_6LO@['I(=P89UW%/E\AC-H-)04L^7W-A]M[:
MS-9M^JAR%;X;3VQP*V>N24/"GNO=&E]^Z]U[W[KW7O?NO=?_T=_CW[KW7O?N
MO=>]^Z]U6E@O^9[?(K_Q(?7W_N^PGOW7NN\%_P`?)W'_`.(M^#O_`+O<I[]U
M[HNW8O\`Q\/='_B+.G?_`'1]2>_=>Z7*?\S3Q_\`X@WY!?\`NLROOW7N@B^3
M?_916]O]?IW_`-XO;7OW7NA2IO\`F7'3G_B//GW_`.ZZK]^Z]T'+?\?YBO\`
;Q8W;O_O&[5]^Z]U>;[]U[KWOW7NO>_=>Z__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g664229g72q23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g664229g72q23.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0E64&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````+@```8T````&`&<`-P`R
M`'$`,@`S`````0`````````````````````````!``````````````&-````
M+@`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````!KH````!````<`````T`
M``%0```1$```!IX`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``-`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#JK>BX/_.FCITY'V2SI]U[ZOM61!L;=C5,LW>ON]M=MC4#[=UKI[OK
M)U#!;C/Q<'+??=5=O]2WT\7$?=75960S'VT,_16/9D^K;^93_.+=?]@_YTT3
MZO[0^P7;(CT?1];']7=^?Z_J^CL_X/>J5W['_9?UGW?:/L^_(_:4;=\_9*/6
M^Q_^@OI>GZG^'4EGJ#MU6@#I^#6ZK];LFC.R:,5U%8PPP>E?5?8^^QS*\KTJ
M[<7]#B,]&YE;;K/M/Z?_`+3^E_.6<?KO5^H=0;5AT4T8+*,3,R;<HN;8RK(%
MC[,?T6>W[3LJ_G'V>EC_`)_K*OU#[%]K?]@_:F_TZ_VE^SMNW;L9Z7VGUO?]
MK^S;/^2O\I^AZ7_=57\?]C_:^ISZO]$Q_MOVC=M]#9D>E_._K'J>GZWVGUOT
MJ%QK952O=R\/ZW=2LR,=MGH9%&:R[TK*L?+I8UU=5N76^O)S&-HZA18RC9^@
M]!_^$]]:L8O7?K".G]/ZSFTX@P<XXS;**O4]6L91IIIR!<\^G;^FO;ZF+Z'Z
M.O\`[4WK/H_9\8'_`"ILVW?L7[5L]#9]ER?]%^DV?9=_H_M'_*'_`%K[0A?5
M[]E_8NB_:_VC]BVXWV7UOZ#]LVU^GZ?_`&O_`*1_1OM'^2_5_HG_`&G1)B@6
MV[_KMDUY5KVBI^/5E.Q_L3*KWY+JF6.Q;LEF2UOV3U=['7UXGI_S'_:JNY:-
MWUAS*_J_U'J@KK-V%DY%%;#NV%M.0[%8Y_NW;G5L]_\`+57]3_:5GV3]K?8/
MM3OM'V7^B?:=[O7C;_E39]KW?:_L'^3_`%_5^T_]JE1ZK^P)ZEO_`&G^RO7/
MVO[/M^R?;/4;ZGI[OUOU?M7\]_WF_:/YS]*A<--$U+5TL.[K;NL=<;==3;@T
M60ZDBW<UIQZ[,=F.?5].ENUS/M/M_27^M9^C0>B]6ZSU'"Q\;HU6+C-P\'%=
M>[)]6QIMNHKR*L3':RSUF4U4O9ZF7?;?9^D_F;=EBM/^P_\`.'.]#[;/I#]I
M>EL^R>IZ/Z+U?5_3_:_L?I?T?]7_`)CUOTJRV_L;T,+]B_M3[1^SL;U_V?Z?
MJ_9-GZC^T?7_`%;[5Z?J>C]F_P`H?SGH?HDK'Y=$4?S=#JGUAZOA9M6-<,7`
M#ZJ2VW);=91;=87-R,>OJ%/IU8GV?;['95/J7^K_`#*,[+R<+JG4<XNMOPZ[
MJZ<C&:"_8#1CV5Y./7]+^=L]/(K9^8_U_P#`JEU?]F^D?4_:_P"R?LU?V_9O
M^S_9MO\`VI^W_KW\Q_3?V;^M_P#<W]*M_`^R_:^H>ANW^LSU]T;=WH4;/1C\
MST/2_P"N)6*VZ:HG$DC6M;'^+)Q;?MP=EG.L>VW)_9S[*6V'94+<JRAV-2YF
MS_`,:R][/Y^WU;%>R<48&9B-Q++6U9UAQ[:/4<X"*[<EN11ZCG^C8ST-MFS]
M'94_WINI1^U'^A]M^T>A5ZWV7T=FS?D?9]_VO_";_M'T%/IGV/[:/6^T_M'T
MW;/MOTO2EGJ>AZ7ZG]/TO5]#]+_-^M_@T;TO\/HQ"(XJTOI(D<5<4I2?_]DX
M0DE-!"$``````%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`
M:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``-@`N
M`#`````!`#A"24T$!@``````!P`(``$``0$`_^X`#D%D;V)E`&1``````?_;
M`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``
M$0@`+@&-`P$1``(1`0,1`?_=``0`,O_$`-D```,!`0$!`0$!```````````)
M"@@'!@4$`0,!``,!``,!`0`````````````&!P4#!`@"`1````8!`P($`08'
M"P<-`````0(#!`4&!P`("1$2(1,4"A4Q02(C%CA1,G07=[=X8;,D-+0U=;6V
M.3I",]7&5Y<9@:&QP5(E5I;61QA8&A$``0($!`(&`PD*"0H'`````0(#`!$$
M!2$Q$@9!!U%A<2(3%(&1,J&Q0G*R<W0V"-%28B,SLQ4U%C?!@I*BPM+#M'53
M8X.3)#14A"55\--D12='./_:``P#`0`"$0,1`#\`UO\`FB]S#_XOR]_O5PM_
MIO5A\URY_P`DS_(<^Y$B\MO_`._?_EH^[&1=TFX[F_V8*TE'<=GC+F/E,B)V
M%6H%-<:!8/BQ*J:%).F`:V,N#7T1K"T\%O+[_-^AU[3=-6VV_9EW#QM]"RX&
MY:NZH2U3EG+.1C,N%?NZU%I-?6/ME<],U`SE*>1.4Q&A\<P7N-,L4"EY/H>0
M\O3=)R%5X.YU*9#)>(F(2M<LD:WEH:0!G(2C5\U]6P=IJ>6LFFH3NZ&*`@(:
MZ%0OE_2OO4S[#*7FU%*AH69$&1&`E'>83OJI9:J&'GU,K2"DZTX@X@XF&P\5
M5$YA*SN-LLAOYGKY)X84Q%9&D(WL]VQY8X\N1%+71E815-C5)%W))NRP",J!
M53%!$I3&`P]QB]5;=#^TW+<VFQH;%9XHGI2H'1I5/%0E*<H9MM,[I1<5JO*G
M32>$J6I22-4TRP!)G*<*<QU_B6I']I/*'ZI[9II?_=T/HR/EIA;9^OY^DK^0
MJ+=M1B+!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&
MB"#1!!H@@T00:((-$$&B")KICF`W.1_+:CL21J>%38?4S[!8N&;4K%R-D'[/
M24='NW#D)@N020'Q8JCHP%4^%^4``'5(?$1HS>TK8K:QO9=>\WY<KEJ3IF)\
M-$Y8??1.W-UW-&YA:`AGRGF4MSTJU:20,]<IX_>RZHI1U.8HD*PY>,([L<][
M8H"F;.9&RQF4VN6*U.R#BK9'+B^1-46<#:FLFF>PGG:^"[49!\T$S;SQ\PP`
M;L'LZ@S[3K;707)QZ[!)IBT0)HUC5-,L)'@#C"SNJBN5?;VV;65>8#H)DK2=
M,E3QF.)&$>GXH\/;G,&[2(JA[N']ADLPH7V[2CMS9[^7)4H-?DG3,\&0UG+,
MSP*($23/V(>H'R?$.TO77'NFLMM==5/VH)%)X:1@G0)B<\)#WHY-KT=QH;9X
M%SU>9\11Q5J,B!+&9Z\(91I<AB@T00:((-$$&B"#1!&;-XMMLE#VL9\N=/EW
M<!::SB^US$#-,#$*]BY1E&JJM7K8RA%"%604`!*(E$.NMG;M.S57RU4U0V%L
M+?2%).1!.(,(O,VY5UGY?;ONELJ5,W!BA=6VM/M(4!@H9XB$9\9/)AD>4S&;
M$.Y?(DC<(;):C-C1[793LP7K-S2,=)G#K/$$6I0B;414$0\SN!)Z1'M[054$
M:=O39E&BW"OLU&EMUF96E,^\CB98XISPS$^@1Y1Y%<]+V]N8[=WU>EU-)7E*
M6'793:>R2@J`'<=GIQG)81*0*HI?U&(]T0:((0-RQ<B%UQ1:(7`&WRXJ5FVQ
M0MK!DVXP:J"LK$G62.:'I#0ZR+ANV67;K%>OS``J@44$P$H"L4U6V'M&FKF'
M+K=J;6PJ:6T*R/2L]/0GAF>B/'OVAN=%TL%QIMG[-N98N#4G*IYL@K22.XP"
M00,"%N<?83,=X'?O&1DV_9?V=8[OF3+1)W*X2LS?4)"?ESI*/W:,9=IV/8)J
MG1213$K5DV(F7H4/HE#2IO6BI;?N&KI:)A+=.E*))&0F@$^LQ8>1%^O&Y.6M
MHNU]N#E5<EO5`4XN140EY:4@R`R``$)YGLK[_<Z[Z,^;>\$;AY>JDK%SR.\@
MHR;F21<!&5NL3Y&)8]LNUK\NY`Z*;Q,J11(/4H#U-^&A-4&U+9MBUW:Z6E*]
M;3>HA,U%2DSF9J`X&/--7N/G!NSFMNW9NTMY.L>#5U);2MP(;2TTY+2"&UG`
M$`"7ICO#G;IS95HGQ6)W)5VR.VH>8G&)W"*>G<F+X@F5I;:$VA%1-T^18Y2C
MK+3=^6SQ\-RSJ0D\=!'NH65>J&YS97VIJ(>9I]ZM/.)R0'T*GZ'F$MGL48^'
M7.4W=GM@ND9C??9A!1RV45("ERA8I"MV5S'F-VKRT<2.75Q]<T&QC%'LCQ8`
M4.I3'[_`.5[8]AO=,NLVQ<I*E[!.I,^@S_&(_C:NR.I0_:`YB[#N;%DYL[6*
MT$B;R$!ITIXK3I/EG@.AOP^@JG#KS[A*)+8.;YXH#U&]U*88Q"U:/'K^A))R
M$_,L:Y&1[]9TB*D&9"<D4T7XKI=[$"*"<@B02C-A:*I%T-JJTEI]).J>,@D%
M1(E[7=$TR/>PD<8]1N;UM#VT4[PL[@K+<XA!:TG3J4XM+2$J)'XN3B@ES4)M
MR42,)1D9MOZL3G&4U>/S2=C^&6K$@+3XN_.T<U>RR=OKA9`$21(RC=ZRM=4%
MF)5$P160<`Z34$J2J96)6TV$UK5-^D>XH*$](F%)"%2SD04+GT@C21B#$R;Y
MSW!=@JKM^S`%0TII6GQ#I+3JWFM7L:@I+S.B1$E)5XB2=*DC_]"_C1!$AONF
M/YTV1_D&X?\`E&%-5?EG[%Y[6O[2);S&_*V?XKOOMQ1)QS?<"V6?LN8,_5O7
M=(&X?U[>/I+GRC#WM_\`4=I^CH^2(V=K'C7B!7*FX"F;6.>++NX'(#>6>U/&
M.<LHSDE'P;8CJ7DUW&-;#$1,5'IJJ)($<2DS(MVX**G(BCYGF*&*0IA"Z4M`
M[<]D4E`P0'76$`$Y#O@DGL`)Z\HB=57-VW>557/));;?62!F>Z0`.TD=F<;6
MD.43FXW6MW.2MIFV";I>&EEG1ZV\JV'UKX669-EU4#`2ZWI@I'6]XW41,FL:
M(9()E6*8GE@8.@8Z=L[,M9%/=+BE=7+'4YID?BI,TCHU$]L:BMQ[ON<ZBVT*
MT4O#0WK!_C*!U$<=('9'T=K7N$=PF.<PQ^%^0C&$?&QR4\E6;C<6E0EL<Y(Q
MN^<*I)%DKA1'92L)"/CS*@9X@@TCW2;<153!8Q025^;GL*@J*1578:@Z],TI
MU!:%CH2K,3X&9$\,,Q]6W?-?3U*::]L`H"I*5IT+1UJ3@#+B)`RZ\#7PP?,I
M1BSDXUTW?1TBT;OF#YHJ1=J\9.T2.&KILNF)DUF[A!0IR'*(E,40$/#4F4E2
M%*2H24#(CH,51*DK2E:""DB8(X@Q.7R,\\B.WS+$MMIVDX\B\QY?KTRM4[?:
M)TDO(56!NI7`QRE*K5:KRC:9NEGCY(?(=]KAN@W=D%N4KA3O\JA[?V/Y^E1<
M;J^6J50U)2)!13GJ4HX)!&(P)(QPA!OV]?)5+E!:V4N5"3I4I4Y!66E*1(J(
M.!,P)X`&,7O]XGN.JA#&RY/X&FG=)10&9=5M7!-/?&:Q8%!RH5]4JZL7*<>U
M;M_%45?+72(414,':80V$VCE\ZORC=8D/93\56?4H]PGW(QC=M^-)\TY3.>#
MG(M)E+K`&L#U$<3#/.+;FGI>^R?5PKE6J16)-P:+%W(P4?%R+AU2\DL(Y$SB
M3"KFDQ&3B+'%MB'66BUU'(J-DSK(KG`BJ:2UN;9SUD;\Y2NEV@G(S'>03E.6
M!!Z1+'`CB67;F[VKPX*.K;2U6D33(]U<LY3Q"AG*9F,0>$:5Y<=X&5MC^THV
M;L-M:B\N(9,IE1!&ZQ#Z:A?A4^WG57QO11\M"N/5E-')^6?SNTH"/4H]?#-V
MI::6\W7R=85>#X2E=TR,Q*6,CTQH;INM59[8*NCT>,74I[PF)$$G"8Z(4XZ]
MPZYQ[LHQ'>+15J5DC>%E(;P[7I-<)(5S'=%KD'=[!6H*QW!+XG,3)5I-K$E%
MM&H.2+O.Q14RK9(4Q4:OV`2_>:IEIU;5H;T]XR*U$I!(3@!@3B2,,I$SDK#?
MBVK33N.-H<NJRJ8$PA("B`5"9,R!@`1/,D83ZCQ`\AO(!O-W-VICN(K'P;!"
MN&;-;:NYA,/OJE3OM8UMU"8PJ$9>)!J[=2AU(27?F(W/(K"L4IE`*/E]2];=
MM@L5GMC2J!4Z[QDI,W-2M.E9,TSD,0,9".QM6_WN[7-::W_<BRI0DB2=0*0)
M*E/(G`J/N1R[=OS7[ZX3<UEG:CM?V@L7EUQK:Y*J`H>"O.:+I--V2O5A:F58
MIS6!:1T7/QJR+QLFHF]*1%4HF5/U$-=FU;-LB[;2W2Y74^"X@*S2VD3S25*G
MB#@<1V"."Z;PO*+A56V@MH#S:RF4E.+,CF`F68Q&!P.9C,5CY+^?3"\<ODG*
MVW>>;8_BT_7S2EKVP2\;58J/`?K%9N8KZ,9)P#8O<`>:Z=I`4W3J(_(.DWMS
M8U8H4]+7)+YP&EX%1/4"2#Z!&:O<.]:,>8JJ5P,#$ZV))':0D$>DB'"\5G,?
M5.0.4F,2WVELL69^@(9Q9&\3#2#J3IM[KC)9!&2DJRL_+\2B92'.Z3%S'.5'
M`BB8%DEU"@J1%2W/M%RQ(15T[Q=H5&4R)*23D#+`@\")8X$9$MNVMUHO:U4E
M0R&ZT"8E,I4!G*>((Z"3AB#F!X_FRY*-PO'PYVW(X)C\<OBY80RRI9_M]7)6
M?%,U)4QP6'"*&,L4#Z4#A:W7G=_F]_0G3M[1[N;9NW;??DW$UQ<FT4:=*@/:
MUSG,'[T2CAWAN"X61=O30^')T.%6I)/LZ)2Q'WQC&68N?/.61%L=X2V#X2+F
MC-LICZIR&0[BRIEHM[!*\O:[%/+A&8ZQU!*#(.8>LS+M5%:4D7!VA#D,4$E$
M2E<J;%)L6AI_,5E\K/"H@XH(3J2GNS.DK6<)J'`8]<\!C5.^*ZH334MGI/$K
M"VG4K2I7?D"H(0,9`S$S/LEB<X6[DVYW-JA&V1]QF%7"N.5'")7HWO!3.,IS
M;U"A029N[5C_`.$KUYVX$W8D5X\`QC>`$,(:T&MM[(NDZ>WU0\Q^`Z2KMTJG
M,=@],=%S<.\K84OU["O`/W[0">S4D)D>@3]$/HXQ>5?&'(M6IR')`&QIG2BQ
MK:3NN-UY$)5@^A5G";$+?2I<Z+1Q)U_UZR:+E)9$CF/77334%0BB2ZJ-N7:]
M3M]Q"_$\2A69)7*1!STJ'`RR(P(!RQ$.^W-S,7U"VE-^'7($U)G,$9:DGHG*
M8.(F,3G##LSYDQSM^QA<<Q99LK.I4"BQ"TQ8)IYW'\M$AB(MF3)JD!G$A*R;
MQ5-NT;)%,LX<*D3(`F,&L"CHZBX5+-'2-E3ZS(#^$]``Q)X"-VLK*>@IG:NJ
M<"6$"9/O`#B2<`.)B4RS<W?(EO)R1/4/CDVW*LZ]$+'.E*FIQLD7A*(44.A'
MS5PDGZJ6.**E)BB82(."+$(H/E%=+&+W#4&MF;?M%.A_<%PFL\-6A,^(2!WU
M2[>N0B9O;POUU?6Q8Z(I2.A.M<N!43-*9]DN$S'G9SEOYCMC<Y"+;V=OD78:
M;./")-W%KHS.FH2`E$5',77<D8T5<4Q.9!LD<X(+MWRR9>AS)"3IUY$;5VC>
MFU_H:N*74CX*M4NLH7WI=DNV.-6Z-UV=Q/Z5I-3:LM:-,^I*D`"?KET13QLR
MW@XGWQ8,@<Z8C</4XI\\<P-FK<N5,D]2;E&-F3F8JLV5$QVZCIFA(H+I+)&%
M)RT<)+%Z`?M":WBT55EK5T54!J`FDC)23.2AZB".!!$4:T7:FO-$BLII@3DI
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MI;31,>V2,H=1Q_:;A&2K^>RA!5JS!$T.OR3JS/6T=473QWVIN3BAY`K'$4R&
M#7XFTVIO=;MIJWRW:TK6"I2TI(`05)FLB0FJ0RQG+./URZW1>UFKI2LARY*0
M@A*4*5.:PE4D"9,DS/5*>419R6>=V[GD/3W`O<3O4=X1<NQ5L)B(<:W!)\;(
M35FS185_\V!W'VS%5=LBF8&/F>I/W=0'H(:L*:*UBPFA34@VGP2G7K3+1C,Z
M_9].421=9<3>16J8/Z4\8*T:%3US$AH]K/AG%"F`.23FWNV=\*4S*.RNP5C&
M=NRWC>L9$LBVTS.E>1KU%G[E#15NG%9^5DSQ<&G$U]VX7,\<E%NV!/S%`$A1
MTA5^W=F,T-8]37=*JE#2R@>.V9J"24B0Q,S+`8G*'BAW!O!ZMI&JBUK33J=0
M%'R[HDDJ`49G`2$\3@,X;URV[O<J[(MHSO.&'&M3>7)'(U*JA$;I$O9J%^&6
M#XKZXYF3"6AG`NB^B)Y9O.Z%\>I1^93VI::6\W7R=85>#X2E=TR,Q*6,CTPU
M;JNM59[8FKH]/C%U*>\)B1"B<)CHCV/%SN?R/O&V68QW`99;UEK>;?+9#92J
M%0C'<1`E1J^0+)6(T6C!])2[E$YHZ)2%43+G[E>XP`4!Z!P[FMM-:+Q4T-(5
M>`D((U&9[R03C(<3T1S;;N-3=;2Q6U6GQE*4#I$A@H@83/"%W<DO.[3]JU[D
M\`;;*?$YKS;#.QB+=-RCMX;'U%GCCY):TFVA3DE;I;6K@Y2.FK==HW9JCY1U
ME%RJH),&W=CNW-A%?<G2S1J$T@>VH=.."4G@2"3G("1.#?\`>K5N>716YI+M
M2G!2C["3T`#%1''$`'#$S`7B.]GW&,E%#E-G@.Y-:>*7Q8E=0VU1!`-&]/.`
MJ-8D&:V2W#0Z(]2F`3+&)](#C\NF#]#<OTJ\J:QLO93\8Y]H.B?_`(E&!^F-
M]J2:D4SO@YR\$2EU#3JEZ\,9QKKCUY_W>;,O5G;EN[QC%8VOUPGV-*JM]IB,
MPS@%KN]=EBV59NM.G5W\M6'<G*F*V3=(NED4W*A4UD$"=RQ<F_[$31TCMPM-
M27&4)*E(5(G2,24J$@9#&1&61)PC6L>^%554U0W1A*'%J"4K3,#43(!23.4S
MA,'`Y@#$-EY)-_U+X\\!'RE-PY+C>K1,$J>+,?\`KS1H6>R&0,\>O)-^D@Z7
MCJW7(Q,SEXN1(YC'%%N42J.4S`J[=L+U_KO+(7H82-2U9R'``<23@/2>$,^X
M;XU8J(/E&NH6=*$Y3/$G\$#/KD,)SB>NK\C?/EN/AB9@P3MY2;8L?&5=085G
M"K)W`3+!(YRB>&DK[)O)^U(`8@IBO'*&(90HE+T,`@#^YM[8UN4:2NKO]I&>
MITA0[0F03V$0AHO^];@D55%2J%.<M+0*3V%0)/1@8T9LZYN=XD]N:Q]M*W:;
M0I!M?[S.,JT0:C6K+C;($"N]4$PV6;H=^=JL'U:C6+==R\63<QY4FB2BY#*`
M3RS9UWV7:$6Y^Z6NZCP$))[R@M!EP"DX@DR`P5CAQG&A:MY75=P8MMRMLWEJ
M">ZDH6)\2E6$@)D^SAC/"4/9WY^.S'<R'X<.77^J5M*.U?K'9?I"/?C[YO\`
M[L-\_P"'._)B:+!6RYUN$X_KOF#'+%0^9<-YRN;MHDP(<).W4EM0L8RC^`;G
M1,5525@W)E7\:``)C*'72('>N40L]TW&FT[KI;=6*_Z=44J,\D+\1P!1ZE"2
M5>@\(\+[3Y8.;QY07C<UE:)W+;+L\0$SU/4XIZ5:FQ+'6V9N-@8DE:1BH0]#
MBZWJ*[I\1.:E=W1/SQXD;1<3:%%52@XML`LFHUA;D1$P@JH[5.S,WDNT!*F[
M`B@]H.4R!,-[[;%CKTU%,G_I]024_@*S*.S&:>J8^"8]9<@N:*M_[<7;+JX/
MVEMR4)=).+S9$D/2S)PTN\`J2L/$`CLN_;>!"[/L)O[8F+.1R/:#.*_C*MN#
M@/KIPZ("YFWJ!1\TT'6D%`<.!#H"B@I(=2F6`0SMJ[><W#<DL&8HV^\XH<!P
M2/PE9#JF>$,_-_F53<M=K.UZ-*[Y43;I6SQ7+%Q0ST-`ZE=)THF-4XGK>[39
MYEL`SSO2S8F^E,JY9FJ*]I"LZ)E)!A6Y_*557F+DX(J3S$I:Z*J&*@;Y21GB
M7Z#DP!6DWYI6Z[9MRVD)H6$K"].14EM4D#J1Q_"^+'C)WEW5M\H-V<T-TI6N
M_7!Y@L%S%0;<JFBX^9_#?)(2>#4R,'(=WP__`'#<6?T_DS]W_P!P['J:<P?K
M37?$;_-ICU7]FS]TEB^?J?[PY"\MF']\GN:_*L\_VNA--VXOW=V?XK'R3$6Y
M8?\`Z9WM\Y</SJ8I$U'(]PQQ3/\`@#&NY3&TWC')\(C*0\JW5&/D2)HA-5B8
M\HY&5AKKY1-0\?+,%#=Q3!U35)U25*=(YR&T[3=JVS5C=;1.E+B3B/@J'%*A
MQ!]S,2,*N\MFV+?5CJK#?J4+IW`=*P!XC2Y=UQM1'=6GU*$TJ!22"@WC<MUA
MV\[K<P\>V656=HHUGEKA#1["22*XAU;+`,EWR4@R8.1631BK]3F_FJ(&ZF\P
MK?J`&`XC5-XT[-VL5OW9;P453:4*)&>E1E(GI;6<^WJCQ_R1N-;LWF%N3DWN
M,HJ+34N/-A*A-!=;25!24F<D5#(F4YST3Q!A_9,`8@3BG$.G3&I&CN19RKM8
MDG.EEG+R.C'\+'BO/!*!.*MF,/*.6B3<S@6Z;9PHF4@$.8!E1O%Q+B734G4$
MD#!,@"0H]V6F9(!)E.8!G,1Z_&R-K)I7*1-I2&E.)63K<UE24J0F;FOQ"$H6
MM`3JTA*E)`D2(__1OXT01(;[IC^=-D?Y!N&_E&%-5?EG[%Y[6O[2);S&_*V?
MXKOOMQ1)QS?<"V6?LN8,_5O7=(&X?U[>/I+GRC#UM_\`4=I^CH^2(V=K'C8B
M!S(N#:KN2Y_;IA>\I&<TRX;IYL]I8E.*?Q6"K4$O;I.&.H7Z::4TU@3-#F+T
M,!%A$!`>@A=*:M=MVQ6:QG\LBE$NHDZ0?03.(G4T;=PWH]1N_DEU1U=8`U$>
MD"47I1$1%5^*C8*"C6,-"PS!I%Q$3%M$&,;&1K!`C5DP8,FQ$F[1FT;)%333
M3*4A"%````#4-6M;BU..**EJ,R3B23F2>F+4A"&T);;2$MI$@!@`!D`(DV]S
MUA2D,HS;AN"CHIHPOLQ.V7%]FDVJ"2*UB@F<0A8:Z,F<A"G=.(%9%VFBH<1,
M"+KLZ]I"@%3Y;5CRC<:!2B6$A*TCH),C+MP](B8\PZ-E)H*Y*0'E:D*/2``4
MS[,1V=D,ZQ+N,M.%N#.E[@VSP7-VHFS=FM67[[^%`2TLX4:?27CPBHCZI%G+
M'9'4((_6$()>H==+=5;VJS>SU`H?B5U?>'5/4H>D3A@IJ]VCV6U6H/XY%+))
MZ#[*3Z#(Q.KPB9GV*8"R/E#<EO'RM'1&86KM"'Q.WLM=M]L=,S3:3E_=<@@[
MB:].)EL4@HNFR1<J+%<$3.Z'I];W:H&\Z2]U]-36^T4Q-*<7)%*<O93B1AQ(
MRRA%VA56:AJ7ZZZU`#Z9!L$*5B?:5@#CD`<\3%.'_&YXP_\`[01'_D/*/_HK
M4V_8S<G_`&T_RD?UHHG[8;=_[@/Y*_ZL2+<A6:]M=+Y#*QNMV`7Z/EH9S*5+
M+\FE7X.?K,;7,K14^Y/9F#:.F8>"5"-M"#!%XY22(=$YW[@O4"F["U>P4=Q>
ML+ELOK!"P%-XD**D$8&8)Q$Y#C@(EM\JJ!J]BX6-Z;<TN8`I"5@X@`@8&0/1
MB1U12E[BAXWD.-UL_:G\QJ^S9BEXV4Z=.]!S&VI=$_3YNY,X#_RZG7+])3N%
M23F&5CW4Q0=]J"[`VM/LEY!]85"T_;V<<>,\L1D]O.S;66=R;U2Z*U'#%3G6
MR#VMI6"!;,7\[?9.+<I*(2[V)=OD6T657N0;N$UUA(98B!TF/?NX:FD+=HHG
M"A2T:G%#`R,P$@\)R)5Q(D,IS7MD6"GK/$NM:V%H0O2A)RU``E1'&4P`,IS.
M8$K'``"@`````````!T``#P```/```-2**Q"7=UG-=L-V?7>VTQB,KEG*Y)$
M$[S%8;@X-P@A.QR"<:#6WW>0>Q$.[F8YLV(W,FDJ_7:E2\I0$Q)V`XVO9M\N
MS+3RR&J67=+A.1Q[J1,@'/@#G"?<MWV6UONM-H+M3/O>&!*8P[RC*9&6$Y91
MBB-]SUMP?.Q9V+;-F1C$+]R*[AG/4><5%NH!B'\V,<NHA%4ADQ^D3SA`0$0\
M?GV5<MJ](FW<VBL=(4/=Q]Z,E/,2C42'+8YHZE)/N$#WX3)M5R[B1[S<8@RA
MM3BYNEXAR+GZ.0KE8EXQI!/(2(RG`*U^\5P8B->OH]I%-I"Q2";1%)4Z2;<$
MNWIV@`.%TI:H;-JZ:YK2NK;ISJ4"3,H,TF9`,\`3USA1MM33G=E)46Y"D4JZ
MD:00`0%X*$@2`.\0.J4,H]TS_'MD/Y)N)_?L(Z7.6?L7KM:_M(8N8_Y6S_%=
M]]N'*<06R7'.T;:1C29BX)FIEO,U)J^0\I75PW04G'KFT136>C*FW>^45=K6
MJNS?)HHM2B!#."J+G`5%!$%'=MYJ+K=:EM2SY1E:D(3P[ID5=I(SZ)"&K:=H
MI[;:Z=X(!JWT!:E<9*$PD=0$L.)F8:--PD/9(>4KUABHZ=@9M@[BIF%EV;>1
MBY6,?H';/8^18.TU6KQD[;J&(HDH4Q#D,("`@.EA"UMK2XVLI<29@C`@C(@]
M,,KC:'4+;=0%-J$B")@@Y@CC$(N3*4GQ5\V]$:XA6=Q.-W>2<>3$7"G<*J)E
MQ'FQ=O`W.G*#W%]8QADI*2;,!6\P4CLVRIA.JD!QM],]^T^S7C5@&H\)8)_S
MC>*5=4Y))ETD9&(M4LG;>[&A2DAE+J2!_FUR"D]>!4D3Z`<Q#`O<]YMM,;$;
M:]O<8]4:5.T'MV4;8V1443^+R%=6C:]5$'8%,!%FD>,I(+`00$/.,0WRD+TP
M>6U&THW&O4F;J=*$]0,RKUR$;W,2K<'Z/H4J_%'4LCI(P3ZL?7&A>.3?OQ-;
M)]J>-L3Q>X6OQUV>PD;:LO2OV"R0M)3V3)J/;.+&9\_;4DQ';6"7-\.9`4QD
MTV;4@%$1$QC=#<5CW3>;I452J!18!*6QJ1((!PPU9G,]9CN;>O6VK/;&*<5H
M%0H!3ATKF5D8XZ<D^R.H>F-$;@N43B"W+8;O^$<G[B*_-4^_U]]"O4U\>Y,4
M<1CQ5(QHN?B55:,IZ.;@)$J;MFN4.Y)=(I@^<!SZ#;6[+;6,5M-0*#K:@?;1
MB.(/>R(P(Z(T+AN+:URHWZ*HK06UIE["\#P4.[@0<1"9?;9YEDJ;NUSKMT9S
MHS./<AX[E;?%*%!P5JZM6,K+&1\1-L&KD$S,B3=2LS\7'5,BJ@(-@/\`YHH`
MX<Q*-+UJHZ\HD^VX$GXJP9@]B@F7IZ84M@5:V;K4T6N;+K9/\9!P/5W2J?HZ
M(\\M_B60_:7;_JJ3UR__`%W_`,K_`$HXA]?/^;BWG46BR1-/[G;[IF`OVAB?
MJXNNJ-RV_6E?]'_IIB>\Q/U?;_GS\A4-#XDO[MS9_P#HCCOZUEM+.ZOK#=OG
M3[PAEVQ^H+7\T/?,2VV;_$@-OVQ:G_4T-JG-?N^/T)7\,3-[Z\CZ<GY0BZ?4
M1BTPB+W%W]W)(?ILQ=_K#IXY??6#_0+_`*,)._OU&CZ0CY*XXKQ^9QD-MOM]
MI3-L-VA8*)3]P[JKJ*";RD+=+Y<NE=J3E8"&(<Z#:RR[510I3%,8A1`!`1`0
M[M]HDW'?C=&O\FM36KXH0DJ]P&.G9:U5OV.[5H_*(#FGXQ64I/H)!C$WMQMG
M],RS;\K[SLI,"7&Q8VN#2J8T+.@22187V18)V>T7YR5V54[FRQS:19D8.3F$
M4%7*ZP?7%243V.85V>I&:6T4RM"'4E2Y8=T'2$]AD9CC(#*<9.P[4S5/U%TJ
M$ZE,J`0#CWR)E7:!*1Z23F!%D&I%%8C*[_91MBDMR\/N\=8EK9L^0D([A6EU
M30,B*JCHA&Y+"_BTC$BW]O81P*,V\JJD9ZDT6,D"@E*GY>HF]7--M7:15*\B
MI4]/]$',))Q*<I^F,M5EMJKDBZFF3YU(E/A/[XC(J`P"LY=@DD+W*^VW*.4\
M+8(SA1(B2L=8P',9%9Y&BHM%1X[AX7)*5%+'W$[-$HJGB8E_3/2O%0`XH`^2
M.(%2*J<KGRZN%-35==1/+"77P@H)XE&J:>TA4QV'C*$_F#05#]-0UK2"IIDK
M"Y<`O1)79-,B>L1X781[AC;O$8MQKAK<W1YS$DM0JE7:.TO5(B%;-CR2CJU%
MM(6-?/()@)[16G"S-F05DD&\@@"G<8IR$$"%[%]V#7N55366U]+J7%E6E1DH
M$F9`)[IZIR/;'!9-\T3-+34=QIU-EM`2%($TD`2!(S!EG*8GT10GAO-6U_=0
MA"Y5PQ=L6Y@=55)ZA$6B"/#RUJI99YL5O)LC$=(%M%.4EVI`3<(*IM3+E+VG
M*8"]`0:RCN=K*Z6L9=92N4TF82J667=5+@<90]4E9:[IHJJ1UIU:`9$2*DZL
M\^\F?$83CRN_/[F.YG]#EU_JE;7>VK]8[+](1[\)/-_]V&^?\.=^3&$>"S[I
M>0OV@[5_SX\Q;\VFCF?^OJ/Z(G\X[$D^R9^[V^?XR[_=J2,J;X<46[CJW0TW
M>IM[8*(T&\S\BVO55(0Z=;93<KVNK!47Y&H$*VKE]:%5=,@$#`RD6ICI]HIM
MBAO;9KZ?=]DJ=N794ZMI`T*^$4C!*Q/X2#(*Z4G',Q/>:VW;ER5W]:^9^S6B
M+/5/*#S6/A)<7BXRJ6350F:VQ\!Q!*9:41\7$=?M'+OO!DLOY&C'L'MJPL+)
MC%5,RI>UPQ!VI(0U/<+$%1%>:M2Z9GLZX2\2-2E;IG*7TQB\E>\QL#;Z+?1K
M"KS43)5URD5]B<D`\<3\*.KMRBN/VC^93^X[VPIK8]LTA+4_@ZBIM@G(K=(*
MWU#X/=!`\.3,^6]JV9<?^5V3-NBU9M'^+&K5JV2(BW;-F^2:@D@W013`J:2*
M*1`*4I0`"E``#PTE[!4I6ZZ%2B2HI=)/$GPU1=OM&-ML\GK\TT@):2Y2A(`D
M`!4M```8``8`<!'\X@/N&XL_I_)GZP['HY@_6BM^(W^;3!]FS]TEB^?J?[PY
M"\]F'3_C)[FORO//]KH33=N+]W=G[&/DF(MRP_\`TSO;YRX?G4Q2'J.1[A@T
M01+_`'T"R7.;!$K("*[;)U%-*>GZAXQV,XI>Q&4$O4/"/15*I^YU`=6VD[G+
M)WQ\BPN7I<.GW91X(O`\?[5M**`=\7&GU2_!ID%W^:%3],5`:B4>]X__TK^-
M$$2&^Z8_G39'^0;AOY1A357Y9^Q>>UK^TB6\QORMG^*[[[<42<<OW`MEG[+F
M#/U;UW2!N']>WCZ2Y\HP][?_`%':?HZ/DB-G:QXUXB)QU_B6I']I/*'ZI[9J
MSO\`[NA]&1\M,1]GZ_GZ2OY"HMVU&(L$3"^Z`^[MMF_318O[#N]4GEK_`+_<
MOF4_*B=<Q/\`<[;\XKY(C7.$<*RVXK@7IV&*ZD+BS7G:`Z9U1H`E#UUNC$GT
M]5(\QS_133D;%%-D#G_R"J";YM9=96(M^^7:QPR:15C4>A)D%'T`DQHTE&NO
MV0W2-";JJ8Z1TJ!*@/20!U3B=CA6VR[%=U]]RA@+=K5)4^84A:SV*0^W-II"
MTU'QB3II=:B6/C)..1=6"$511>D1,3U1FXN1Z"5`W;0-X7&]VNGIJZU.#RN3
MG=2J4_95B#('*>4Y=,(FT[?9[I4OT5S2KS!`+<E%,Y3U)P.)R(XRGT12)_\`
MG_XR/]D=S_WN9$_T[J=_MYN3_BD?ZM'W(?\`]AMO?Y!S_6*^['')OB"X6JYE
MZK8"GFGPG,UUA7]AJN.'N=[RA:)J(CC$*X<-6)I_P44`3F;HG$J[M-!<Z!%"
M-US)]Q&[-XN4CM>W(T:"`I?A)D"?1ZSD)B<IB.FO:VT6JQJ@<6H5BQ-*"ZJ9
M'KX\!F9&4Y&/J^XF8MHOC;:QK)/RF<=FK$[%JEW&-Y;5I&6EN@GW&$3&[$DP
M#J(]1Z:^-@**]Q*4KVBRL^ZF.7?24HL#:$CNAY`'8$JCKG`6@BCQB83,DF5,
MSFRY;77$H``JK#DVSH^8?\)O*1*7K^`H:ZN^R3N2KGP0W\@1V=C_`%>I_G'/
MEF-D\B60K9BG8UNHR#17R\7;JSA>YNX&5:"8KN)?.(T[`LJT.3H9)U&)NS+I
MG#Q(=,#?-K'V^PU57NV,/I!:4\F8/'C+TY1K;@?=IK+<GF5$.AHR(S$\)CLG
M.)=/;T;+-L^Y:2SAF#.U=B,JW+&$]58NKT&VBC*UUBA8V4I(.;K.5YT"B5B=
MNWK$S9L+L%6R)D53"F94R9R4S?MXN5M114M"X6FG0HJ6G`X2[H/#.9EB<,<X
MG.Q[1;KBY65%:@..-:=*#EWI]XCCE(3PSF,HK3E-I6U67BC0\MMLP(\B`1%(
M6+G$=!%JFB`=.A"?``!$I2A\I>G34L3=KJE6M-R?"OG%?=BFJL]I4G2JV4^G
MYM'W(B<C_P`Q"?/EC:/VU0U8@L/0>ZW&%>KC"E((-JGZ^!""B[2O7TFIC-/A
MB]J:O3)G1^I4#Z:?T#%U95>>_8>I5<EJ56*I%E15[6()$^O3+KZ8D*/)#>5.
M+>E(HQ5H"=/LX%(,NK5.7#HPC??NF?X]LA_)-Q/[]A'6!RS]B]=K7]I&[S'_
M`"MG^*[[[<.PXD-X-%W:;-,4+0\S'FR+BBG5G&65*F5PF$O!SM4B4(./F%F)
MCBX"&MD;&D>M''04CF.JB!A405*5.W9:7[7>*HK0?+O+4M"N!"C,B?2DF1'8
M<B(;=J75FY6BF0E0\PRA*%IXC2)`]B@)@],QF##-'CQI'M'3]^Z;L6+%NL\>
MO7BZ39HS:-DS+.'3IRL8B+=NW1()SG.8"D*`B(@`:6DI*B$I!*B9`0R*4E*5
M*40$@3).0$0DYRN;+D[YQ*`TQ$(V#'D9D[&]1C;#'D,HV>XRPL[)8[_<T5NA
MDOASI-A+N&*A^TBZ:C</QE`#5OHF3MK9CYJ^Z_X2U$?AN8)3VXI!],16L?\`
MVBW<UY7%DNH2#^`C%2NR04H>B-U>Y_PW9GK/;'GM@R6=52""YXNLKM),YTXF
M5FEHRRU<SHQ0$$4I1*.D2%,/@)T0+U`3%`</EK5MC])4*E?C3I6!T@3"O5AZ
MXW.8E*YJMU:$S:`4@GH/M#UX^J.M<?/%SQ0[U=K.,\SQ&.K$^M:\%'P.58=G
MEZ^I.*SDZ(8MV]JCGD<E/=T<B]>?PYD40`JC%RB<O4!UUK_N;=%FN=31J?2&
M=1+9+:<4$]TSEC+(]8,<UAVWMN\6VGJ@VLO2`<'B*P6,\)X3S'41&U%.`/C$
M13456Q-<$DDB&5554R_D)----,HF.HH<T\!2$(4!$1$0``#6,-][D)`%2B?S
M:/N1LG8VW@"2RY+YQ7W8]AL!V.\8^/+S-[@MD+EI:K#47EOQ)-V6%RG9[S%1
M$EYC(ECA%V<I*.V/J#)HHJ(N"D,FNW4*J@H=)0IQXK]>MROL(H+TG0VL)6`4
M)22.!F!/M'`X'&.2Q6;;C3ZJ^SK*W$%2"=:E`'C@>K(Y$8@Q.9N$NL/MQ]Q$
M]R%D=RC#U:)W#XVGI>7<G!)E'5J_8WJB*4XX7,/81G%LK*59<XCVD!$_7IVC
MTH-`TNX["2Q3";JJ9:0.E25*P])$A"%7.IMV]EOU&#::E*B>A*@#/T!4XNF1
M62<))+H*IKH+ID6161.51)9)0H'3524()B*)J$,`E,`B`@/4-1(@@D$8Q:`0
M0"#,&)/_`'.V=J2O4=OFW"/E&4A?FUOE,MV2-;."*N:W7T(!]6*_\32(81:J
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MLJT:80`PE3D[!!-FYC``B4J@B`"(=-=^]UJ;?OYJK<_)I4UJZDJ0$J/H!)CH
MV>C77[%?I6Q-Q0<('24K*@/20!&/_;9[O*9C^Q98V=Y!DVE9G,C6-G?\6GEE
M`8%F[:QBTZ_;*6!W)DRA.N8V,9.6380`ZPMW)`ZG["CJ\P[2]4-4MV825(:2
M4KEC)),TJ[`203PF#TQE[!NC-.]4VQ]0275!2">*@)%/:1*73(C.46,:D<5B
M.`V7=-M[I^<:7MLLN6*C$9PR#%/IBIX\=2'_`'W),V12'`B@D3.SCGTDD)SL
M&SI5%Q($06%L14$C]O?;M=P>HGKBW2K-$V9*7+`?PD#B1,#"<IQT'+I;V:UF
MW.5216N":4\?3P!/`$@GA./>V_)N,:A8*31;S=:A7K)E5[+0=!J]DF8UA)7I
M]%1X/YF+K\:_634FEF<>J4RR293]`4*40ZG*`\#-+5/-OOL,+4VT`5*`)"03
M@21EC',]54K+C%/4/H2XZ2$I40"J68`.>?NCIA?&X;AIX^-QZTA*6'"##'MJ
MDE#KN+AAQX./)<SE01,HZ5BX]!S3GKE0PB)CN8M<QA\1ZZWZ#>%_MX2E%87&
MA\%P:QZ_:]2HPJ[:-BKB5&D\)P\6SI]S%/\`-B5[<=A.\\)7(QB$=N^6YJUP
MUHB:M<XEC,"@VG96BS]SDZO-XWR0PAP9QEA:R"M>5%)VDV:IK"8BJ2**[?J%
M.MU8QO+;]5Y^D"5)*DF6("@D*"T$XB4\IF61)!B;7"C?VE?:<454532E8G@2
MDJ(*%@8&>DSP`.!`!&%F&^\XJ;+=RQQ*9,3X9N1Q(;P.031"HB4WX#%Z]!_=
MU*MK8;DLP_\`4(]^&?F^?_B_?)E_[:[\F,)\%GW2\@]>OW@[5\OZ/,6Z9^9_
MZ^H_HB?SCL27[)G[O;Y_C+O]VI(:]EW%%*SAC>VXJR'%A+5*Y1*T5*-RB1-T
MW$PE69RD8X436*SEXE\DFY:K=IO*<)$-T$`Z"B6^OJ;964]=2+TU#:ICH/2#
MT@C`CB#'H;<FW;5NRQW';UZ8\2W5+92H9*'%*T&1TK0H!2%2,E`&1RCQFVS;
MMC_:YB:OXDQV@N:+B16>RLU(%;_&;187PE/)V":5;)(I*/'9B%(0H!VH-DDD
M2_03+KLWF\5=\KW:^K(UJP"1DE(R2.H>Z23QC+V-LJS[`V[1[=LR266YJ6XJ
M6MUQ7M.+D`)F0`&24A*1@(R5R\_<)R]_2^,?UFU+6_R_^M-!\5S\VJ)U]I#]
MT6XOG:7^\M1^?A_^X9BS^G\F?K#L?X-?O,'ZT5OQ&_S:8^/LV?NDL7S]3_>'
M(\%MZV*9DQ7R!YCW1V.5H+C'-^6R:I"L8F:FG-K2+<9Z.DXH)",<UME&H"FW
M:F!?L>J]AQ`"]X#U#MW;=%NKMIV^QLH=%8T&YDI`3W`09'43V81B[,Y2;GV_
MSCW'OZNJ*,V2K55%"4+671XRPI&I);"1(#O269<)PW34_CTE&3-W&\3$^T/'
MK^TW>79OK<\8N?L+CEH]1"RW"5`IR-BI-2BHO'P"#D`];(J$\ALF`@7S%S)(
MJ;]@V[7[@JT,TS9%,"-;A'=0../%4LDYGJ$R)SS'YF;>Y;V9ZNNE0E=T4@^!
M3!0\5Y>0PS2V#[;A&E(P&I92E2F>)S!=^S'F?(N_[,C90CNS2MI"ABHW.V;3
M-ALSAPC:;!%-US*J)5ZOQYS13#H8Q!$ZA"F'T_B^;\NE);K;2;4MRNZA*=?&
M24RTI/X2CWE=@Z8\[_9WVG>-S;HO7.#<R#K><=\"8D''720ZX@&<FVTDM(QE
M,D`]R*&=22/9T?_3OXT01/ESG\=VYC?@^VS+[>8*KS2>+VN7D;8-CMT75Q;G
MN*V-3PGHPD1#UH*EK#OS.S_-]I>OXP:?=DW^VV1-R%P<4DNEO3))5[.N>67M
M"$3>=CN5X<MRJ!D+#8<"IJ"9:M$LR)Y&&^[.\:6K#.T_;9B.\MVC2YXSP;B^
MB6MJP>)2+)O8:K38>%ET6C]#ZAZV2?LS@14GT3E`!#P'2G=ZEJLNMQJV"2RX
M\M29B6!42,.R&JT4[M):[?2OID\VRE*A.<B``<1A&D-9T:,3+4_B^W9PW-&\
MWM/J[4"8%6S/>+J273NL0I8!@9VA3]?CUAK91^(`X/)2"13)_C%*(F'P#5(=
MW+:E[.%G#JO/>"E,M)E,*!..60B=-;>NB=W&[%@>1\92M6I,Y%)`PG/,]$4T
MZF\46$B\WVQG<!OHQ!A6G;?H>NS,Y2,DS%FGTK%9H^L((Q3RL.(M!1NXD1!-
MRL+M0`$A?$`\?DTZ;+O5!9:JM=KW%)0ML`2258@SX0F[QL]?=Z:B;H&@I:%D
MF:@G`B7$B&`;"</7;;_LXV[X8R.U8L;UCG&\36K.TC)!"58-Y5HJY.LFUD6W
MU#Q(`5#H<G@.L&^U;-?=[A64ZB6''"4DB1EV1NV.E>H;304E0D!]")$3GC,\
M1A":>1;@@6S%D^:W.[+;RVQ/FF9L3F[V2GRLI)P=>F;JN[&3<VZEVN'(M)T>
MS/I03.52"0[11T<52';#U[G#;^^!24R+;>&2[2)3I"@`2$REI4DX*`&'3+"1
MA1OVRE550NX6AT(J%*U%!)`*ISU)4/9,\993R(C'2%8]SM&,2XV;V"Y.(I!,
M(LED6E]L4B^.W*'D@X'(4B@M<5E!*'7U2CH7/^4)^[6N7.6ZCYDH;UYRD\/Y
M@[OHE*,@-\PD@4P4]HRG-H_S_:],XT[L5X'+I$9<C-T/(#E-YD_*D=88ZZ1=
M+AK;/6)5>V1KI!_'S>1<C2!T9:Q.6#IL0Q63,WIS&(4#N54NJ0YE[WPRJE5;
M;#3!NF*2DJ*0.Z<"$(&`GTGU3QC2LNRGA4IN%\?UO!05I"B25#&:UYGL&?WT
ML(9+S%;3\Q[S=GQL-X-C(66O`Y2I%K])/3K*NL!AX-M/I2"GQ%^((><0\@EV
MD_&-U'I\FEW:-TH[1=O-URREGPE)F`3B92P'9#%NRVU=UM0I:)L*>\5*I$@8
M`*GB9#C'O.*;;=E':9LCQ?@S,C"*C,@5:6O[R79PDPUGHY)&PWF>GHT49-E_
M!US'CY!,Q@+^(81*/B&N#=-QI;K>JFMHU$TZDH`)!!P2`<#UB.7:]OJK99V*
M2L0$OA2R0"#FHD8C#*-UWVC5;)M)MN.KO$MYZG7FN3%4L\,Z[O(DX*>8+QLF
MS.8@E43\YHY,`'*('(;H8H@8`'6&P^[3/M5#"]+R%!23T$&8C;J&&JIAZF?3
MJ96DI4.D$2,2+7WA=Y#-CF:I/,G&GEA:?A%CNDXN/+9(&N7]E!.%RN"U>XP-
MQ2+CW(D0U4(3H9<3E6.F546B9R@(5AC>&W[U1II-Q4H2OC@2@GI24]Y!][+5
M$MJ-I7ZSU:JJPU!4C&4B$K`Z%!7=4/6#GI$=&#;W[A[>.T'%N?<M,<"XDG"?
M#[I+I+XDJ[Y]$'`"OFWI<+L/MG.`_1ZD.R,\:1[@IA(L8I#"`]?S^P+0?-4-
M+X]6G%(_&*QX?E#I$NF1(X8QS>0WW=QY:NJ2U2JP43X:<..#8U*GT3D>,H\O
MA_@JW%[<.1#"&3<;(P]JVW8HR;BVT.;M9+G7V=QE6<(PA7=TE#5-N4B[83V$
MKP6K0G>8J`$+WJ#],W+5[VMUPL%;3U!*+@ZTM.D))2"9A(U992F>F<<=+LZY
M4%]HWF4!=`TZA6LJ2"0)%1TSGG.0]_./U>Z9_CVR'\DW$_OV$=?'++V+UVM?
MVD<G,?\`*V?XKOOMQ\UWPS;EL<TK!V[;C$S-.T&^W7"^-Y^Z8Z<7=U4Y)61L
M=.@IR?+6[2X4^#3M;EI<P+*0DYT;IG`!*JH4I$R<G[7VVHJ*^U;DHTK80^L)
M5IU"25$":<P0,-2?4(X1M.Y,TU!=+!5*2\ME!4G5I5-203)6`*2?@J]V.:7;
M:%[AK=ZS'$N=;E8H?';PZ;2=-8\B8KI=+D&(&`IOM%'XC`DM<&1>G?Y"[1Z!
MC@!NWJ`&#L,W;8-I/FJ)I!J!EI0M2@>HKP2>L$1P/6O?%U'E:Q3@8XZEH2D]
MH0>]ZC#V>,#B:QEQWP\M:W4]^<K/MTA$H.VW\[+T$/"PGJD9%>JT>-5%5VQB
M7#]LBH[<KG%P^.W2,8J1"%2!'W+NJIOZD-);\.@0J:4SF2<M2CTRG(#`3.><
M.NW-L,6)*GEN>)7K3(JE@D9Z4\93`F3B9#`0Q;.N#<9[D<4W'"^7ZVWM-!O,
M8:-F8Q4YD'"1B*$<,92*?)='$9,Q#Y%-PT<IB!T5TRF#J'4!7Z&NJ;=5,UE(
MYI?09@^^".((P(C?KJ*FN-*[1U;>IA8QZ>H@\"#B#$I-QX=N2[8?DR>OG&OF
MR7LM,FU.\8AE:X*IV_T*"JJD?%7BGV\28XOQ8P%1!!R8#F$QC&!LCW#UJ+.[
M=N7RF0QN&C"7AQ*2I,^)2I/?3/T=IB9/;5W#9:A;]BJ5+:/WJ@E4N`4E4DJE
MZ>P1\6R[6?<1[SV0XTSQ?Y:AXZE`"/L8SEPQ/CJM/XQ4>CE&>AL&LDYFV,E"
M&'JV7;.$5!``,``'4/MNY[`LY\Q0LI74#$22M:I]1<P2>L$1QN6W?5W3Y>M<
M6E@X'4I"$D=8;]H=H,/PXSN,C&W'/0)]E#V.1O\`E?(:<2;)5^=`XCHQZ2&!
MT>+@JS6_5+M8J#BUY!<Y55!5>NCJB953L!)))%W)N2HW`^V5-AND;GH3F<<R
MH\29#J'NEXV[MQBPLN$.%RK<`UJR&&02.@3S.)ZLAFCEJX<XG?HY8YFQ+88B
MA;BH&$;P#H]@*X)3\CP,<*YXN.L#EBW=/8>=BP7,FUD"(KE,AVH+)B0B9TM+
M:N[E6-*J.K;*[>I4Q+VD$YRGF#Q&&.(S,\_<^U!>5"MHUA%>!(S]E8&4R,E#
M('&8P/3"@L;;9_<<85@V6#\;V2\Q-#B$BPT*N?)N&+'`0T441(@A`6.V/Y2R
MP42U3-]2BV,@#<@`4B9.@%!MJ+CR^K%JK:A#9?.)[C@)/6$@`GMG.%.GMV^J
M-`HJ?Q4L@2'?04@=`)49#LE'T\U^WUW<VC#T9D>1R*VSKO+O^1DIK*+NR9!.
ME78&F#7Y8JK8MKM@!*72SKSGH@5<G\I))%,$D$Q(45#_`!1[\M+=6JG2QX%H
M;;DB2,2J8^"G!*93P])Z(^ZO9%W52HJ"[XUT6Y-8*Q()D<U*D5*G*9]_.*>]
M@.&[QM[V:;><+9*:,&-[QUC]G7K.TC)%"6CT)-%\_<'3:R37^#O$@3<%^F3P
M$=32_5;%?>+A64RB6'')I)$C*0X12+'2O45IH*2H3)]#<B)@XS/$80D[EOX7
M<P;A<Y*;N-H,U%)9+F20+J\4>3L'V0DW%FJK1E'P=THMH4,BP92P,(QL59!P
MNU$BS<JZ2PF.)`=-J[PI*"A%JNR3Y=,]*@-0TDDE*AG*9,B`<#(B$[=&TJNM
MK%7.UD%U4M22=)U``!22<,@)@D2(F#C'/=KFVKGMN6=,$.MR^7+=7,&XQRKC
MNXWF.L66JDDI<*M2[3%3<G7G;/&RCZ<NBDPRCS)`E+',T7.8!74^?78N=RV.
MS15PMU*A5:ZTM*2EL]U2DD`S7()D3\''HCJV^V[T?K*(UU0XFC;>0I6IP=Y*
M5`D22253`XX=,-HYA=J68-Y6SIYAG!T;"RMY6R71K.1I/3K.NL!B8+XO\04&
M1?=$`6)ZPG:3Y3=1Z?)I4VC=*.T7?S=:LI8\)29@$XF4L!V0T[LME7=;6FFH
MFPIX.I5(D#`!0.)D.,>TXH]MN4=I6Q[%>"LRL(J,R#5)?([R890DPUGHY)"R
MY$LUCBA1E&75NN92+E$3'`OXAQ$H^(#KAW3<:6ZWJIK:-1-.I*`"00<$@'`]
M8CGVQ;ZJV6=BCK$!+Z5*)`(.:B1B,,H6ER-\"\/G.\36XK9W:H[$.:).74MD
M_2I)P\B:39;6"Q7XV.KS<2DH_H-G=2)//4$B2K-5T;S0],83',Q[>WRJB81;
M[NV7:0#2%#%03E)0/M"6'3+IA>O^R4U;KE=:5ANI4=10<$DYS21[)GC+*?1&
M%FF,_<SP,8&*V=LR2[@P2"*+97%\P'-2`-NWR0<ER;,.W5^*<"!U]2+X'`?+
MW`;6X:GERM7FBVT%YRT.`?R`-/HE&(*?F`VGRH4_HRGK;/\`/)*O3.-9[!.!
MJWU;+L/NBW[9(_.7E&(LL?>HBB1=BE;41Q<HYXC)1]AR5?9;M?6AZPD$$U09
M-^YNHJF457*R7<B;)ON^&7*5=ML3'ATQ24E1`3W3@0A(RF.)QZ`#C&I8]E/(
MJ47"]/:W@H*"`2J:@9@K5QQX"<^)(PC9?*CQ"(\@,O`98I>9+#CW,](KR%=K
M$98W3R6Q:ZCFL@XE"IIQK(@2U.F7#UT8ZLBR]1YPD3!1N<2%.7(VQNS]!(72
M/TB7*-:IDIP6#*7'!0D,C+MC7W+M4WM::MBJ**M*=("L4$`SX8I..8G/HA4<
M-@CW*.W=J2@X^R9-7ZL-"A'QDPI>,+91;)LDP\M#T4GFI@[N$:T13``33.1'
MRB@`%*``&FE==R[N!\>HITH=.)&EQ&/6&Y))]<+"*+?]O`88><4V,`=3:Q+J
M+DR!ZI1V[9?PO;G\A;F8G>#R:Y!2N-HK\O$VF)HA[6G=+%/V:O.6SFLEMTNP
M3-5X:G5Y1L4Z,1&**I*=A$NB"('34Z5XWC;:>W*M.W&-+:@4E6G2D`YZ0<2H
M_?$=>)CN6C:-QJ+@FY[A=FH*"M)5J4HC+41,!(ED"<)#`11!NIQ[9<L;<,UX
MTIR#5S:;QCJRUN`;O7:3%HM*2;!1NT3</%OJ6R1E#``G-X%#Y=(UBJV:"\6V
MMJ"0PT\E2B!,R!QPXQM<P[+7[BV/NBQVM"57"JHW&VPHA(*E"0!4<`.LQECB
MZVSY5VK8"MV/LOQ\3&V68RY.W!DA#3+2<;&A']0HT,V54=LA%)-<7T"X`4Q^
MD!2@/R&#6YOB]4%\NM/5V]:E,IITH)(*>\%K.1ZE"$#D%L7</+_:%SM&Y:=M
MNN=N2WDA"TN#0IEA`,TS`.IM6&?'C#)=)L7&#1!&+.0?"-]W$[4\A8FQFSCW
M]RL4A27$8UE))O$,E$X.[0$Y("J_=?4(B2/CU3%`?QC``!XCIDVE<J2T7VDK
MZU1%.A*P2`2>\A0&`ZS$MYR[6O&\^7UXV]86D+N;SC!2%*"`0AYM:N\K`=U)
M[<H4!B?:YS+X,HT9C;%-SJ52I,,O).HV#1F\3RB;5>7D'$I(J%>SE8DY)7U+
M]VHH('6,!1-T*`%``U0:^]\NKG4KK*YA;E2H`%6ET3D)#!*@,!U1YLV[L'[3
M6T[4Q9-OW!BFM;:E%+8<HU`%:BI7><;4K%1)Q)EPPCI/YNN=O_:Q5Q^;H+K!
M_P#T_8G_`*M=/S?*_P#X%?J?_KQM_H7[6O\`WYG^50?^5'^:F%.<:U$&*F,Z
MUZOLEP%-5^A8L?PJR13^!CD>TJD!,IF*'R"F(&#YA#7Z+ERS8[[=L4M71I</
MN+7*/Q6UOM6W$>7J=U-,-'-0=IVR/XS#.L>B/>8<X98Z2LXY(WB9?L.;K<[<
MHO9*#CI:=".DET3$[4['=)IP>VS[<R*8$$B(1PE+]$#B4`UU+CS%4AGR>WK>
MBFIP)!1"9CXJ$]Q/IU=D;&V?LQ-/5_Z;YE;D>NEP4H*4VA;FE9'^5?</C."0
MD0GPSP"H=U`0$'582*K59B(V`K\$P;1<-"1#-"/BXN.9)%0:,6#%J1)NU:MT
M2`4A"%`H`&IH\\[4.N//N*6\LDE1,R2<R2<S'JJBHJ2W4E-04%,AFB90$(;0
MD)0A*1()2D2``&0$?7UQQV8__]2_C1!!H@@T00:((-$$&B"#1!!H@@T00:((
M-$$&B"#1!!H@@T00:((-$$2@^YOK4+87NR\9;(-0HHM&NX$$`M3*^NQDP75P
MQYHL?L32+B"?H_*+YGJ1;]?-+Y??T/V5+ENXMM%XT4ZUS+7LZ</RF>I2?<G$
MRYA-H6[:-3Z$22[GJQQ;RTI5EURBD':F@FVVO;<&Z+QO((M\#XB12?M"NR-'
MJ:5`KY".VQ'[5B^(W<E*!R`LBBJ!1#O(4W4H3V[&=TN1*2#YAS`RP[YZ)CU$
MP^6@2M5L`4"!3MXXX]P=,CZP([[K/C1@T00:((-$$&B"#1!!H@@T00:((-$$
M&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"
'#1!!H@C_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g664229g93b60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g664229g93b60.jpg
M_]C_X0F_17AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!````
M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4
M````D(=I``0````!````I````-``+<;````G$``MQL```"<0061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q-#HP,3HR-"`Q,3HP,CHQ-P```Z`!
M``,````!``$``*`"``0````!````[:`#``0````!````$P`````````&`0,`
M`P````$`!@```1H`!0````$```$>`1L`!0````$```$F`2@``P````$``@``
M`@$`!`````$```$N`@(`!`````$```B)`````````$@````!````2`````'_
MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`#0"@`P$B``(1
M`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`/@]!R.K/ZA5BXM]F5]NR
M*J>O9MUVW&HJM^S5_8#]H=E=0RF-IMN_P&/]J?Z=]WZ/TET%GUN?B=3PL4V4
M5]*.1;@.RLU[F7VNQ:GG+S:['"K';11DU_9'O=ZGVK)^AZ/^$W.@_L[[-D?L
M[?Z/VO)]3?/\]ZUGVKT]W^"^T>ILV+.Q?^8L]6]/[%'V@?M?UMNWUMX]/UOM
M7LV?:OYK9^K_`&SU?3_6?524UL7ZZYG4^L973>B].^VLQS4YN398^BKT7U^K
M]JML?CV>V][F,Z?70R_[75ZV7^CQ]GJ5?JCU/?U'J=6)=4<6O.S<SJ]MY.]N
M^VW'PJ<;<]NRIF-B5WWY#V?9]GZ"O]+ZWH]+@?L?]J=3^Q1^T-]/[3^ENW>D
MS[+._P!FW[-LV^C[/^N^HN:?_P"-9]BZ5ZWV7[++_P!G^MO^CZMGJ_:/6_2?
M9?M?K?\`*'ZKZZ2F[@_72N_)RJ[/3M>_+;C=+P,8%V397M;;]OM=8]M7V*^F
MS[:S)8RO&IQ/\/?D?HT'_&'F/=AU=-Q&_:<EI^W96'KL=ATG9>[-])[+_LGJ
MV5.].AMMV3Z/I,J_G5<^J7['W97H_:/VSO=^T/VEM^WQN_1>IL_1?8MFS[)]
MC_4O3_X;U4OK/_S5^V8_[7];[;Z5OI?9/M/K?9_;]I];]E?IOLG_`!WZ+_P1
M)2OJCU3*R<=N`*G9.)T]GV<=9-U=E>2^KTV,MH])]KW^O6[U;/=^KV_JMEMF
M17:C?6'(SLC,PN@8%S\1_4!;;EYE4>I3BTA@N^S[C^BR<FV^G'IR-MGV?])=
ML]3TT+ZL?\S?M>9_S;V>I#?7]'U/1VR[;]E]3]4V>IO]3[%_A/YU%^LO[!]7
M"_:?VC[9NL^P_8OM'VF(;]K]+]F?K/H^GZ?VC_!_0_D)*<L6X?U9SLKIO1GO
MZAU;JV16*<%]ECZ<9QJW>OG6O?D65;ZJK\W(L_IF?L_1U_HO5K"WZ_=2Q\'&
MS.H8%#<.W+=ANZG3D!U%@I-S;[\3':RS*=ZWV._[)3_A/T/Z='M_\;;_`)KM
M]3[-^P_M#>=^[[5'^&_[6_;?2_GO7_3_`&?^>_0+;RO^;GV7IGVC[/\`9/7H
M_9,;?2];:[[#]D]/]'_-_P!'V?V$E.+1_C!J-^+1F8C,-QR7XG5"_(86X=@]
M?[*RV[:VJYV5]CO_`)M_Z#\_^>H]2GU'_&/>*<K)Z;BUMP\+(97]JRRYC,IM
MC:GU8_3V-#+795[;;,CU-MM.-AUTY7Z7[5^AZF__`)N?9,S[1]B^R>N/M_J>
MEZ7VB:MOVS=^C^U;OLW\]^E_F/\`@UA_50=+_:&?]L-9ZI^U>H_8O6#1<&;J
M_5^Q[B;'5^AZ6[9^9_P:2D.3]?[3U'$&-17C],LSOL%MF>31?:\']8MQ,>S8
MZFC!;L]:S+9^EMNKQ/2HN1,G_&%7Z_4!TS$_:-'3JQ<][;/2!I8U]N;F,LL:
MYEM#=V/5A>G_`$ZW[0^G]6K]=6*O_&\_:/5_^3_M<_Y7];9'TJ]_J?:/T.S[
M3Z/VGTO9]M_I'ZVMIG[#]3-V?9?4]-G[1CT]WI[#Z'VW_@OL^_TO7_P*2G.R
M?K;T]O5\;I^/=3926W79^8YX;3372QKMK;W$4V9'JY&+ZE37_H<?]+;_`#E:
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MFN+K,VZ[;^@HQ=S:F8U#M_H8E-=./1^BR<J[]7]95,7_`,:O[%U#TOL_I^B[
M]H>IZOVCT_49N]7U_P!?]7[9Z'_#_:?1_P`+Z:U?JY_S7^WW_8/5_;'IC[1^
MT/7^V^EIM_Y4_6OLO\W_`#/ZO_-I*?_9_^T1NE!H;W1O<VAO<"`S+C``.$))
M300E```````0`````````````````````#A"24T$.@``````Y0```!`````!
M```````+<')I;G1/=71P=70````%`````%!S=%-B;V]L`0````!);G1E96YU
M;0````!);G1E`````$-L<FT````/<')I;G13:7AT965N0FET8F]O;``````+
M<')I;G1E<DYA;65415A4`````0``````#W!R:6YT4')O;V93971U<$]B:F,`
M```,`%``<@!O`&\`9@`@`%,`90!T`'4`<```````"G!R;V]F4V5T=7`````!
M`````$)L=&YE;G5M````#&)U:6QT:6Y0<F]O9@````EP<F]O9D--64L`.$))
M300[``````(M````$`````$``````!)P<FEN=$]U='!U=$]P=&EO;G,````7
M`````$-P=&YB;V]L``````!#;&)R8F]O;```````4F=S36)O;VP``````$-R
M;D-B;V]L``````!#;G1#8F]O;```````3&)L<V)O;VP``````$YG='9B;V]L
M``````!%;6Q$8F]O;```````26YT<F)O;VP``````$)C:V=/8FIC`````0``
M`````%)'0D,````#`````%)D("!D;W5B0&_@````````````1W)N(&1O=6)`
M;^````````````!";"`@9&]U8D!OX````````````$)R9%15;G1&(U)L=```
M`````````````$)L9"!5;G1&(U)L=````````````````%)S;'15;G1&(U!X
M;$!RP```````````"G9E8W1O<D1A=&%B;V]L`0````!09U!S96YU;0````!0
M9U!S`````%!G4$,`````3&5F=%5N=$8C4FQT````````````````5&]P(%5N
M=$8C4FQT````````````````4V-L(%5N=$8C4')C0%D````````````08W)O
M<%=H96Y0<FEN=&EN9V)O;VP`````#F-R;W!296-T0F]T=&]M;&]N9P``````
M```,8W)O<%)E8W1,969T;&]N9P`````````-8W)O<%)E8W12:6=H=&QO;F<`
M````````"V-R;W!296-T5&]P;&]N9P``````.$))30/M```````0`2P````!
M``(!+`````$``CA"24T$)@``````#@`````````````_@```.$))300-````
M```$````>#A"24T$&0``````!````!XX0DE-`_,```````D```````````$`
M.$))32<0```````*``$``````````CA"24T#]0``````2``O9F8``0!L9F8`
M!@```````0`O9F8``0"AF9H`!@```````0`R`````0!:````!@```````0`U
M`````0`M````!@```````3A"24T#^```````<```____________________
M_________P/H`````/____________________________\#Z`````#_____
M________________________`^@`````____________________________
M_P/H```X0DE-!`````````(``3A"24T$`@``````!``````X0DE-!#``````
M``(!`3A"24T$+0``````!@`!`````CA"24T$"```````$`````$```)````"
M0``````X0DE-!!X```````0`````.$))300:``````-)````!@``````````
M````$P```.T````*`%4`;@!T`&D`=`!L`&4`9``M`#$````!````````````
M``````````````$``````````````.T````3``````````````````````$`
M````````````````````````$`````$```````!N=6QL`````@````9B;W5N
M9'-/8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG``````````!,
M969T;&]N9P``````````0G1O;6QO;F<````3`````%)G:'1L;VYG````[0``
M``9S;&EC97-6;$QS`````4]B:F,````!```````%<VQI8V4````2````!W-L
M:6-E241L;VYG``````````=G<F]U<$E$;&]N9P`````````&;W)I9VEN96YU
M;0````Q%4VQI8V5/<FEG:6X````-875T;T=E;F5R871E9`````!4>7!E96YU
M;0````I%4VQI8V54>7!E`````$EM9R`````&8F]U;F1S3V)J8P````$`````
M``!28W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<`````````
M`$)T;VUL;VYG````$P````!29VAT;&]N9P```.T````#=7)L5$585`````$`
M``````!N=6QL5$585`````$```````!-<V=E5$585`````$```````9A;'14
M86=415A4`````0``````#F-E;&Q497AT27-(5$U,8F]O;`$````(8V5L;%1E
M>'1415A4`````0``````"6AO<GI!;&EG;F5N=6T````/15-L:6-E2&]R>D%L
M:6=N````!V1E9F%U;'0````)=F5R=$%L:6=N96YU;0````]%4VQI8V5697)T
M06QI9VX````'9&5F875L=`````MB9T-O;&]R5'EP965N=6T````115-L:6-E
M0D=#;VQO<E1Y<&4`````3F]N90````ET;W!/=71S971L;VYG``````````IL
M969T3W5T<V5T;&]N9P`````````,8F]T=&]M3W5T<V5T;&]N9P`````````+
M<FEG:'1/=71S971L;VYG```````X0DE-!"@```````P````"/_`````````X
M0DE-!!0```````0````".$))300,``````BE`````0```*`````-```!X```
M&&````B)`!@``?_8_^T`#$%D;V)E7T--``'_[@`.061O8F4`9(`````!_]L`
MA``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,
M#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1
M"``-`*`#`2(``A$!`Q$!_]T`!``*_\0!/P```04!`0$!`0$``````````P`!
M`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)"@L0``$$`0,"
M!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+1
M0P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25
MQ-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%
M!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C
M<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2E
MM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1`Q$`/P`^#T'(
MZL_J%6+BWV97V[(JIZ]FW7;<:BJW[-7]@/VAV5U#*8VFV[_`8_VI_IWW?H_2
M706?6Y^)U/"Q3917THY%N`[*S7N9?:[%J><O-KL<*L=M%&37]D>]WJ?:LGZ'
MH_X3<Z#^SOLV1^SM_H_:\GU-\_SWK6?:O3W?X+[1ZFS8L[%_YBSU;T_L4?:!
M^U_6V[?6WCT_6^U>S9]J_FMGZO\`;/5]/]9]5)36Q?KKF=3ZQE=-Z+T[[:S'
M-3FY-ECZ*O1?7ZOVJVQ^/9[;WN8SI]=#+_M=7K9?Z/'V>I5^J/4]_4>IU8EU
M1Q:\[-S.KVWD[V[[;<?"IQMSV[*F8V)7??D/9]GV?H*_TOK>CTN!^Q_VIU/[
M%'[0WT_M/Z6[=Z3/LL[_`&;?LVS;Z/L_Z[ZBYI__`(UGV+I7K?9?LLO_`&?Z
MV_Z/JV>K]H];])]E^U^M_P`H?JOKI*;N#]=*[\G*KL].U[\MN-TO`Q@79-E>
MUMOV^UUCVU?8KZ;/MK,EC*\:G$_P]^1^C0?\8>8]V'5TW$;]IR6G[=E8>NQV
M'2=E[LWTGLO^R>K94[TZ&VW9/H^DRK^=5SZI?L?=E>C]H_;.]W[0_:6W[?&[
M]%ZFS]%]BV;/LGV/]2]/_AO52^L__-7[9C_M?UOMOI6^E]D^T^M]G]OVGUOV
M5^F^R?\`'?HO_!$E*^J/5,K)QVX`J=DXG3V?9QUDW5V5Y+ZO38RVCTGVO?Z]
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M0_IT>W_QMO\`FNWU/LW[#^T-YW[OM4?X;_M;]M]+^>]?]/\`9_Y[]`MO*_YN
M?9>F?:/L_P!D]>C]DQM]+UMKOL/V3T_T?\W_`$?9_824XM'^,&HWXM&9B,PW
M')?B=4+\AA;AV#U_LK+;MK:KG97V._\`FW_H/S_YZCU*?4?\8]XIRLGIN+6W
M#PLAE?VK++F,RFV-J?5C]/8T,M=E7MMLR/4VVTXV'73E?I?M7Z'J;_\`FY]D
MS/M'V+[)ZX^W^IZ7I?:)JV_;-WZ/[5N^S?SWZ7^8_P"#6']5!TO]H9_VPUGJ
MG[5ZC]B]8-%P9NK]7['N)L=7Z'I;MGYG_!I*0Y/U_M/4<08U%>/TRS.^P6V9
MY-%]KP?UBW$Q[-CJ:,%NSUK,MGZ6VZO$]*BY$R?\85?K]0'3,3]HT=.K%SWM
ML](&EC7VYN8RRQKF6T-W8]6%Z?\`3K?M#Z?U:OUU8J_\;S]H]7_Y/^US_E?U
MMD?2KW^I]H_0[/M/H_:?2]GVW^D?K:VF?L/U,W9]E]3TV?M&/3W>GL/H?;?^
M"^S[_2]?_`I*<[)^MO3V]7QNGX]U-E);==GYCGAM--=+&NVMO<139D>KD8OJ
M5-?^AQ_TMO\`.5JQ]6NNMZST?'ZE8:Z_M=M[*&B6AS:[;ZZ-K;?>ZQV-C^J_
M_KGZ.M8_5!TZ.FNZ&[HIH][>E5Y`I%7V@OUNZ5=0YS_M->3Z?J8]-&RZW_M5
M1>J6$WH8Z=]4O6?DOZ8+F#%)96QAZE%WIOSYLMSJ[_M/VK]%C^IB_:?Y^[TT
ME.Y]>OM#_JY;BXMSL?*S;\;%HL8XM<'79%-3MKFEO^#-BG]>,F_&^JG43BAS
MLBRMN/2UA._?D/9AU[(]V[=<I?6O]@?8\7]N^KZ7VNK[)Z'K^K]IA_H>E^S_
M`-8W[?5_]6^FL/%_\;7]DY7[.V_9]V/]J^R^O]IW^LW[%N]/_*'J?;-G\OU$
ME/1=<S[>A]`MR,6LY610RNG&K<2XOML<S$Q?5<7-<_=?;7ZOO6.[I.)T+,P>
ML]0ZCDYG56UVU.J:XNLS;KMOZ"C%W-J9C4.W^AB4UTX]'Z+)RKOU?UE4Q?\`
MQJ_L74/2^S^GZ+OVAZGJ_:/3]1F[U?7_`%_U?MGH?\/]I]'_``OIK5^KG_-?
M[??]@]7]L>F/M'[0]?[;Z6FW_E3]:^R_S?\`,_J_\VDI_]D`.$))300A````
M``!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````
M$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`$,`4P`V`````0`X
M0DE-!`8```````<`"``!``$!`/_A#F-H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C`O`#P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED(C\^(#QX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C`Q,B\P,B\P-BTQ-#HU-CHR-R`@("`@("`@(CX@/')D9CI21$8@
M>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S`R+S(R+7)D9BUS
M>6YT87@M;G,C(CX@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN<SIX
M;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+VUM+R(@>&UL;G,Z
M<W1%=G0](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C945V96YT(R(@>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N
M8V]M+W!H;W1O<VAO<"\Q+C`O(B!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G
M+V1C+V5L96UE;G1S+S$N,2\B('AM<#I#<F5A=&]R5&]O;#TB061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RDB('AM<#I#<F5A=&5$871E/2(R,#$T+3`Q
M+3(T5#$Q.C`R.C$W*S`U.C,P(B!X;7`Z365T861A=&%$871E/2(R,#$T+3`Q
M+3(T5#$Q.C`R.C$W*S`U.C,P(B!X;7`Z36]D:69Y1&%T93TB,C`Q-"TP,2TR
M-%0Q,3HP,CHQ-RLP-3HS,"(@>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#HY
M0S$Y.4%!-#E#.#1%,S$Q.#$X,$1"038Y13=#-C<W02(@>&UP34TZ1&]C=6UE
M;G1)1#TB>&UP+F1I9#HY0C$Y.4%!-#E#.#1%,S$Q.#$X,$1"038Y13=#-C<W
M02(@>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)X;7`N9&ED.CE",3DY04$T
M.4,X-$4S,3$X,3@P1$)!-CE%-T,V-S=!(B!P:&]T;W-H;W`Z0V]L;W)-;V1E
M/2(S(B!P:&]T;W-H;W`Z24-#4')O9FEL93TB<U)'0B!)14,V,3DV-BTR+C$B
M(&1C.F9O<FUA=#TB:6UA9V4O:G!E9R(^(#QX;7!-33I(:7-T;W)Y/B`\<F1F
M.E-E<3X@/')D9CIL:2!S=$5V=#IA8W1I;VX](F-R96%T960B('-T179T.FEN
M<W1A;F-E240](GAM<"YI:60Z.4(Q.3E!030Y0S@T13,Q,3@Q.#!$0D$V.44W
M0S8W-T$B('-T179T.G=H96X](C(P,30M,#$M,C14,3$Z,#(Z,3<K,#4Z,S`B
M('-T179T.G-O9G1W87)E06=E;G0](D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I
M;F1O=W,I(B\^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)S879E9"(@<W1%=G0Z
M:6YS=&%N8V5)1#TB>&UP+FEI9#HY0S$Y.4%!-#E#.#1%,S$Q.#$X,$1"038Y
M13=#-C<W02(@<W1%=G0Z=VAE;CTB,C`Q-"TP,2TR-%0Q,3HP,CHQ-RLP-3HS
M,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@4&AO=&]S:&]P($-3-B`H
M5VEN9&]W<RDB('-T179T.F-H86YG960](B\B+SX@/"]R9&8Z4V5Q/B`\+WAM
M<$U-.DAI<W1O<GD^(#QP:&]T;W-H;W`Z1&]C=6UE;G1!;F-E<W1O<G,^(#QR
M9&8Z0F%G/B`\<F1F.FQI/G5U:60Z,&4Q8S0Y86$M834S,"TT,S9E+6)A-S<M
M,&4V8C-C-&4X93)B/"]R9&8Z;&D^(#PO<F1F.D)A9SX@/"]P:&]T;W-H;W`Z
M1&]C=6UE;G1!;F-E<W1O<G,^(#PO<F1F.D1E<V-R:7!T:6]N/B`\+W)D9CI2
M1$8^(#PO>#IX;7!M971A/B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(#P_>'!A
M8VME="!E;F0](G<B/S[_X@Q824-#7U!23T9)3$4``0$```Q(3&EN;P(0``!M
M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@<U)'0@``
M`````````````0``]M8``0````#3+4A0("``````````````````````````
M`````````````````````````````````````!%C<')T```!4````#-D97-C
M```!A````&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"&````!1G
M6%E:```"+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D```"Q```
M`(AV=65D```#3````(9V:65W```#U````"1L=6UI```#^````!1M96%S```$
M#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```"`QB5%)#
M```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L971T+5!A
M8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV-BTR+C$`
M`````````````!)S4D="($E%0S8Q.38V+3(N,0``````````````````````
M````````````````````````````````````````````6%E:(````````/-1
M``$````!%LQ865H@`````````````````````%A96B````````!OH@``./4`
M``.06%E:(````````&*9``"WA0``&-I865H@````````)*````^$``"VSV1E
M<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````%DE%
M0R!H='1P.B\O=W=W+FEE8RYC:```````````````````````````````````
M``````````````````````````!D97-C`````````"Y)14,@-C$Y-C8M,BXQ
M($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(``````````````"Y)
M14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`
M````````````````````````````9&5S8P`````````L4F5F97)E;F-E(%9I
M97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````````+%)E
M9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`````
M`````````````````````````````'9I97<``````!.D_@`47RX`$,\4``/M
MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G;65A<P`````````!
M`````````````````````````H\````"<VEG(`````!#4E0@8W5R=@``````
M``0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4`%D`7@!C
M`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`Q@#+`-``
MU0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%`4P!4@%9
M`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!\@'Z`@,"
M#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!`LL"U0+@
M`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#QP/3`^`#
M[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P!/X%#04<
M!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&609J!GL&
MC`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E!_@("P@?
M"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)N@G/">4)
M^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP"\@+X0OY
M#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-^`X3#BX.
M20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A$'X0FQ"Y
M$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#$V,3
M@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#%B86219L
M%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`911EK&9$9
MMQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC',P<]1T>
M'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@;""8(,0@
M\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-)'PDJR3:
M)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$HHBC4*08I
M."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,+4$M=BVK
M+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ\C(J,F,R
MFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I-R0W8#><
M-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\93RD/.,]
M(CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N0C!"<D*U
M0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(!4A+2)%(
MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE3FY.MT\`
M3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU4H5755
MPE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N56^5<-5R&
M7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=C
MZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/
M:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S
M77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC
M>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"](-7@[J$
M'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6B_R,8XS*
MC3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4])5?E<F6
M-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`GJZ?'9^+
MG_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$J3>I
MJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+LL*S.+.N
MM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]%;V/O@J^
MA+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_R#W(O,DZ
MR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'31-/&U$G4
MR]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZBWRG?K^`V
MX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OL
MANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[]XKX&?BH
M^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@`.061O8F4`9$`````!_]L`
MA``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`@("`@("`@("`@(#`P,#`P,#`P,#`0$!`0$!`0$!`0$"`@$"`@,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P/_P``1
M"``3`.T#`1$``A$!`Q$!_]T`!``>_\0`=P```@(#`0$```````````````D(
M"@4&!P$$`0$`````````````````````$```!P`"``0$!`0""P`````"`P0%
M!@<(`0D`$Q46$1(4%S(8&0HA(C8W,2910F)3)&0E-55F)Q$!````````````
M`````````/_:``P#`0`"$0,1`#\`VZ%T7E^1;`[59%VQ=F>JK!RUCB?T[3D`
MF-TZVF53J9I>#S!'*;7D@AE4TNXQE)RDBKL-,A9(W&&X\[E/SR8$CD7(BRP9
MSTN@EM/+]O;'<93I;.O3ZGA;$MS'!-S6C,)E+5[7!4S@[V1J5&FM!6X3&G:N
M?6=(`MG;1J#>7U&H`K'P(1"?D0,2QMW*TIM'1[;GJ(T%J>K"[!I%^T;GZT;L
MK-O@L*T%2D:EK3"U]B0EL%)7"<,D;>G-[3JF,][:FX+LUF`4!\H1I!)H2&NO
MLQR'G;0\BS7<EBB@LPA.6G[8E@2EW1`*KFOZ48YPBKLMPELG"J$:BDLBE:\"
M9I:BDIZMP-$664'DY0E*/!'O:#N.D>SO&N-HKCR86J[QC0G;GC'-3V[G0"W*
M<=AM"TV16P[/Z1-+H_$7A]A22+Q<EUY<D7"A&G\H!A@RCB.>"P<EB/LDB>^K
M<TDR4/4DY<,T4#)0UW']AN#@SE51?5GM2]4@G,>II`7\[G*XM#S$_'QD1!IK
M<LY&'DOY2S4YAX9S.O8;$]1[#U3E^IJBLYU@F05)<$L_4:TAI04TNT(D6-?$
MHH"(^:LY?GZ7PMK=>#G0\!/!*(Y,:4<$H!S<>O"<,1GL'GY#\I@LQB\S2Q:6
M2*!R55%7YKD"9AG$/<!M,MA[PH:E2LEND\6=RAI')`:(*I"K+&2>`!H!!X"F
M-^X6M23V'V05WC`MYO2T5DUZ^YP;B/.^6+96PF7MG9O-K6-9ZSMZ]$D>FD0&
MW5W758H>'].L?3O3TR1M7&%<<%&+.1`^W&G:3AV00?->:)-V&YWOO7@(K7U(
M3@45F03I#:^@8G&4$7L)[9(^L0-SV-++)LS+UB50:E()4%'!&#GX##\0;QX"
MNCH#0.KNSS;=R]<^&;G?\JY@R6!C:M\;:KT*4VY'>S)(4H6-^8,R.I_F)8A*
M6M*A.#(I*#XK&A40>5SP3].0E?PZ1U=]?MK]95B;^LR]M*GD99GD\C@Z&@MA
MW[-;2;(;7L&1KT:^^K>LFXRV9/';<MXUT).?T+8%.SH5!`B@GJR`H/I0UJ-?
MN2L#'6*UH;58;[SYFZS!R=-F3;%Q51(F'-6G%D"D'$8FX:[D:!.YOC2@;',8
M1IE;PA1$&I>!#5"0C&G*4!).']Z_5_/YG?4<A>EV"2P[,U%$:`N>\6=M<UU&
MQ6*J)@AA)$933M.09S)K$6O#NAX1,[4D6FN8UQ2=")2MX-2E!E9SW?=:%>9@
MSOL"2:+0E4?JB9'P2E'=-$ID=)Y0^M$@5QF:F'P0;$5,&=GK=W0'%2!<J1E)
M6\?D@Y&,U6B+4A+[3NS<]8\YI'[_`,U'"RM!W5&:"K=5Z.ZNB%1/I4WO#JB,
MD*UN2J$D4B;<W,:@]Q>G`:=M;20^8I.++^(N`7OGSO`HG1FO*<S3%:.T+':Y
MU$W7<=D'5,UB*./T_J%PSLT\2*UCJR;U+A[S!#FV.`,5H'MP0I"'#@'`0E%\
MFD\F!C=?=]F0\LRJRXK$81>&N09Y;&>1ZRF66(S&)W6>68V]OQ,;;@6S8[W+
MXQ$"9TY.IHP)8RWJEKL+A&KY4%IN4P^.08#L#;U(8CR](-;W*;+5-9LG$$*1
ML\,CHGJPY8[65)&&+0^.Q&'."QD5NLB<G.1$"$D&8280G+.-,^4))G/`<\A'
M:/A2R-J2KKVA%]L$CU?"F9Z=9+73:TR-0@0+HPG(62R(%SH#1S`W&>1%"H\U
MU94KD<O0<$J0'%@.1JRR`W+5&\:(R#/LKU79IDN>K)V+>3!0]-0>OF%/*),J
M>'<PD#Q.W]J&Z-BELJZ!<+4HW]V*X4B;BE90_(&'D?(`^-BW764A[!YQUT-T
M7G(K6K[,+%J.03<U"U%UR7&9!/D<"0Q%.N$[>O'RSDYQ(6_P0_0\IN1AX/\`
M.+$7X";?@%S]N]S/.?>K_>=MQF2.D.ED7R];::%RMC7'M;Y&YQ*(JNB$*>V1
MS2C+5-SPV2I_1G)3RA!-*/``0.>!<<<^`SO59';(B_6UAILN"92N?6>?F"G7
M^<2B;O:^1RI7()7#&N4K6]Y?74T]R=%$>$\\-P33S##!%)`_,(7/\W(+EONQ
M[5GG[D?"U!0JU["9*QHS!5[:4N*L8[*GAM@4O^X#]*J9C/,ZC2,\MGD1[=(!
M-"U-]:6<)*<0F,)\L0OB('HV]:\"HFJK'NJTG]/%JVJ:#RBQ9W(E(#3BF:)P
MYE6/[\X?3IP&JE9J=M0&<ED$@&<>9\I981#$$/(59&K/?8/WG9XLW9EMVA/L
M[T38\"E[OUR=?<1M244=$9FVJV1V259=FT[5KIJ<;`ER69JU"9Y1L;8(M!PD
M+3'D'$IU(_-!EXL):B!TR$]:8]OO@-Q*,OJ8XGT2*6+PR8^0HI(D?5C$2]\I
M>)\;4"0M>17ALA"BY>BXP<6I$#AQ&$OD/__0:EU3=8M-OV_^W;3.M\BHY3>#
M'V26RZY_M.Z(8[.K`94\N-!/(:_5<QRD!T$6*D9;T6H+?D2,Y>F\\HH"DODO
MY.`8'WM9YTIIK'M<UUGBHN-%LC;KG.%@Z7S43/([6KGHC,]?2U3)YO4S5,):
MI11MJ.>)8@8%:@:HXO@")">,OS#0`)-""[7UT]U,AU$3V31_260\_P"G+DJ*
M19GF6>Y;7DCN.J\AY0]TQ:8U;!Z8E3":SCM2XXM(F-4]214X!;(PY/SH>6E!
MZ<00$81QJ#H>E2;O"^Y5\%W!H#,<9S=7][6]>MTOQ,C9-F[:;94N;V--/8V!
M9PULL7KL]9P]-$*1$>WV5+%61.84>09QR<#"N[G"%Y]B5S=:6>8"XVU6%'E6
M9I6<Z#TE42IK2/%(H62A%;!`F_D:UR0JBU5LK94XQ\@9!9X"RCC_`#0_+SP$
M0<=STK[L<FY]18`(RSE*N8E0,1716*=HS=-X\1GZ,9]BJ-08&SN,7Q9$?:$M
MT(W1M(I4>@F&-C&YR+D*AP4!1C-.5@O_``]4FK-HZ+T^Y]95^:>S=UFZ@CE4
MJ-;;2O*"((9?.@-)P],Z,%RW)A"._1L:&NYEHF,\(@RB7FL2!.TNYBM4D2$J
M6]I;BPN#YUSQ3N4*6@&?*"A+97M45HR\,L6C39YQW(>#5)[@ZO+PYJS#W.0R
MF2O2Q0XNSJM-/7NCDJ/5*333SC!B"B'(,.[02M6I:/G/6_K^;=KLAWV^:XS;
MVNU`?6J.LN7IK<"4M0N<AT!+WQO!"Z;9F14KY.@W/G$IB50#.4B1>D**3@X'
MI4J'9]3Z\TL^;OZX71EU=?4T?+%NWL!1R*DPT<"-P^.I(?4%<T!%H:@]1;FU
MQ9S1\+BTAO+LK./.6/1PQEED)PM2^`J-X>N?4W4G(=O99GG5UO'4ELW7O"_M
M*U?>^;ZWC\OH>[(I<)S`?&'ZQKO>I6V,U5NZ-*T%%N"=<6K,0"/XX-+"=YW'
M(>=CW6KVX=L6+KLE&C7J$U'92=OATCR5UH5!:B(-:QU[;)Q&W.8N^H;^/0)6
M:Z[K65^G=&V-IDPT$'8G(TE5P;P-0H-(":66<E;$TOI[+>A]B9BK'!>7<!57
M,X#CS",1M*)WU*%<QL.NN*9>YU;\UAS:56Q,&B51<#;8Q'T'!JQ.H5<G*3"N
M21`5!Q)ZZA-"W-WDW%H*VDD>8>LE&PY0LV'5RP/C(4ANNVLTP0335-:3"!LJ
MA&X(:[J^V)-(9FM1.!`V9T7)6<')*O@9OT(<&@7[;>WYCDS;].Z>OZ&2FSIR
M@MRKL#K&,M]7UYFBJ93IYRUR<_JV\]G9S6V>7S<9B,$P4(4:U>VQMO(0)5RH
MD0TH`CCV;8&T%H/3_4?6O9[HUOOV[--:1L-J'3-!CD]1Y&KBF*1I8$LF]7P1
ME4$JK$>)/?LL5(R9=8[J=ZN@:UA2-M;4Z5O*+/!A<&Z8]6;-NZ*:C[-KQ;*&
M:853Q^=ZPP=UZO\`)*MJN`T`>Y$&OE:2:ZD2\B9FMMDMK:E0R5-$P,@U;226
MW%N0&T(4!0+AS1TH=E5FX`E_5],JXI[KPI5HLVX;ANR[&65,5VR+=5\(Y^L?
M,XMD=@K.I4!J_+$$0Q^,&NHWU0HDSH".MI*9(1\Z\0@FQMKIA[6]^U;7,VT-
MOBH_S6U1==1S"F(74$:F5=Y%HMFCCN9S.K61QY>VR":W1?QA(DZUH5OP$"!M
M+3J4"3A.6N&<`)!7_P!.UZT2S=8EB]6DBI<W0/7*^7_PM-U\OG)K!HXO6<)3
M1F^K+MV60%(X2]\L:0R4D][&'@1!`#7$[Z4P@*5*D,"-MA]4G8G$-Q94WS6F
MHLLZV[*8E%+I%?[+JQ^GD*I*MZ_M=B4P&I_RR4E621QED-I*E0K9`WC&)00Z
MRIV<5:]2HX5+E)2,/MZFH3,XKV[=R^F]):=27B?054T#1MP:2D3;'*KIIIG!
ML;.MBY(17S8!T/9*^JS.:2*H6964XKAK$QA1BQP/,/4''"!L75_O"S=XR+<<
MH5L\"?\`,=3ZG?ZKR'H&N6N3,\<O>MV1K)YD"Q-Q)7-S+F/,(D/P0CE31R2P
M/QIP^$)?`4HQC#@'[D>"WG;/51:U/T+4%M76^6E9U$1N;Q.D(NLFECI:Q:;2
MCTYECPQ1EM`:XNO(!1!,D,`46,(0K/F.^5.$XP`:XT;I[C9T@8D68.D<JL*E
M;$C(T1AYU]KZK*KF!L?2%DH"$ZRF(>@E,HAGI+:67\P52M49\..0@*,$'Y>0
MAS+K,VOGCO2[!+]@W5UJK6RR:YUS)0>8)=#3(O6-&*H>S1=EGEM@D=^6.(F(
M,!"NU#0D)BTP5A_S-YW*A.4+Y?`=FV5$NY/L8ZZ.P+.MOX@IW+$AFU+QE?0[
M1"M4,%Q3>P);&;(B,XD-5NBAJ962(M_,KB,86-93@H6H$GURPDH81)S#E"<-
MHJ+LQW-.J@K/.6+NF#6E:7+!Z]AE;.LDW1'FW-&1J:61>.HHX->CF)3RYS6[
M(9'!-H>4R..-J!P<D')0B_(&+DL(=$2]/^D$C&^Z@+WU.#.VV0RB)S=9JI3%
M4"FCTL2AS+,T#;A]GH@_DQ,R8<<#YTK6.34E4%/;I*TR&5*C37!O1HR0_]&_
MQX`\`>`/`'@#P'@?PA_#^'C\/X?\/]7_`&?]'@/?`'@#P!X`\`>`/`'@#P%>
M_L@]N?K9]"/J?L/UKU/?'HOO#[K>L_-]DHAYOL7VC_D#UK_>^O\`\OS?3^7X
M"PAX`\`>`/`50>\3[;_GVSI[O]4]S?EL=_:'Z=WYK?UK?A]PI/ZM['^QG_R3
M\I'R>3Y/OG^/N3U7TW^?ZGP'7^B'VC^E%I_V7^4CTO[XZM^J]Y?>_P"/K/M=
MC]7_`%-_O[_G'[]_5_'W_P#1?]`]J^G^F_\`#?+X"Q36O]O(+_1/](QW^VO]
>O/\`M*3^A?\`U'_QW_*>7X#=O`'@#P!X`\`>`__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g664229g96q07.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g664229g96q07.jpg
M_]C_X0M_17AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!````
M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4
M````D(=I``0````!````I````-``+<;````G$``MQL```"<0061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q-#HP,3HR,R`R,#HR-3HT,P```Z`!
M``,````!``$``*`"``0````!````[:`#``0````!````)@`````````&`0,`
M`P````$`!@```1H`!0````$```$>`1L`!0````$```$F`2@``P````$``@``
M`@$`!`````$```$N`@(`!`````$```I)`````````$@````!````2`````'_
MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`&@"@`P$B``(1
M`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`X^JC.R\M^/AUWY-Y<\BF
MD/>^`]TOV,_,_EN]B+;TKKE.17BW8697DW;O1H-=N^S:-UGHM$^MZ;?=9Z7T
M%HY]UF!]6L&O"<ZG]K79UO4'UNA]KL>W[-CXKGLVV^C30_U/L^_T_4N]15LO
MI6=A]+HSV=1HR\-M_P!GK;B9%MAINMK-[V['UTMH]2JO]-Z3UH"=UL+-"_!I
M&%7\QKU&BB_8GUD&IZ;U``:DFB\`#_-7L?U,,_5/I!Y_5*?^H"\FZID9/[!^
MKI]:T%U&7N(L>"8RGM]WN]WM7</MN_YB?5K!8]U='5+,'"R[&$M<*+1-K&/9
M_-^OZ;<;=_PRASW*,;KYB-/ZK-B`!E5[`ZO5#ZQ?5\Y/V0=3Q#D[O3]`7U^I
MOG;Z?I[]_J;OS%HKG.M7]"Z!@,Q;>B69/3:V.O<W&QJ[**A5M>ZR_>YC6/\`
M\+O_`)'J*+NJ=:RNNYV'C7T8O3L"K%R;+GU.LMVV"VRVAK-[6?I64_S_`/VG
M_P!!=ZGJ55^'J&:WI4EP6/\`7+J]WV?J%3S?]J=7MZ)7@Y$^C:]NQU?5K&UT
M69=>._U7V?T'^<]/_3HO4/K?U"[,S1A9(P*^GW68]%-F#DY0R;:?9:[(RL-K
MZ\;&];]$ST/UG_#V_P"@1]N2N(/<*MDY^/C9&+CVDBS-L=50`"07-KLR7;C^
M;^BI>N?/4?K)U7J+,+#MKZ.+.FXV=:+J3??5;<^]C\;TWOQJ_;Z6RUUK?9Z?
M\U^D_14[\_JW5/V(6OHQ^J4=4R\2RXL<^C?13GX]M]='J5VNWULWU5NN_G4.
M'Q5;VJ2Y:[KW5N@?:Z.LN9U$48-N?C953/0-GHN95=BY%.^]M=F_(Q_3NK_1
M^G_@_8JW2_K)UAW5,2BZ[]H_;'BO*QJL#)QFXOL<]U].7F!C;\9EK?3M]?\`
M3/\`YRK_`$*7`=56]D@9>=A83&V9F15C,<[:U]SVU@N@NV-=86^[:U<EB?6'
MZSN^K-_UCM./<RMMU=.+759J6Y'V;]H93V&RYM.+4RZVW#QZ_?17ZGVG_0DZ
M/<_K75;>GY^7A?6/IF'0R\9+,:LUC)M<]GI&SULFGU:**W>GZ5?\UD_IK/\`
M3'@J[Z*MZ.OK?1K;64UY^,^VP@5UMNK+G$_1#&!^YVY75Y_AUX72NB]4ZKB=
M,Q,C.P^M758K7U,:0'9K,5E55VT.HVUW;*'_`.!_J>Q;75.I=9Z9AT/ZGU;I
MO3[+GNW.^SVV=JO3Q\6G[57;D;'>MZ]_[GI?J]*1CV1Q=WIDERW2OK5FY[/J
M^\UT@=5MRZ,HL#RV<5F1%V)ZOI65UWVXOJ;,BOU&56>E_.>]-U[ZU=1Z:>N>
MA539^RJ\&S':X.EYRK'TW,MVV-_T?Z#;LV?X3U$.`W77^WA3Q#=Z=]U5;F,>
M]K'VG;6UQ`+G`%Y:P'Z;MC'/4USU]_4J<[H]?5*L.^_+S+6L-=;C]G8,:ZYK
M<>ZYV]V1OI].S*].GU:G_P!&I69E?6?K3LQ[,;+P,>T]0'3Z^E75OLRA6;6X
M_P!O=LR,=SW>G^O-J;5]F^P_]JDA&U6__]#F,3JSL1N1A9&/5G].OO-MN'<7
MM`L:[;]IQ<BAS;L3(],>D^RO^<K_`)QB?J'5Z<C#;T[!P:^G8#;QE&MMMM]C
M[@PXX?9DY)^@VIW\U76J-G\[9]#Z;_\`JG*/^8M#T<7C_P`WB_[YI'W.$]M?
M[W"V,G.?D873\(L#6].9;6QX))?ZUIR7.>V/9LG8O8?JYT_#ZG]1NFX&=4+L
M:_"I;96[O[6N:06^YKV.&^M[?H/7BPY_,7N/U,_\2?2/_"E/_4!1<S7#&OWC
M]K+@OBEQ=HM2[ZJ]7R*']/R/K!DV]+LK--E+Z:#>ZLM])U=F?Z6YV]OT[?1]
M;_A%JX?1Z<3J>;U!CW..;714:C$-&.+6LVN^D[?Z_P">M!)5CQ?ATK\>%GTM
MPL/ZN]0P+J:<+J]U?2*'`LP'UUV.#`2X8E>;:UUS<1O\VQCO4OKI_159#$LC
MZN9=>7=D]%ZD_I3<QYMS*!57=6ZP@-=DTLN'ZODV;?TK_P!)3;_.64>HMU)+
MU>'_`#?^<K1H4]*;5U9_4S<]]C\6K$+7`:BI]UWJN<T-_2/^T*A9]58I'V7-
MMQLNK-R.H8^0&,>&69/K"VI]-K7,MI]/*L9^9;_PJWDDA:M'$Q?JQ4[[3;UG
M(=U;*S*#B76O:VI@QW%SGXV/3C[?18_=^D?ZEEWL_G5+IO1NKX637ZW6K\S!
MH;MKQ[:JO4=[=C/M6:UGJY&SZ?M93;99_/V6K922]6NWX?\`-_\`05:/)=8Z
M6[HOU+=TFC?E8CK#5FY&TNLJQLFY]F;ELHH&ZU^+7>_;L9_PS_YM$^K?4G6=
M5=@8'4CUOI3:"]V0:V`X]C34RJAV;B5X^+D_:6/OL]/TOM-7H_I%U*2)NC?<
MW_>1I8<'_FL/V9EX'VH_KG4#U'U-@]LY-?4/0#=WN_FO2]3_`*Y_P:/UCHF7
MF9N/U'IV;]@SL>NVCU'U#(K=5=L<]OH/?5LM9;3597<RS_@[?6K6NDAZDZ/-
M5?4^^C"HJHZG9]KP,NW+P,RVMECFC(W_`&JC,K]C,OU_M&3OM9]FM_2,]/T_
M20\CZEY&9C]3;F]3?=D=6;BBVX5-:VLXEK[V-QZ0_P!M+V/97Z=C['_3N]:W
MU%U*2<..]-[\._\`WR#P]6CG],^V9O3LOU?3_9US[MFV=^^JW%V;I]G\_O7"
MXW4WX9MZQ1F4LZ_D93CE_5RYK7W.>]U>.,/&M<'=4I?Z%3'LOWV],_PGV:C$
M7I"'_A_S/H?V^?\`SVA&Z\/V*+__V?_M$UY0:&]T;W-H;W`@,RXP`#A"24T$
M!```````#QP!6@`#&R5''`(```(````X0DE-!"4``````!#-S_I]J,>^"05P
M=JZO!<-..$))300Z``````#E````$`````$```````MP<FEN=$]U='!U=```
M``4`````4'-T4V)O;VP!`````$EN=&5E;G5M`````$EN=&4`````0VQR;0``
M``]P<FEN=%-I>'1E96Y":71B;V]L``````MP<FEN=&5R3F%M951%6%0````!
M```````/<')I;G10<F]O9E-E='5P3V)J8P````P`4`!R`&\`;P!F`"``4P!E
M`'0`=0!P```````*<')O;V93971U<`````$`````0FQT;F5N=6T````,8G5I
M;'1I;E!R;V]F````"7!R;V]F0TU92P`X0DE-!#L``````BT````0`````0``
M````$G!R:6YT3W5T<'5T3W!T:6]N<P```!<`````0W!T;F)O;VP``````$-L
M8G)B;V]L``````!29W--8F]O;```````0W)N0V)O;VP``````$-N=$-B;V]L
M``````!,8FQS8F]O;```````3F=T=F)O;VP``````$5M;$1B;V]L``````!)
M;G1R8F]O;```````0F-K9T]B:F,````!````````4D="0P````,`````4F0@
M(&1O=6)`;^````````````!'<FX@9&]U8D!OX````````````$)L("!D;W5B
M0&_@````````````0G)D5%5N=$8C4FQT````````````````0FQD(%5N=$8C
M4FQT````````````````4G-L=%5N=$8C4'AL0'+````````````*=F5C=&]R
M1&%T86)O;VP!`````%!G4'-E;G5M`````%!G4',`````4&=00P````!,969T
M56YT1B-2;'0```````````````!4;W`@56YT1B-2;'0```````````````!3
M8VP@56YT1B-0<F-`60```````````!!C<F]P5VAE;E!R:6YT:6YG8F]O;```
M```.8W)O<%)E8W1";W1T;VUL;VYG``````````QC<F]P4F5C=$QE9G1L;VYG
M``````````UC<F]P4F5C=%)I9VAT;&]N9P`````````+8W)O<%)E8W14;W!L
M;VYG```````X0DE-`^T``````!`!+`````$``0$L`````0`!.$))300F````
M```.`````````````#^````X0DE-!`T```````0```!X.$))3009```````$
M````'CA"24T#\P``````"0```````````0`X0DE-)Q````````H``0``````
M```!.$))30/U``````!(`"]F9@`!`&QF9@`&```````!`"]F9@`!`*&9F@`&
M```````!`#(````!`%H````&```````!`#4````!`"T````&```````!.$))
M30/X``````!P``#_____________________________`^@`````________
M_____________________P/H`````/____________________________\#
MZ`````#_____________________________`^@``#A"24T$"```````$```
M``$```)````"0``````X0DE-!!X```````0`````.$))300:``````-/````
M!@``````````````)@```.T````-`#8`-@`T`#(`,@`Y`"``10!8`"``-0!?
M`#$````!``````````````````````````$``````````````.T````F````
M``````````````````$`````````````````````````$`````$```````!N
M=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$`````%1O
M<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<````F````
M`%)G:'1L;VYG````[0````9S;&EC97-6;$QS`````4]B:F,````!```````%
M<VQI8V4````2````!W-L:6-E241L;VYG``````````=G<F]U<$E$;&]N9P``
M```````&;W)I9VEN96YU;0````Q%4VQI8V5/<FEG:6X````-875T;T=E;F5R
M871E9`````!4>7!E96YU;0````I%4VQI8V54>7!E`````$EM9R`````&8F]U
M;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P``````````
M3&5F=&QO;F<``````````$)T;VUL;VYG````)@````!29VAT;&]N9P```.T`
M```#=7)L5$585`````$```````!N=6QL5$585`````$```````!-<V=E5$58
M5`````$```````9A;'1486=415A4`````0``````#F-E;&Q497AT27-(5$U,
M8F]O;`$````(8V5L;%1E>'1415A4`````0``````"6AO<GI!;&EG;F5N=6T`
M```/15-L:6-E2&]R>D%L:6=N````!V1E9F%U;'0````)=F5R=$%L:6=N96YU
M;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O;&]R5'EP
M965N=6T````115-L:6-E0D=#;VQO<E1Y<&4`````3F]N90````ET;W!/=71S
M971L;VYG``````````IL969T3W5T<V5T;&]N9P`````````,8F]T=&]M3W5T
M<V5T;&]N9P`````````+<FEG:'1/=71S971L;VYG```````X0DE-!"@`````
M``P````"/_`````````X0DE-!!0```````0````".$))300,``````IE````
M`0```*`````:```!X```,,````I)`!@``?_8_^T`#$%D;V)E7T--``'_[@`.
M061O8F4`9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8
M$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.
M#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`S_P``1"``:`*`#`2(``A$!`Q$!_]T`!``*_\0!/P```04!
M`0$!`0$``````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#
M!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84
MD:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E
M\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>W
MQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(C
MP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#
MTW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`
M#`,!``(1`Q$`/P#CZJ,[+RWX^'7?DWESR*:0][X#W2_8S\S^6[V(MO2NN4Y%
M>+=A9E>3=N]&@UV[[-HW6>BT3ZWIM]UGI?06CGW68'U:P:\)SJ?VM=G6]0?6
MZ'VNQ[?LV/BN>S;;Z--#_4^S[_3]2[U%6R^E9V'TNC/9U&C+PVW_`&>MN)D6
MV&FZVLWO;L?72VCU*J_TWI/6@)W6PLT+\&D85?S&O4:*+]B?60:GIO4`!J2:
M+P`/\U>Q_4PS]4^D'G]4I_Z@+R;JF1D_L'ZNGUK0749>XBQX)C*>WW>[W>U=
MP^V[_F)]6L%CW5T=4LP<++L82UPHM$VL8]G\WZ_IMQMW_#*'/<HQNOF(T_JL
MV(`&57L#J]4/K%]7SD_9!U/$.3N]/T!?7ZF^=OI^GOW^IN_,6BN<ZU?T+H&`
MS%MZ)9D]-K8Z]S<;&KLHJ%6U[K+][F-8_P#PN_\`D>HHNZIUK*Z[G8>-?1B]
M.P*L7)LN?4ZRW;8+;+:&LWM9^E93_/\`_:?_`$%WJ>I57X>H9K>E27!8_P!<
MNKW?9^H5/-_VIU>WHE>#D3Z-KV['5]6L;719EUX[_5?9_0?YST_].B]0^M_4
M+LS-&%DC`KZ?=9CT4V8.3E#)MI]EKLC*PVOKQL;UOT3/0_6?\/;_`*!'VY*X
M@]PJV3GX^-D8N/:2+,VQU5``)!<VNS)=N/YOZ*EZY\]1^LG5>HLPL.VOHXLZ
M;C9UHNI-]]5MS[V/QO3>_&K]OI;+76M]GI_S7Z3]%3OS^K=4_8A:^C'ZI1U3
M+Q++BQSZ-]%.?CVWUT>I7:[?6S?56Z[^=0X?%5O:I+EKNO=6Z!]KHZRYG411
M@VY^-E5,]`V>BYE5V+D4[[VUV;\C'].ZO]'Z?^#]BK=+^LG6'=4Q*+KOVC]L
M>*\K&JP,G&;B^QSW7TY>8&-OQF6M].WU_P!,_P#G*O\`0I<!U5;V2!EYV%A,
M;9F9%6,QSMK7W/;6"Z"[8UUA;[MK5R6)]8?K.[ZLW_6.TX]S*VW5TXM=5FI;
MD?9OVAE/8;+FTXM3+K;</'K]]%?J?:?]"3H]S^M=5MZ?GY>%]8^F8=#+QDLQ
MJS6,FUSV>D;/6R:?5HHK=Z?I5_S63^FL_P!,>"KOHJWHZ^M]&MM937GXS[;"
M!76VZLN<3]$,8'[G;E=7G^'7A=*Z+U3JN)TS$R,[#ZU=5BM?4QI`=FLQ6557
M;0ZC;7=LH?\`X'^I[%M=4ZEUGIF'0_J?5NF]/LN>[<[[/;9VJ]/'Q:?M5=N1
ML=ZWKW_N>E^KTI&/9'%W>F27+=*^M6;GL^K[S72!U6W+HRBP/+9Q69$78GJ^
ME977?;B^ILR*_4959Z7\Y[TW7OK5U'IIZYZ%5-G[*KP;,=K@Z7G*L?3<RW;8
MW_1_H-NS9_A/40X#==?[>%/$-WIWW55N8Q[VL?:=M;7$`N<`7EK`?INV,<]3
M7/7W]2ISNCU]4JP[[\O,M:PUUN/V=@QKKFMQ[KG;W9&^GT[,KTZ?5J?_`$:E
M9F5]9^M.S'LQLO`Q[3U`=/KZ5=6^S*%9M;C_`&]VS(QW/=Z?Z\VIM7V;[#_V
MJ2$;5;__T.8Q.K.Q&Y&%D8]6?TZ^\VVX=Q>T"QKMOVG%R*'-NQ,CTQZ3[*_Y
MRO\`G&)^H=7IR,-O3L'!KZ=@-O&4:VVVWV/N##CA]F3DGZ#:G?S5=:HV?SMG
MT/IO_P"J<H_YBT/1Q>/_`#>+_OFD?<X3VU_O<+8R<Y^1A=/PBP-;TYEM;'@D
ME_K6G)<Y[8]FR=B]A^KG3\/J?U&Z;@9U0NQK\*EME;N_M:YI!;[FO8X;ZWM^
M@]>+#G\Q>X_4S_Q)](_\*4_]0%%S-<,:_>/VLN"^*7%VBU+OJKU?(H?T_(^L
M&3;TNRLTV4OIH-[JRWTG5V9_I;G;V_3M]'UO^$6KA]'IQ.IYO4&/<XYM=%1J
M,0T8XM:S:[Z3M_K_`)ZT$E6/%^'2OQX6?2W"P_J[U#`NIIPNKW5](H<"S`?7
M78X,!+AB5YMK77-Q&_S;&.]2^NG]%5D,2R/JYEUY=V3T7J3^E-S'FW,H%5=U
M;K"`UV32RX?J^39M_2O_`$E-O\Y91ZBW4DO5X?\`-_YRM&A3TIM75G]3-SWV
M/Q:L0M<!J*GW7>JYS0W](_[0J%GU5BD?9<VW&RZLW(ZACY`8QX99D^L+:GTV
MM<RVGT\JQGYEO_"K>22%JT<3%^K%3OM-O6<AW5LK,H.)=:]K:F#'<7.?C8].
M/M]%C]WZ1_J67>S^=4NF]&ZOA9-?K=:OS,&ANVO'MJJ]1WMV,^U9K6>KD;/I
M^UE-MEG\_9:ME)+U:[?A_P`W_P!!5H\EUCI;NB_4MW2:-^5B.L-6;D;2ZRK&
MR;GV9N6RB@;K7XM=[]NQG_#/_FT3ZM]2=9U5V!@=2/6^E-H+W9!K8#CV--3*
MJ'9N)7CXN3]I8^^ST_2^TU>C^D74I(FZ-]S?]Y&EAP?^:P_9F7@?:C^N=0/4
M?4V#VSDU]0]`-W>[^:]+U/\`KG_!H_6.B9>9FX_4>G9OV#.QZ[:/4?4,BMU5
MVQSV^@]]6RUEM-5E=S+/^#M]:M:Z2'J3H\U5]3[Z,*BJCJ=GVO`R[<O`S+:V
M6.:,C?\`:J,ROV,R_7^T9.^UGV:W](ST_3])#R/J7D9F/U-N;U-]V1U9N*+;
MA4UK:SB6OO8W'I#_`&TO8]E?IV/L?].[UK?474I)PX[TWOP[_P#?(/#U:.?T
MS[9F].R_5]/]G7/NV;9W[ZK<79NGV?S^]<+C=3?AFWK%&92SK^1E..7]7+FM
M?<Y[W5XXP\:UP=U2E_H5,>R_?;TS_"?9J,1>D(?^'_,^A_;Y_P#/:$;KP_8H
MO__9`#A"24T$(0``````50````$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T
M`&\`<P!H`&\`<````!,`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'``
M(`!#`%,`-@````$`.$))300&```````'``@````!`0#_X0X1:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@8F5G:6X](N^[OR(@:60]
M(E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B`\>#IX;7!M971A('AM;&YS
M.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U
M+C,M8S`Q,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@("`@("`@
M("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY
M.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2(B('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O
M,2XP+R(@>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O
M(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+VUM
M+R(@>&UL;G,Z<W1%=G0](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S
M5'EP92]297-O=7)C945V96YT(R(@>&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R
M9R]D8R]E;&5M96YT<R\Q+C$O(B!X;6QN<SIP:&]T;W-H;W`](FAT='`Z+R]N
M<RYA9&]B92YC;VTO<&AO=&]S:&]P+S$N,"\B('AM<#I#<F5A=&5$871E/2(R
M,#$T+3`Q+3(S5#(P.C(Q.C(R*S`U.C,P(B!X;7`Z0W)E871O<E1O;VP](DUI
M8W)O<V]F=,*N($]F9FEC92!7;W)D(#(P,#<B('AM<#I-;V1I9GE$871E/2(R
M,#$T+3`Q+3(S5#(P.C(U.C0S*S`U.C,P(B!X;7`Z365T861A=&%$871E/2(R
M,#$T+3`Q+3(S5#(P.C(U.C0S*S`U.C,P(B!P9&8Z4')O9'5C97(](DUI8W)O
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M;6%G92]J<&5G(B!P:&]T;W-H;W`Z0V]L;W)-;V1E/2(S(B!P:&]T;W-H;W`Z
M24-#4')O9FEL93TB<U)'0B!)14,V,3DV-BTR+C$B/B`\>&UP34TZ2&ES=&]R
M>3X@/')D9CI397$^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)D97)I=F5D(B!S
M=$5V=#IP87)A;65T97)S/2)C;VYV97)T960@9G)O;2!A<'!L:6-A=&EO;B]V
M;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+VIP96<B+SX@/')D9CIL:2!S
M=$5V=#IA8W1I;VX](G-A=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7`N:6ED
M.C!%1D(U-#8X,S0X-$4S,3%!138W0D4S1D-%,S`X13`S(B!S=$5V=#IW:&5N
M/2(R,#$T+3`Q+3(S5#(P.C(U.C0S*S`U.C,P(B!S=$5V=#IS;V9T=V%R94%G
M96YT/2)!9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(@<W1%=G0Z8VAA
M;F=E9#TB+R(O/B`\+W)D9CI397$^(#PO>&UP34TZ2&ES=&]R>3X@/'AM<$U-
M.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(B\^(#PO<F1F
M.D1E<V-R:7!T:6]N/B`\+W)D9CI21$8^(#PO>#IX;7!M971A/B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(#P_>'!A8VME="!E;F0](G<B/S[_X@Q824-#7U!2
M3T9)3$4``0$```Q(3&EN;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A
M8W-P35-&5`````!)14,@<U)'0@```````````````0``]M8``0````#3+4A0
M("``````````````````````````````````````````````````````````
M`````!%C<')T```!4````#-D97-C```!A````&QW='!T```!\````!1B:W!T
M```"!````!1R6%E:```"&````!1G6%E:```"+````!1B6%E:```"0````!1D
M;6YD```"5````'!D;61D```"Q````(AV=65D```#3````(9V:65W```#U```
M`"1L=6UI```#^````!1M96%S```$#````"1T96-H```$,`````QR5%)#```$
M/```"`QG5%)#```$/```"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H
M="`H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P``````
M```2<U)'0B!)14,V,3DV-BTR+C$``````````````!)S4D="($E%0S8Q.38V
M+3(N,0``````````````````````````````````````````````````````
M````````````6%E:(````````/-1``$````!%LQ865H@````````````````
M`````%A96B````````!OH@``./4```.06%E:(````````&*9``"WA0``&-I8
M65H@````````)*````^$``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W
M+FEE8RYC:```````````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````
M``````````````````````````````````````````````````````!D97-C
M`````````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C
M92`M('-21T(``````````````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="
M(&-O;&]U<B!S<&%C92`M('-21T(`````````````````````````````9&5S
M8P`````````L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q
M.38V+3(N,0``````````````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO
M;B!I;B!)14,V,3DV-BTR+C$``````````````````````````````````'9I
M97<``````!.D_@`47RX`$,\4``/MS``$$PL``UR>`````5A96B```````$P)
M5@!0````5Q_G;65A<P`````````!`````````````````````````H\````"
M<VEG(`````!#4E0@8W5R=@````````0`````!0`*``\`%``9`!X`(P`H`"T`
M,@`W`#L`0`!%`$H`3P!4`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?
M`*0`J0"N`+(`MP"\`,$`Q@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!
M&0$?`24!*P$R`3@!/@%%`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q
M`;D!P0')`=$!V0'A`>D!\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$"
M>@*$`HX"F`*B`JP"M@+!`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F
M`W(#?@.*`Y8#H@.N`[H#QP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$
MC`2:!*@$M@3$!-,$X03P!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075
M!>4%]@8&!A8&)P8W!D@&609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'
M80=T!X8'F0>L![\'T@?E!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0
M"24).@E/"60)>0F/":0)N@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+
M"PLB"SD+40MI"X`+F`NP"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF
M#4`-6@UT#8X-J0W##=X-^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/
ME@^S#\\/[!`)$"800Q!A$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F
M$D429!*$$J,2PQ+C$P,3(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5
M$A4T%585>!6;%;T5X!8#%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;
M&$`891B*&*\8U1CZ&2`911EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;
MBANR&]H<`APJ'%(<>QRC',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3
M'SX?:1^4'[\?ZB`5($$@;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC
M"B,X(V8CE"/"(_`D'R1-)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8
M)TDG>B>K)]PH#2@_*'$HHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDK
MG2O1+`4L.2QN+*(LURT,+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U
M,&PPI##;,1(Q2C&",;HQ\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U
M336'-<(U_38W-G(VKC;I-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT
M.K(Z[SLM.VL[JCOH/"<\93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`
M(T!D0*9`YT$I06I!K$'N0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>
M1B)&9T:K1O!'-4=[1\!(!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),
M*DQR3+I-`DU*39--W$XE3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\
M4L=3$U-?4ZI3]E1"5(]4VU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9
M:5FX6@=:5EJF6O5;15N56^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!7
M8*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-G
MZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X
M;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9W
MLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E
M@$>`J($*@6N!S8(P@I*"](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(
MSHDSB9F)_HIDBLJ+,(N6B_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&H
MDA&2>I+CDTV3MI0@E(J4])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;
M0INOG!R<B9SWG62=TIY`GJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'
MI3BEJ:8:IHNF_:=NI^"H4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O
M%J^+L`"P=;#JL6"QUK)+LL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*
MN<*Z.[JUNRZ[I[PAO)N]%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$
M4<3.Q4O%R,9&QL/'0<>_R#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\W
MS[C0.="ZT3S1OM(_TL'31-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:
M^]N`W`7<BMT0W9;>'-ZBWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6
MYQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS
M&?.G]#3TPO50]=[V;?;[]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M
M____[@`.061O8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#`P,#`0$!
M`0$!`0$!`0$"`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P/_P``1"``F`.T#`1$``A$!`Q$!_]T`!``>_\0!
MH@````8"`P$`````````````!P@&!00)`PH"`0`+`0``!@,!`0$`````````
M```&!00#!P((`0D`"@L0``(!`P0!`P,"`P,#`@8)=0$"`P01!1(&(0<3(@`(
M,11!,B,5"5%"%F$D,Q=2<8$88I$E0Z&Q\"8T<@H9P=$U)^%3-H+QDJ)$5'-%
M1C='8RA55E<:LL+2XO)D@W23A&6CL\/3XRDX9O-U*CDZ2$E*6%E:9VAI:G9W
M>'EZA8:'B(F*E)66EYB9FJ2EIJ>HJ:JTM;:WN+FZQ,7&Q\C)RM35UM?8V=KD
MY>;GZ.GJ]/7V]_CY^A$``@$#`@0$`P4$!`0&!@5M`0(#$00A$@4Q!@`B$T%1
M!S)A%'$(0H$CD152H6(6,PFQ),'10W+P%^&"-"624QAC1/&BLB8U&50V160G
M"G.#DT9TPM+B\E5E=58WA(6CL\/3X_,I&I2DM,34Y/25I;7%U>7U*$=79CAV
MAI:FML;6YO9G=X>7I[?'U^?W2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ
M2EIJ>HJ:JKK*VNKZ_]H`#`,!``(1`Q$`/P#6?WON;=:;^['1-X[S1%[*[&"H
MF\-RJJC^^^>X55RH51_@./>?5G;6[6EJ3"I/AKY#T'6$V[[A=1[A,L;*%TH<
M(G$HI)^'B222>))).>DW_>G=W_/9[U_]#'<__P!=?:GZ6V_WPG[!T6?O.]_W
MZ/\`>$_Z!Z]_>G=W_/9[U_\`0QW/_P#77W[Z6V_WPG[!U[]YWO\`OT?[PG_0
M/7O[T[N_Y[/>O_H8[G_^NOOWTMM_OA/V#KW[SO?]^C_>$_Z!ZOO_`.$T.;SU
M?_-EV!#D=Q;DR=/_`*`^^C]ME-Q9O)4I84.TR&-+75]13EU(!!*W!^GN+?=^
M&*/DV<I&`?'BX#^EU*WM+=37&_/XQ4D"@.E00#'*2`0`:$@$BM"0*\!U](WW
MB=UDMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U__T*H?A-\#\+\P^W?E/V1W9VNGQU^&'Q5S6_>Q
M?E'WX]"F0R6'Q-7OG<IP/7/7]%/29"EK>Q]Z)13&G:2FK11PJK1T=;5U%'1U
M&9W,/-,FP;?L]EMUI]3OUX`D$5:`D`5=SBB)45R*^JC4RXL;+RA'OVYWU_N4
MK1[3`D98@$ENQ0``,L6(*H%K5@2:Z1'(.U=\P/Y'>TYUV+LG^3WVGVUU[CY:
MC''NCMCY?[\V7WSNJA/[<6Z!MG;M5D]OX#*N?W8Z'^)T4*KI1XZ<ZT!='R_[
MBW"_5W'.T4%V<B*.UC>)?Z.MR'(^974/GTIGYAY#MIA80[!XMG4!I#<S)D4!
M)C@C,.*9\+5&YR"0:]%4PO97\K_8_P`FNY\]/\5ODA\@/B%G<#MR#H7KK=O>
M+=2=P]>[D>EPU?O#(;RW7M*NKZ?<F+ARAR&.QM/+4US"B$,TLLLQ,@.Y+'G2
MYV;;HAO-M;;VK'QG2+Q(W%6"Z0^D@D:2QQW5H`,=$L&X\E6^\[E*=K>3;WRG
MB.$I41D`"&.11I(DX`55E#=X/5H6<VE_)APG\O+KO^8"_P#+=[_J<3V%\H-T
M_&:'JF/YL[\3+8FKVQ@-PY]MZ3;I>;["JHZZ/`&(42TZR1O+?R$+R"H;CG^;
MF>ZY9'-,`DBM!/XGTJ9JX33IU8R:UU</('@.;BWY*MMAM]]DV1/"DET!?%>F
M8O%!U?3ZM6D@$%``:]QQ59_R-=\?&3L#^=?UAG/B;\?]Z?&SK"'XJ]T8S)=?
M;[[7R7<F:K]YT_\`"9LKNJ'=F59ZJEQ^2QM11P+0@^.*2F>10OETAGW&M=YM
M.0+F+?-S2ZO#=H0ZQB,!:BBZ02*@U-?G3RZOR'=[-><V-)LMD(;;PD!`9F&H
M)<:C5DC-2"OX:8XYH-M_^9A_,:H?@;LWK#;.P>KLU\B/EK\F-Y2=8?%GXY[;
MK8\;7;^WFL$,N1S^Y\S(DB;<Z\V='602Y2LTLY:>*)?&CRU--!O*O+#<PSW<
MUS="VV:U37/,14*N:*OJ[4-!Z`FC&BM,>\;L-N6**&/Q+V7X%XXJJEM([FH6
M4!134S*&:--4B%(V_P#&K_A0'V-ACV!V#_,L^+WQRWQDZ?\`B-)T'U+\.=N=
MM=7[6DJT2ICVYE^Q^Q=Q4^^LQ/0,PIZBIIS*@96:&692KL>/NWMO:,]K;\J7
M-W"#0327#QR'RKH0Z#ZC"5%*JIZ)?W;S?<M#<R<P?34^*)(X65O2C-$QB)\U
MU7`4X$CTU&SCXCU'RWVUT,3_`#`,_P!"57<VU\]N^#,[YZ/7/[?ZSS_7^)K&
M.UMZ9&BWG*E1MK.9+"QFHRE."E'2RW$=D%_81W@;/-N`'+L5Q]&ZK19*%PY^
M)1IK45PN6/S/0DLFO(K5FW1T$B\2"*`!14EJ*#G5W:(P5I5%-1T/K]G]:Q9G
M:NW9.P]C1[@WU0?Q79&"?=N`3,[QQ9IY*H9+:N,;("MW#0&EA>3S4B31^-2U
M[`GV7_17ACGE%I+X41H[:6HAX48THIKY&G3_`-9:"2&(W4?BR"J#4M6'&JBM
M6'S%>FC<7=_2VT-WXKK[=O;W5^U]^YUZ:/";(W%O_:F$W?F)*P@4B8K;62RU
M-F<@]46`C$,+ER?3?VY%MVX3P/=06$SVJ\75&*BG&K`4%/F>FY=QV^"=+6:^
MA2Y;@C.H8UX44FI_(="A[1=+.@OVOW?TOOC=.6V-LKM[J_=^]L"LSYS9^U]_
M[4W!NG"I3R"*=\MM_$Y:KRV.6"5@KF:%`K&QL?:V;;MPMH4N;BPFCMVX.R,J
MG[&(`/Y'I'#N.WW$SVUO?0R7"\55U9A]J@DC\QTJLOO79NWZBNI,]NW;.$JL
M7MZKW;DZ;+Y[%8VHQVU*";[>NW-70UM7#)2;>HJCT2UL@6FC?TLX/'MB.WN)
M0K10.RLX4$*35CD**#+'R''IY[B"(LLLZ*P4L:D"BCBQJ<*/,\.F;K[M?JWM
MK'5F8ZJ[*V!V9B,?5?85^5Z^WCMW>>.H:[26^SK*[;F1R5-356E2?&[*]A]/
M;EU8WMBZQWMG+"Y%0'1D)'J`P%1U2UO;.]1GL[N*9`:$HRL`?0E2<]46_P`O
M'L[:777\PW^?/N3M3L?!;'V9C/E-\9<;29OL3>E%MS:F+J*OH*65:"CK]S9.
MCPV/GJR+^*-D:4*."%6T@<QV5Q=<M>W\5E;22W#6TYTHK.U`\?`"I`\\"E23
MQ))"VVW-K9;QS%-=2Q0PD1$LVE`6,MTM68TJVE%45)-%`&!U?CM?=NU=\8.A
MW/LK<VW]X;:R:/)C=P[7S..W!@\@D<C12/0Y;$U-705:)*A4F.1@&!!Y'N.I
MH)[:1H;B%XYAQ5@5(^T&A'0MAGAN(UFMYEDA/!E(8'["*@])WL'MOJGJ6BH<
MEVKV;U[UECLI4-1XRO[!WIMO9E%D:M-!>EH:K<>2QL%74*)5ND;,PU#CD>W;
M6QOKYF2RLY9G45(1&<@?,*#3IJZOK*Q57O;R*%6-`7=4!/H-1%>E,VY]M)MW
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M.KJ0S0`$$?U]O)M>Y26XNTVZ<VIX.(W*'_;4I_/IIMSVU+@VK[A`+H<4,BA_
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M%H1RK,$.D<33`^WTZ&A=`RJ7&H\!7)^SUZ;8=W[3J-P3;3@W1MV?=--`:FHV
MU#F\;)N""F4*S5$V&2I;(Q0*'!+M&%`(YY]W,$XB$YA?P"::J'37[>'5!/`9
M3")E,P%=-1J_9QZ?9*B")XHY9HHI)V*0))(B/,ZC44B5B&D8+R0+FWML`FI`
MP.G"0*`G)Z]-/!3JK5$T4"O(D2--(D2M+(;)&I<J&D<_0#D^_`$\!7KQ('$T
MZXM54RR21-40++##]Q+&TT8DB@Y_>D0MJ2'@^H@#CZ^_:6H#0TZ]J`)%17HI
M_=&=^5U;VQ\4JCXS5GQ[RG0V3W]NR/Y7UW8V2W#-O23KV#;X7;1Z0DVU.V)J
M]RIN*.H6J%;KC5UIP0(ON&4WLH]J6TW4;HMP+\(O@A``NKNKXE16E=%.';K/
MQ:02^XDO6GLC9/$;4DZZG/Q)PH>&CQ.%3XGAU[-?1G\[N+;^UL=)E]S9W#[<
MQ,,D44N4SN3HL1CHI9FT0QR5N0GIZ9))7-E!8%CP/97%%+,XCAC9W]%!)_8.
MELDL4*&2:143U)`'[3US_CN#\(J/XSBO`<:<R)_XC2>$X<6OEA)YM'\-%Q^_
M?Q<_J]Z\*2M/#:M:<#Q]/M^7'K?BQTKXBTI7B.'K]GSZ_]$IG7\-9O#^1;_-
M,VOU\DE3NKK+^9=LWMOO.@Q[$Y!NC:C.[>I,+F\E2Q()JC;F&W#MVIJI6/EC
MB3'5$K!5B=AE?=,EO[B\GSW>()=M>.(GAXH)+`'U*,!\Z@9K3J`+=)KKDS?[
M:T.N?7&="Y;2]OX<8H.%;@%AZ5U8&>JJ_C)COA37YG?$GS<W_P#)/K_:%#MN
M@J^OZWXS;)V7OG<.5W*M?.V<H]U4.]5:BH\-!A$C>D>!HY)*EV#/I0(X]WV3
MF*..W/+UO:R2%CK\9G4!:8IH!-:_RZC#E:UY=NI9HM[:;Q3A`IC45)4#+RQ`
MDU8$5-,'&>C+_P`T#X7=-_"KL'XTXWH?L3M#LKKCY(_$WK[Y183+]O8K;&%W
MEBZ'L7,Y^GP^%JL=M/'X[&TACPF,IY9HG666&IDD3RNH!]E/)7,6X\P6V['=
M+:**[M+V2W(C+%28PE2"V>+'.*BF!TNYWY?VS9)=NDVMW-M/:PRC5QI*9>/<
MV:(.!ID\>/1B=]_]PY/QO_\`&I_:W_OO.Q?9/9?]/6W;_I4)_P!7EZ$6[_\`
M3M]J_P">M?\`M"'0@?\`"9?_`+>T[`_\0'WW_P"X&U/:?WB_Y4R;_FO%_P`>
MZ][/?\EZ7\O^K<W6S9\LIMO[0_X4>_RS]W=I1P4>T-Y_#3Y"=:=*YK-@1X5>
M^X]P9C(9+%8NIJ%:D3=&2V3FX::%%*32M51(MV9088V;Q)O;#FF"SJ9TO(WE
M`X^#2.E?4!E9OD%8\`>IMW#2G-FUO<4,3*GA^='"WBL_#`_5BCU'&N1%K5E!
MM[^8FZOFKM+86V:[X.=2]']O]CU.\:>DW7@N^.Q=P]:[:QNQVP^7FJ<OB<OM
MS!YZKKLZF<BHH5IWB6,T\TKZM2!2"-FBV26XE7?;J:*VT=IC4,2U1@U!Q2OY
MTR.A%?O?I&AV]%:35FH#8IZ&2+S\]1_TIK44G5?SL^1?R]^"_P#/:Z:^573W
M3_5G8?PXZ;[4ZDSF/Z>WAN;?.UMP5>YOCWO3<N5E_B^Z,9B9ZFGIT2)(F6GA
M+"1E=%9>1_!R_M>S\Q^WE[M5W-+;7MS$_P"H`"*21TP`/XOGPX^701O]UO[K
M8N;8IBJ74%I(5*KH(/Z\?^_),AH2P((H"//H!/C[\2^COA#_`">-M?S:HMA1
M=P_/[KKX'4_;W6O>?8]=F=UU/5+9WI0;7Z\V7U_M&>KEV?M7JWJ/9.X8J*GQ
ME+C@'I8*B25WFG=_:[=MVN]]YZFY3DD6'86OS&\:*JEP)-4A+TUZI76IHU*D
M8]=;381VG+=KN=H\SWSP*4+.Q%7`6,NFI8Y'12M7D&HZ0-2JJA2\?'3XU=09
M[XLXZA[^_D._,SYH=P?(78^*WYW;\V-ZYGXO;U[=[5WIV%A8,]6]F=:]C[J^
M0']\=AXJ,92.3;T./;$24U)#!]S`*GSES'=+^[@WF3]W\^V-I:6LI2.W`D5%
M6)B%21!&%8@@UJ"%)(CTJ%`3;5%%<;/;M-M<S/<Q!V8-.=)E4,=!$;#S[F!+
M2Y:9I&9F*B[^WG_,7Z(_E+_RY?A3WJ.]8.W?E?\`*BM^/&^*':&^=K-\L\U\
M4L3E=U;EVETHO8M?N"FV;A^[-_\`7=#C\+/6R9M*=**-Z:HJ29:A/=-LMN6=
MRYPYGWNQ>`6EI:>,A(;P1/3,M-.LHI!+4%0Y+H:A6ZK?R;K;;!M5A-"VN:94
M<4%`C21QE57RCU2UBC9&)C5(I8BID7IG^1/Q-;.]);2VU_+^_D)_*OX._+CJ
M#<.S=P?&+Y0[5ROQCVAGMH;RQ&X\4)G[D[$PO>^:WUOW8^?P+UE/FAF'S+RI
M+K<'U-[]MNZB*^GGW[GRROMJF1Q-`PE*D,":(@C`3O"DB,"HK@FG2F^M#):Q
M16>USI<1LI5JS,YH0":R(%,@0MX+R-2.32=2J#T<[Y3_`!DZ^^6'\_7XB]5_
M*O:V*WQM\?RKLIO+M#KW&Y#+4O7O8NZMH=Y9F:FVUNZDIJC'5>\>LL9O')G+
M18;(:Z"MJJ&D:LIY4C,9*=JW2?:?;7>KG:I-!;=RB,P!94:*,5%00&*54D9`
M8TH:'KUU9)>\YVJWFHLEE`Q`9E&K5=$GM.#J52"#4::5TE@5+W#\5^C?Y>_\
MY?\`E6[G^%VP<!\<L)\OX?E!TK\B.L^JZ)-H=7=D[9Z\ZLH=\[.R68V+AS3;
M>7<&#W!5+-%4Q4\;%X(W:[!B[.W[I>\Q\B\XIO<QN9;)K>6%WRZM(Y5NXY-5
M72*DT!8<#A3?1KMW-6P"UJL<\<VL5)PAC4*M2=*MXNIU``9XXVXJ:HSX@_!/
MXC_,#^:[_.JW?\HNBMD=\5W5'R$Z.P&P,-V;0R[IV5MZGWCT=0U^XLE%L3(S
M2[1K]Q5TF(IHUR571U%;2P1>.GDB1Y1(_OG,&\;/R9R);[7?/`DD,K,4H&)1
MUT]]-0`U-A2*US7%&]KVNRGYFWZZEB)F")G41\4UR"#0BHI&ITM501J`#$DB
M7M?H+8_\KG^=!\3>IOA]'7==_&7^8UU=\B(>W?BSM_(U];UILKM#H+9]%OC`
M=U[#VE65<]-L;^-4DPQ5>*/QTQ0R!4TF..)(][/S7R'O-YN^E]QVJ6'PYB`'
M9)GTF,D4!H:L<5)*DFM27V";-S-MMK:HYBOA(7R6H40MW,268FB>$&)T(LJJ
M0M%%8_Q#W)!\QMX_(3YQ?*_^4I\B/YH78O97>W<G777^XJB;X];X^//Q_P"G
M.O=SS;6VYTIU)U=W-VO@I-KYK"B"5\WD9\(M365K^:"JD:6IDD%.]VXV6+;=
MAVCG"UVRVA@1F`\1999'KJD=T3(:@P&H>#=JHJE>SSM?-=[I=;9-)-(R@!M>
M%T)(H8(KJ=+.?"U']-*%561I6D'W971_?_1O\LK^>]M_<WQZ[9^+?PBW#U/O
MC=OP[^-G>^\-K[JWMU7'F>I=QU?=^W=M4NT]X[_QNW.J*O=DE)-AZ'^)ND4C
MS^.,,9GD+I[W:K_F?V^,=_#>;TLJI<RQ+IC<!U$5:JM6TA@V/EA0H#\=ON-K
MM_,NA3#9L%,/QZ@Y+%V;6%):I6K:>^@9F>0R-T>K^7/_`"N^IMB_"GICYA;/
MP`WY_,CWW\+:3-]=_)?L+<>;R><V1N;LKX\IM[KS8^R\?59,[/V-UMU_MS+4
M.!Q]#18^*&#'P.[ZI9IG<AYJYHGN.9[_`&FY"IR[#?E'B1%[D2<-(2U"Y,C*
M9&&JA:F,=*>7MI`Y;LK^U>3]Y3609"9&H&>+]/4H94=E!5?$=2Y`'<`%"Z\'
M\._EB;\_E<[C^'D'Q&WWV3_/`FJLWUYN[%X[I?>?8?R<J/FRNY:FAW+V7N'Y
M,XW$Y_:%9U@FYFFK*X3[H?'?PK7'+2A]3B2/#YOL^:(-^;=8HN2=*NK&1%@\
M$QC2OA882::`/X8H:4-*+T'UW#EJ\M)MEC5WW/QFK&"P8QK.5;2*BJT4_H+6
M5B*Z"Q\3K<PR/3E'\??Y4V[NF*39^RM@S]=_!K?FW\YM+KK%T6&V1B=WQ=+9
MRHWM_=O'X^.*DAQU=O"HKJD,HO*TQD8EF),)6]VM]SE:7:2,T3[C&4+<='BJ
M$!^Q`HIY4IT-[V&6WY5O89S6=;!PYK6K^$=1J:UJU36N>J7>H6C7_A(E,TP=
MH5_EU=JM*L<CQ2-$*K>1D5)8RKQLR`@$$$>QG/GW>MP>'UL/_5M.D`#GEB\$
M1`D,\X%0"*FZ>E0<$?(]'&_E=?RSOCSUIU+\8OYA/>69W/VA\QLA\9=H;EKN
M_P#?_8VYZ#"=2]>;UZ6Q.+BZXZ]V?3YS%];;%Z\Z[ZTJABZ>8X]JM56HJY:H
MO.Y!9SAS3N=SN.]<M;>BQ;+]8Z^"B`F1UER[,0SEI'4,0&`)I@FI+?+&SV46
MU;1O$[,;LVL;ZF:@5?"(4-IT*VA'8!F4TJ=.E0JKK\_,2@_E&X_X?]X]I_RU
M_@M\YZGL[J6FRF]^I_YI77NP.[J#K?!=D;*S]/5Y#L?._*'LOLC&[@WAM1Z^
M"H@KY4QV3IZCR$P0BT4T<B;)_7&;=[2'F7F/;5@F&B2R=XO%:-DJJK$D=#^$
M_'1@*,6%00S?R;'#%#:[?LNY/$LJ,LB!VA5O%4.NGQ"(),L%5HHGB<ZD\)PK
M"X/YH[XW%V;W[_PF([(W96"KW5V%VU)O?<]53(E%3UNX-U_&+:N?S52E'2"&
MEABFR5?*RQJ@1%;2H"\>P7LUM%9V/NI:0@B&%2BBI^%9)E`/K@>?GGB.CZ>Y
M>\;D^[EIXDMLKG[6FL2?\)Z'7_A146'Q>^'.EY$_[&C?"($QR21$J=V[C!5C
M&REE-_H>+V/U`]E_MD`=UWVO_1JN/\,?^KY]+^;O[#:L`_XR_E7_`(B7)_P]
M%2^0?Q*QGS:_X4#]W=$[_P![[UV[T#4_RZ>D]V]_;(V+N?+;-RO=VU\%W!G(
M-J=3YC=>`GH]R8;8.0W5D5R.<AQM31SY*''Q4S3+&[7.-MW@[%[;6.XVT"MN
M8W-UA=A41,4),@6NDL%!4:@1W9!&"6WVW?O/FU[2X<_0M;.64:>X#Z<,K54D
M@ED(HPTE21WE640_FS\>NH?BC\R?^$YGQZZ!VDO7_4'6GR9^2N(V9L^ER^=R
M\.)H,AU;'N"MCDR>X,GE<UE):G,96HG>6KJ9Y6>9KL;GVEV+<KS>=B]RMSW&
M;Q+V2W@+-0+6GB*,*`M``!0"F!Y]*MRM8;+=>7;:!3X2K*14EC5KJS).IB6J
M2Q\_/H,?YBE5\2L=_-WCF_G,'R_!ZN^+VVH_@E%V:^XJOXLIW)19G(-\@3OC
M$;:>3%R]Q?9U=#_#ILY`\(Q31!&$HHM+_+<>\2<F/_4W3^^!=4NJ:1,4-?"T
MZ\>'@<.[5JTX,E:;HUFO,4'[T6<KX+F+PQ(:`>$*CPJR?$9`^CMH8_'_`.(_
M5-^#^*_P4B3L[Y89'H7NE/Y2U=_-,Z*VGL_M)-M]WG.5'P\Q7QK^1479!J:3
M4W9,?PPH_E#F=JK!6_:+D'H9Y:;RM.OA0>2;WS*39[,E_'_7$;5,6CK%3QS-
M!X?R\;PA)4?!4!Z>#W]!)-OV#PKG<6MO]T?UL15N^M:RZY..GQ-)C7Q/]R/]
M"K];1.O_TJ.?C5\T^ZO@I\GNS^VNFGVUFJ?<6YNU=@]J=4]AXQ]P=4]U=:Y?
M>VX1E-A]B[>26%ZN@9I7DI*J)A444KO82P35%//G!NO+>W\S;-9VE[J21`CQ
MR(=,D3@"C(WD?V@^E0",0;/FF]Y;WJY,0#V4B('C8:E8&)`:J2`P(IJ6JZJ`
M:UX]&RR7?7\BK?%95[XW5_+E^9?66Y*YQ5Y+I;I3Y28)NA9JV2TM=28#)YZN
MP>\MM[=KIV=5I*.FH8:6%M$$,2JJ@@7:/<BV3Z2#F:RE@`H)9("):>555BA(
M]3D\37H2KS#R#<3IN$^W/'>%M96HD756M6>2W:4DGT9PO!30#HL_\PWYQGYX
M=M=<[RP_36W^@>L>C>DMG_'/I#JO";GR^]JW;?5&Q*K)5>WZ?=&\,Q!12Y_/
M1ME'BUQ4\4<--%%&6J)1)42B#E/EH\M65W#+?M<WMS<//+(5"!I'IJ(45"CM
M&*G-3@4`!G-W,L?,-S;?36HALX((XD6I:BQZ](U-W-\9[F"DBE4!!+<]Q?,3
M:^:_EA=6_`*'9&Z(-Y]?_+O>7R5K^QYJW"'9F2P6YMM;CP5)M:@H(ZMMQIGJ
M:;<&N9Y:=*4)#=)'+Z4;M^7KB'G*^YE,Z&VELEA"4.H,)`Y)/"E!_J\U=]S+
M:7/)]ALJ(1=QW(8C/PK;B*OPZ:$BH[B:<1Z6!?\`"9?_`+>T[`_\0'WW_P"X
M&U/88]XO^5,F_P":\7_'NA'[/?\`)>E_+_JW-UOC_/#X#]#_`,POIJ/J/NRE
MW!B*_;N?H-\=4]L]?Y7^[/;'2W8^'.O#;]ZVW7'#/+B,Q2,-,L3I+2U</IEC
M8K&\>,_+W,6X<MWIO+$JR,NF2-Q6.1#Q5QYCT/$?82#D=N.W0;E"(Y:AE-58
M4)'J*$$%3Y@CT92KJK+7OB?C=_/\ZPQB]?['_F#_``H[MVAC*9,3M_M+Y$?&
M/?.*[LCQ5-''3T%5N*GZSWA#LO<^X:>F0+-65*F2LE!FG+R.Y]B-]S]N[MGN
M9^7KVWG.?#AE5HZ^>7*D`G-$"`#"@`=$D=GS3;(D"7T,Z>;NVA@/(*O@2G'D
M999G/XG8DGI[Z6_E']B=>?%?^8]L7L?Y/CN3Y5?S+L!OF;N'N&MZZQ>Q^L-N
M;UW'UCFNNMO3;3ZTVW5R5]+M_!09DM4A\B9*U(D$<=+8AJWG.=K/O/+-U:;3
MX&T[6Z&.,.7=@K(6J[>N@4&:5-6;R]%RY*-LW>UNKSQ;J[B="U`M`S2L*D"A
M8-,]65%4BE(EH0;"_CY\5L/UU\&^HOA?V\V`[5V_M'XU[2^._9!CQ];C=M;_
M`,/C.OJ38.Z1'C9JR7(T&)W%11S`1FH,\4<MA)J&KV&]SWF2ZYAO=^LM4,SW
M;3ID%D)?6N>%0:?+HWLMLB@V>WVBX4/`L`B8'(9=.D@F@K48K05XT'#JK_JK
MX%?S9OA'MP]`_"'YJ_&G?_Q2P<\U+T[M_P";/4'8N\.W^A-FRU4\U%L'!;XZ
MLW=MJC[*V_MN&014#9F&FDB@"PH(88T3V*;KF#D_?7-_ONS746[E>]K9T$<K
M_P`;A\K7&%[C0EG=B3T3Q;;S!MI\#;[N&6S+D_JL495))(0+%(-1)J341>4<
M,2T7H[/R(_E[0?,OX5[)^-GRK[AW!N[NW9@V9OW"_*KKG`8OK'>>SOD?LCR5
M^#[IZZVSAY9\1M@8W,5,T<>*,LT;XN5Z=YO,14H1[=S(=EWRXW/:+-8["34A
M@9BZM"U*QLS5+<`:D$:AE66JDQNMG^NVV*SO+DO=)4K*0-0:C"M$$8RK%"4\
M-J$E#&^EE+SL'HG^>E09+96P.Q/G1\*LOU9MW<>W6W7W3MSXP[SI?DMO_96&
MS=#5Y?&3;9R6]I>C]K[HW;@Z.2AFR%/1U$5$U4\\,#2QH297&X<@LDUU;;#>
MB]8-2)I1].I((%&!\8Z20<FA(I0`T".*UYGU"VEOXA:@#]4$&8D&N4,'AZ2.
MW2"&`_T0MW=&*W/\(=UY[^:GUE_,)BW_`+>I]F;#^'&[/C'5=:R83(ON?(9W
M<79=1ON+==/N!:X8J+$P4DPIVIFIS-Y%+!R&LI9%O\<?*-QRUX#>(]Z)]>*4
MT*M/6O:?(UJ,BF5C;4YW\;OK&CP$CI7(T&8\*4-?%.=0III0UJ)/RI^%&ZOD
M)\R_Y=?R>PN_=O[:P'PHWEWQN?=6TLGA,CD,QOR#M[K:@V-C:7`92EKJ>BPL
MN$JJ-IYS40S":-PJZ2.?;1O\>V[%S+M#0,SWZP@,"*+X3,QJ/GJ\J\*4S4>O
M]J:[W;:-Q#C3;+(*5I_:&,UX&O\`9TI5>-:FE.BC;H_E]_/[H+Y9_*SY2_R^
M_DW\;Z:@^9FY=F[S[:Z9^6G3.\]Q87`;LV1M"EV9B,OLGL'JC>6`W$*9,=%*
MXHJNA,=Y2)'E(613J#F3ES<=GV?:.9=LNO\`$5=4DMY$#,'(-"L@T@8%35B?
M(J,=()MJWBUO[[<-IN(&:=571)5%`5G<DL%D9VU2/IIX:@$`JY%>A6^'W\N3
MM[9WR:S?ST^>'R+H/E'\OZO8E7U7UO!LG9)ZVZ#^-_6.3K?OL[M;I[9=1D<O
MF:O+[HJ$!R.=R=0:^HA9H2MFDDE0[US-93[5%R_L&V?2[0'UN6.J69_)G;R`
MH.P$BH!%``H66&U7*7;;AN-R)+K\('!13@310VFK!"L<=%=M0=RTA"K,_P`M
M[YE?%;O'N/N#^5=\E>G.L^O/D;O?*]J=P?$/Y2]:[DWST30]OYU/]_'V;U'N
M+KK-X#?77%7NJ4"7(XB`2XZ>H`<DQ1TU/3+(^9]CW>QL;+F[;9Y)[9!&EQ`X
M$IC'PHROV&G\1KC@JLSNZ.39]TL+BZN=CNH],IJ8Y>U-7"I94=F`%`@`1E`"
MM(\:11Q#]N;XD_,_OSX!?+/XW_*WY'=1[U[W^2^R.R-E[?W1UIU-D]C=,].8
M/=^RJ/:^$VWAMOUF?S&^=X4>-RL=7DJS(Y'("LJ7K?#''%'`FLLBWG9=NY@V
MC<MGVZ6.RM75B';5)(0Y;4V=*G2572I`.G5C50+A8[A/87L-_<AYI:44$!4H
M!VJXC4D%@6U,A85IF@ZE=\=F5O\`*N_E&9C>>=P^/[FS?PY^(NQ=F2XNB%?M
M[`]@[HV=L_;'6=!--ZLED\'M?+[@>*>J(:6>EQYD.HNNKWNTA7FWG)@C&".]
MO)).()12S2D5-`6"@@5Q6GEU6.([)R_969(=H888`:$@DZ(@2!0D`D$TTU%<
MKQ%2WQ=^!7\U7^7]\.]M]G_#OYK_`!YW1M;^YF<^0F>^#':G3$S?&K"'=U'4
M]H9K8727>U'NZM[GP6,ACR,U)15V6KY:2MGT5=28%>1E&N\\P\H\R;]+9[SL
M5RDWBB$722?K'3^F&>(*L8)-&:BN5%553@=!C;-MW[:-GBO;/<XWA\$RF,@D
M'4H:K/([F30H`54>U#FIDESK%RWQ[[W'\T#^6+@^Y=F8.+K7(_+;XV;\Q%'@
M=P5LV5QVR]X;DP.Z>O<K25>3H:.&JR^W\-NVGG\=5'31RU5"BRB)'?0`)?V(
MY3YK^EF<RI9W4;5``+("L@Q4@,5(J-1`.*^?0L5GWK9+E"H26:*6(BIH&&N)
MJ$J#IU`T)6M,TZ+9LK^6IW%MK^1I/_*]K=]=:3=U3?%/>W1`W[2R[I;JY-T;
MGDS\E'DS42X"+=C8&F&6C663^&BH.AF6#Z+[7R<RVC<[Q\S!)/I%G1Z:0'(1
M54G1XA6I(J%\7Y:_/IJ/;[I=E>S9(_K&9WTZSHU-*TNGQ/"U::FFKPJTSIZ/
MIM3XQI4?!+;/PS[(SBSI+\2\+\9=^;DV;)44J3!NGJ7JS=&;VM)D84JH8Y?W
MYZ(U$8<`IY$OJ7V2S[Q_R))M_M8_^)QN$5J?[],BAJ5'H#3IZ#:@NP0[),^!
M9B!BI/\`OL1D@]I^8-`?LZHSB_E<_P`V?>_PQA_E4]C?(GX:;/\`A;M;K>;J
MND[^ZOV/V;4?)KM'K?;<,TG7>P]R[!S\E/UCL..NJ:2AI]SY/'UM;5SXZ%XZ
M6\\LM0X]/-?)D&\CFRVVZ_DWUY-;12-&($9A1V5E[V(!)2H"ZJ]J#2%(5VKF
M9X#MTES:+8JQ9642%]2OXB$DD!E+<4H"@"ZY;BCB0RW<G\L+Y8]U?"[^7ECQ
MW=TYU-_,0_EU5VT-T]6]C;5V]NC=?QTS^=VEMT;`GVSN7![AIJ3>,VV]X;%Q
MF._B%9'3"6'(1SF&D-/*L2%=GS9LUGO_`#)(;&>;EO<]0D1BJS+K)8LM&TU5
MF?2I;@02^H5*D['>G:-J@#QC<;1`J48T*HRF,&3PS0UBA9V\$JQ5U$05AI"#
MY+_`?^<)_,)PG3%)\J>V/@ITY@>@ODAT=W9@.I>@,?W9N#!]GUVP-WQUFZMU
M=@=@;]H9LY@ZO!;6^Y&U<!C,>U-/7U[OE,@%A@*KMKYCY(Y:DOCLMIN$SW-K
M)$TD_A50-0JJ(A4$,0-;DU72"JL"5*.[VCF;=H[?]Y36@:*4,HB,D8.I&C>M
M1*:J&;3DK(K%2L+!9.K(=G?"WL3;O\V+N3Y]5>Z]ES]7=C?#'KWXW8C9M,<X
M=_46[]I=F5&]:_.9)9<:FW5VW/CI!%"8JN2J:=K-$BKJ<*S;[;R<GV?+HC?Z
MJ.^:8F@TZ2C+0'54FI&-``I74:T!\FW3C?GW-M'T_@,@[CJ+.8:@KHH`!"*-
MXA)U$:12IA?-;X2=C_)?Y<_RSOD'L[=NR,#M7X4=T=I]D]BX3<QSPW!NK#[[
MZ_HMIXRBV5_"\978Y\E1UU*SSK734D7B<,CLRF-K;%OUMM>R\T;;-&YEOHHU
M0@`@%"Y.HEE*CN!!`?@105U#6Y;;<7>X[3=Q:/#AU!ZL00"\,@*@(P8UA"T+
M(`&K4TH:F.UNK?DA_,P_FD?(7N+X<]K;%^(VXOY:.(G^',O8_:6RO]F'?OG=
MN]L7C.R=S;:J^C]U5T>P.L.N,-)E9:0[CQXDW+EUFN&"11QTHPL-PVOE?E*S
MV_>;*2\CW)_J-".8A$%``;Q$H\C4T-H+!001VC,@?O;&^WG?);FRN$@-L@6I
M56+]\B?C5PIJLJ_`RA6#TD9J0B52?/;^;C-VYN#^6)4])?"ZF^?N-PNS^Q,-
MW^NX>Q)_B'F_BEF\/OC%;E[AFZX"1]FXOL3:^]]OXG#1[8:::DKZG,/.IAH:
M-C.G/+G)_P!$G-@O;[^K19D,=$^H%P"I6,-\!4@LY-1I50/%9V(6W[YWT7/[
MA,%O^^"-0X^'X0'=5JX&519A&6,A8FS5%&K_T]8W?%.#V!V.?O<>O_&2^QN"
MV1N/]_OGOKIQA'^\^\_K(M]':]A_LU]/0=8.;R(SN,U7([4\O^%KZ'SXC^=#
MCI-?;#_E>QW^WR?_`-:_:K4W\!_E_GZ*],7^_3^S_9Z]]L/^5['?[?)__6OW
M[4W\!_E_GZ]IB_WZ?V?[/7OMA_RO8[_;Y/\`^M?OVIOX#_+_`#]>TQ?[]/[/
M]GJ_7_A,U"$_FT;`(J:27_C`???IA-9K_P"`&T_Q/0TZ6_Y"]Q7[PDGDR:JT
M_7B_X]U+?M`$&_R!6)P/*@_LYOG7^7D:D8K])KWB7UDYU[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T$O??^AG
M_0CVU_LQ?]SO]`O^CO=_^F/_`$@_:_W(_P!&W\"K?[X_WI^]_P`F_@G\"\WG
MU<Z+Z?5;VMVWZ_\`>%E^Z]?[Q\5?"T?%KJ--/G7_`&<=);WZ7Z2Y^MI])H.N
MM?AIGAFOI3-:4S3K533HS^3P_P`;?[ZT7S+_`)TD7\MG^$M6)U!0;4_F9GX7
M?Z.?O&=L73Y9/BO)N/\`T-Z[H3'N7^%Z>?/^?<O?O+G07GTYV#8_ZRZZ>+JM
M/K/$KQI]375_S;TZ/+1T`6V_8?JS,^^;G]#IJ8V63Z+3YJQ:W\#7JXZG\?Q.
M+>)UM+?&?_0'_LOG3/\`LK']R?\`9<?]'&U/]"G^CGP?W)_T<_PFF_NS_=[P
M?\H?\.T:O)_E'EU>;][7[B/=?WA^\K[][:_WEXK>)J^+77-:8^RF*4IBG0_L
MOI_I8/I*_3Z<5U5^>K5WZJUU:^_575W5Z'#V@Z4]>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=:[WR#Z4^#O;GS_`.[O]E@^8GS)^*GSWQFTMDI\L9?@KL#M
M??\`LC<.+DQ:OL)_D5C\?T5VOT1%V1#@-*XUJFMQ^X12_KCD'(DO;+[?[3EV
MR7=-ELKOE]F;Z<W3Q(RFO>(2\J/I)^*BMBF0M.@A?0;7)N4DMO?7$=^#1TB6
M5@:@D,_@@2:!W`4D$'BEZJ9ZD%3Q7Q^_E?C?.^NL\?\`.O\`F;G^96W>/5&3
MW;\C)NN_E9_L]Z;E3J[N>+KS`8W9E9\8A`?B[+UN^Z)*U<=ML[(^W2D&1KP?
MX6K&S;ES5H@N3R]M?]6_`<"$/!])IU1ZF9A/I\37ITZF_M->A/$U]%8M-ATL
A/WI>?7^*&J5F\?5I(\-08_'KHR^D_4^!X>N7Z?0.O__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
